OUR EXPERTS

Floyd Abrams is a member of the Executive Committee and Cahill Gordon & Reindel LLP's litigation practice group. Mr. Abrams has a national trial and appellate practice and extensive experience in high-visibility matters, often involving First Amendment, securities litigation, intellectual property, public policy and regulatory issues. He has argued frequently in the Supreme Court in cases raising issues as diverse as the scope of the First Amendment, the interpretation of ERISA, the nature of broadcast regulation, the impact of copyright law and the continuing viability of the Miranda rule.

Howard Abrams specializes in copyright and related areas in entertainment and computer law. Professor Abrams has authored a multi-volume treatise on the law of copyright, co-authored a casebook on copyright, and has authored and co-authored a number of significant scholarly articles. He served as the American Reporter on author's rights for the XIIIth International Congress on Comparative Law (Montreal 1990) and as the General Reporter for the XIVth International Congress of Comparative Law (Athens-Delphi 1994).

Claudia H. Allen serves as co-chair of the Corporate Governance practice at Katten Muchin Rosenman LLP. She counsels boards, management and investors in public and private companies on corporate governance matters and related issues, such as shareholder activism and engagement, shareholder proposals, defensive measures including shareholder rights plans, takeover preparedness, board/committee process and structure and fiduciary duties. Her practice also encompasses transactional matters, including private and public mergers and acquisitions, and securities matters, including compliance with the Dodd-Frank and Sarbanes-Oxley Acts.

Rand L. Allen is a partner in the Washington D.C. office of Wiley Rein LLP where he represents clients, ranging from IT and professional services firms to the nation's largest aerospace and defense contractors. Mr. Allen represents clients in every aspect of government contracting, including bid protests, disputes, commercial litigation, terminations, mergers and acquisitions, “procurement fraud”/False Claims Act investigations, suspension/debarment, and regulatory issues.

Thomas Y. Allman is an attorney residing in Cincinnati, Ohio and an Adjunct Professor of Law at the University of Cincinnati College of Law. Prior to retirement, Mr. Allman served as General Counsel and Chief Compliance Officer of BASF Corporation.

David Angeli of the Angeli Ungar Law Group LLC in Portland represents individuals and corporations in the most serious of criminal, regulatory, and civil matters.

Cristina Arguedas is a criminal defense attorney who has represented high-profile clients in some of the most visible cases around the country, as well as many little-known clients on relatively routine matters that never make the nightly news. Ms. Arguedas is equally adept at handling complex white-collar cases, high-profile murders, and the full range of less serious criminal cases. She works closely with other ACH lawyers as well as a team of investigators, jury consultants and other top experts she has assembled over more than two decades.

Joel S. Ario, a Managing Director Manatt Health Solutions and member of the advisory board of Bloomberg BNA's Health Insurance Report, has 30 years of experience helping to shape and implement public policy, including two decades devoted to leading health insurance reform efforts at the state and federal government levels. He provides strategic consulting and policy analysis to assist state governments, health plans, hospitals, foundations, and other stakeholders in preparing for the broad implications of healthcare reform, with a particular emphasis on planning for and implementing the exchange-based marketplaces.

Bob Armitage is a consultant on IP strategy and policy. Mr. Armitage served for a decade as Senior Vice President and General Counsel for Eli Lilly & Co. Prior to assuming his general counsel role at Lilly, he had been Lilly’s Vice President and General Patent Counsel and a Partner with Vinson & Elkins, LLP.

Erika Arner chairs Finnegan's patent office practice. She focuses on patent office trials, patent prosecution management, client counseling, and litigation, with an emphasis on electronic technology, computer software, and the Internet. Ms. Arner helps clients of all sizes to establish and grow patent portfolios, align intellectual property strategy with business objectives, and adapt to the evolving legal landscape, including the America Invents Act.

Kevin Arquit focuses on antitrust litigation, transactional and counseling issues. Prior to joining private practice, he was General Counsel of the FTC, and then Director of its Bureau of Competition. Mr. Arquit represents a wide variety of companies in high-profile antitrust litigation as well as before the FTC, the Antitrust Division of the Department of Justice, and numerous state and foreign competition authorities.

Leslie Auerbach has been a Partner in the law firm of Auerbach Law Firm since 1975. During that time, he has been actively practicing law in Florida, Maryland and the District of Columbia. He served as a Chapter 7 Trustee for four years, lectured with the Continuing Legal Education Institute, served as a court-appointed bankruptcy examiner, and has testified as a bankruptcy law expert.

Alan W. Avery is a Partner in the New York office of Latham & Watkins. Mr. Avery is a member of the Corporate Department and the Financial Institutions Group. He concentrates his practice in federal and state regulation of banking organizations, advising domestic and foreign banking institutions concerning the impact of U.S. federal and state banking laws on their global operations.

David F. Axelrod is a highly experienced trial lawyer who practices in the areas of Business Litigation, White Collar Defense, Corporate Investigations and Compliance, and Tax Controversies. Before joining Shumaker, Mr. Axelrod was a founding Partner of Axelrod, Todd & Laliberte LLP.

Matthew D. Babcock is Assistant Medicaid Inspector General – Compliance, of the New York State Office of Medicaid Inspector General and a member of the advisory board of Bloomberg BNA's Health Care Program Compliance Guide. Mr. Babcock oversees and manages the agency’s Bureau of Compliance, drafting compliance guidance, assessment forms, and metrics to test Medicaid provider compliance programs and conducting effectiveness reviews of those compliance programs.

Robert J. Bach is an employee benefits and ERISA attorney based in New York. He has practiced for more than 25 years, and has been counsel to large and small single and multi-employer plans providing pension, medical, disability and other benefits. Mr. Bach counsels plan trustees and their committees and has supervised other attorneys involving the establishment, administration and termination of plans. He is also a past Chair of the American Bar Association’s Joint Committee on Employee Benefits and Co-Chair of the Employee Benefits Committee of the Labor Section of the American Bar Association.

Donald I. Baker, a former head of the U.S. Department of Justice's Antitrust Division, established an independent D.C. firm specializing in antitrust, competition policy and international law issues. His firm works closely with corporate law departments and law firms in handling litigations, appeals, arbitrations, transactions and government civil and criminal investigations.

Robert L. Ballow is a founding Partner in the law firm of King & Ballow. Mr. Ballow is a member of the Nashville Bar Association, the Labor Law Section of the American Bar Association, the Tennessee Bar Association, and the American Bar Association’s Committee on Antitrust and Labor Relations. Mr. Ballow has been a guest lecturer for the American Press Institute and Vanderbilt University. Mr. Ballow is a founding member of the Tennessee Supreme Court Historical Society.

Vinod Bange is a Partner in Taylor Wessing LLP's IT, Telecoms and Competition group. Mr. Bange has specialized in data protection and information law matters for over 10 years. With a wide range of data protection experience across various data rich sectors such as financial services, life sciences and healthcare, he has advised right at the heart of specific data matters and also from a strategic perspective.

Raymond Banoun is a Partner in the Washington, D.C., office of Cadwalader, Wickersham & Taft LLP. Mr. Banoun is one of the leading business fraud litigators in the nation. He represents corporations and financial institutions, their audit committees, law firms, and executives in all aspects of criminal and civil enforcement matters; defends federal and state investigations, and in litigation, both pre- and post-indictment, including in whistleblower, False Claims Act and RICO actions in all courts.

Barry P. Barbash is a Co-Head of the Willkie Farr & Gallagher LLP's Asset Management Group and has been a practitioner in the asset management area for over 30 years. He combines deep private practice experience with extensive knowledge of the regulation of the asset management business, having served from September 1993 until October 1998, as the Director of the Securities and Exchange Commission’s (SEC) Division of Investment Management.

Rosina B. Barker is a Partner in Ivins, Phillips & Barker’s Executive Compensation and Benefits practice in Washington. She advises corporations on tax and ERISA issues raised by their employee compensation plans. Ms. Barker devotes significant time to cash balance and other qualified plans with complex or novel designs. She has extensive experience in the taxation of executive compensation, and has drafted, interpreted and negotiated stock-based plans, nonqualified deferred compensation plans, change-in-control agreements, employment agreements and severance plans.

Aaron Barkoff is a Shareholder at McAndrews, Held & Malloy, Ltd., where he specializes in pharmaceutical and biotechnology patent litigation, and a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. He has over 15 years of experience in all aspects of ANDA litigation, representing both innovator and generic drug companies.

Mark Barnes is a Partner with Ropes & Gray LLP in Boston and a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report. He focuses his practice in the area of research, advising clients throughout higher education and the health care industry, including pharmaceutical companies, medical device manufacturers, hospitals, and universities. Mr. Barnes has extensive experience in legal issues related to research with humans and animals, stem cell and genetic research, research grants and contracts, research misconduct, and international research. Mr. Barnes also frequently advises clients on clinical trials compliance, Medicare reimbursement, False Claims Act issues, and medical privacy.

Lynne Barr is a Partner in Goodwin Procter LLP's Financial Institutions Group and chair of its Banking and Consumer Financial Services Practices. Her practice focuses on banking and consumer financial services law. She advises banks, bank holding companies, brokerage concerns, mortgage companies, trade associations and other entities on general corporate matters, including the offering and operation of their products and services, particularly in the context of federal and state regulation of financial institutions and their activities.

Jane Barrett joined the University of Maryland School of Law faculty to supervise the Environmental Law Clinic. Professor Barrett was most recently in private practice at Blank Rome, LLP in Washington, D.C. While at Blank Rome, and before that while at Dyer Ellis and Joseph, PC, she chaired the White Collar, Internal and Government Investigations Group.

Keith A. Barritt is a Principal in the Washington, D.C., office of Fish & Richardson and a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. His practice is primarily focused on all aspects of trademark law, including prosecution and inter partes proceedings before the U.S. Patent and Trademark Office (PTO), Internet domain name issues, and trademark selection and enforcement, as well as all aspects of medical device regulation by the U.S. Food and Drug Administration (FDA), including obtaining marketing authorization for medical devices, use of new devices for investigational purposes, and import and export issues. His prior experience includes three years as a legislative aide to Congressman John Murtha in Washington, D.C.

Jerome Barron joined the faculty of The George Washington University Law School in 1965. He served as Dean of the Law School from 1979-88. He has argued and participated in First Amendment and other constitutional cases in the U.S. Supreme Court, and served as a consultant to the Senate Committee on Presidential Campaign Activities (Watergate). He has served as Chair of the ABA Committee on Graduate Legal Education and as Chair of the AALS Section of Mass Communication Law.

Jane Bartley is a Partner in the Kansas City office of Shook, Hardy & Bacon L.L.P. where her practice has focused primarily on defending major pharmaceutical and medical device manufacturers in products liability litigation, and a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. Ms. Bartley has defended complex cases in both federal and state courts throughout the country. In her role as regional and national counsel, Ms. Bartley has managed all aspects of pre-trial preparation and provided on-site trial support. She has particular expertise on the issue of the preemption of claims against manufacturers of prescription medical devices.

Steve Baughman is an intellectual property partner in the Washington, D.C. office of Ropes & Gray LLP, where he returned after spending three years in Japan to open the firm’s office in Tokyo. For 20 years, Mr. Baughman has worked with leading international companies to resolve their IP and technology-focused commercial disputes in a broad array of litigation, licensing and counseling settings. These include patent and trade secret disputes—as well as trademark, copyright and other complex commercial matters—presented in trial and appellate courts, domestic and international arbitration tribunals, and the International Trade Commission.

Linda Baumann is a Partner and the leader of the Arent Fox Health Care group in Washington, D.C. and a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. She concentrates her practice on matters involving False Claims Act Investigations, fraud and abuse compliance, and Medicare/Medicaid reimbursement. In particular, she counsels clients nationwide on matters related to the Stark Law, Anti-Kickback Statute and the False Claims Act.

Michel Baumeister, a trial attorney with Baumeister & Samuels, P.C. in New York, has concentrated his practice in the field of aviation accident and complex tort litigation. Mr. Baumeister, who has more 40 years of aviation experience as a pilot, has dedicated his career to helping air crash victims and their families receive proper and adequate compensation, as well as to making improvements in aviation safety. He has served as a leading member of the Plaintiffs' Steering and Executive Committees in every major airline disaster in which the firm has represented victims and their families.

Kathleen M. Beasley is a litigation Partner in the Dallas office of Haynes and Boone, LLP. For more than 20 years, Ms. Beasley has represented corporations, individuals, boards of directors and board committees in business disputes and government investigations. She has tried lawsuits in federal and state court, and before arbitrators. With extensive experience in conducting internal corporate investigations, Ms. Beasley has also assisted clients being investigated by the U.S. Department of Justice, the Securities and Exchange Commission (SEC), and other governmental authorities. Her practice is concentrated in the areas of antitrust, fraud, and complex business disputes.

Nathan A. Beaver is a partner and food and drug lawyer with Foley & Lardner LLP, and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. His practice focuses on the representation of manufacturers whose products and activities are regulated by the Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), and the Federal Trade Commission (FTC). He advises clients on regulatory issues affecting prescription and over-the-counter drug products (including animal drugs), medical devices, dietary supplements, cosmetics, and foods with special emphasis on the strategic considerations involving the approval process and patent and exclusivity issues related to the Hatch-Waxman Act. Mr. Beaver is a member of the firm’s Government & Public Policy and FDA Practices, and the Food & Beverage Industry and Life Sciences Industry Teams.

Judge Bechtle is Chief Judge Emeritus of the U.S. District Court for the Eastern District of Pennsylvania. He was appointed to the Bench on March 7, 1972. In 1994, then Chief Justice William H. Rehnquist appointed him to a seven-year term as one of the seven members of the Judicial Panel on Multidistrict Litigation.

Brandon Becker is Executive Vice President and Chief Legal Officer at TIAA-CREF. Mr. Becker leads the company's legal and compliance, government relations and internal audit functions. Previously, Mr. Becker was a Partner in the securities department at the law firm WilmerHale. He was also Chair of the firm's Broker-Dealer Compliance and Regulation Practice Group. He specialized on a range of regulatory, financial and corporate matters on behalf of companies, banks, broker-dealers, trade associations and other organizations.

John Beisner is the leader of Skadden Arps' Mass Torts, Insurance and Consumer Litigation Group. He focuses on the defense of purported class actions, mass tort matters and other complex civil litigation in both federal and state courts. He also regularly handles appellate litigations and has appeared in matters before the U.S. Supreme Court. Over the past 25 years, he has defended major U.S. and international corporations in more than 600 purported class actions filed in federal courts and in 40 state courts at both the trial and appellate levels.

Michael D. Bell is the founder and President of R-Squared, a consulting and software group that helps companies develop more efficient and effective ways to assure compliance with the web of regulations and laws affecting their organization, and a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. Mr. Bell frequently consults, publishes and presents on topics of healthcare corporate compliance, privacy and third party coverage and reimbursement issues. With more than 15 years of direct involvement in compliance and regulatory matters, he serves on manufacturer, health system and health plan compliance committees.

Hugh Bell, Jr. is a Partner in the Atlanta office of Smith, Currie & Hancock LLP. Mr. Bell has published papers and book chapters concerning contracting issues and has spoken at many seminars and programs. He has served in various positions for the Section of Public Contract Law of the American Bar Association, including Chairman of its Committee on Dispute Resolution, and of its Construction Division for three years.

Elisabeth Belmont has served as Corporate Counsel for MaineHealth, a family of healthcare services located in southern, central and western Maine, since 1998 and serves a member of the advisory board of Bloomberg BNA’s Health Law Reporter. As Corporate Counsel, Ms. Belmont is involved in a myriad of complex issues hospitals face on a daily basis ranging from hospital-physician relationships to corporate organization and governance and regulatory matters.

Katherine Benesch is a Principal at Benesch & Associates, LLC and a member of the advisory board of Bloomberg BNA's Health Law Reporter. She practices primarily in the areas of healthcare law, litigation and alternative dispute resolution (ADR). As a litigator, Ms. Benesch represents clients in trial and appellate cases and administrative hearings involving physician, hospital and managed care liability; contract, credentialing, commercial, employment and reimbursement disputes; state licensure issues; and research misconduct. As an arbitrator, she handles many types of cases, including disputes over clinical research trials.

Linda Bentley chairs Mintz Levin’s FDA Practice Group and serves as a member of the advisory boards of Bloomberg BNA's Medical Devices Law & Industry Report and Pharmaceutical Law & Industry Report. She has extensive experience representing pharmaceutical, biotechnology, medical device manufacturers, and insurers on corporate and regulatory matters. Ms. Bentley advises health products manufacturers on the regulatory and reimbursement status of products and procedures and on strategic pathways for bringing new products to market.

Steven N. Berger has focused his career on resolution of complex business disputes through effective representation of clients in bankruptcy or other reorganization proceedings, loan workouts, litigation and business transactions.

Robert Bernius, a Nixon Peabody LLP Partner since 1981, has tried jury cases and argued appeals in state and federal courts throughout the country. Mr. Bernius also serves as General Counsel to the firm. He is a fellow of the American College of Trial Lawyers and a member of the District of Columbia Board on Professional Responsibility.

William Bernstein is a Partner, Chairman of Manatt’s Healthcare Division, and a member of the firm’s Executive Committee, and serves as a member of the advisory board of Bloomberg BNA's Health IT Law & Industry Report. His practice concentrates on providing strategic, business and legal advice to clients in the healthcare industry, including provider organizations, managed care companies, emerging companies and financial institutions.

Alden Bianchi is the Practice Group Leader of Mintz Levin’s Employee Benefits & Executive Compensation Practice in Boston. He advises corporate, not-for-profit, governmental and individual clients on a broad range of executive compensation and employee benefits issues.  Practice issues include qualified and nonqualified retirement plans, stock and stock-based compensation arrangements, ERISA fiduciary and prohibited transaction issues, benefit-related aspects of mergers and acquisitions and health and welfare plans.

C. Stephen Bigler, a Director of Richards, Layton & Finger, PA, counsels corporations, officers, directors, board committees, stockholders and investors on matters involving the General Corporation Law of the State of Delaware and related issues of fiduciary duty arising in a wide variety of transactional and operational contexts.

Ted Bilich is the Chief Executive Officer of Risk Alternatives LLC. Mr. Bilich has an extensive background in counseling clients about business risks and resolving disputes. Before founding Risk Alternatives, Mr. Bilich was a Distinguished Visiting Professor from Practice at Georgetown University Law Center. Prior to full-time teaching, Ted served for more than 20 years in the Washington, D.C., office of Jones Day.

Mary Nell Billings is Director of Global Retirement Programs for Hilton Worldwide in Memphis, TN. where she specializes in the Americas.  Ms. Billings has more than 25 years’ experience in human resources and finance from both a plan sponsor and a third-party administrator perspective, including qualified and nonqualified retirement and health and welfare benefits, training and communications.

Bert Black, a Senior Attorney with Schaefer Halleen, has been practicing law for over 30 years. His current cases are mostly in the areas of condominium development, employment, and consumer protection litigation. Trained as an engineer, many of his cases have involved complex scientific, technical, statistical, and financial issues. He has represented both plaintiffs and defendants in matters involving environmental pollution, pharmaceutical products liability, construction defects, real estate transactions, securities fraud, and bankruptcy.

Timothy P. Blanchard an attorney at Blanchard Manning LLP and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. His practice comprises health care regulatory issues, including Medicare and Medicaid coverage, billing and payment; fraud and abuse audits and investigations, and health care compliance programs; clinical trials billing and compliance; electronic health records and HIPAA privacy; certification, licensing, and enrollment; and medical necessity and utilization review. He is a member of the original faculty group for the University of California, San Diego, School of Medicine’s PHYSICIAN ASSESSMENT & CLINICAL EDUCATION (PACE) PROGRAM, MEDICAL RECORDKEEPING COURSE, presenting “The Law and the Medical Record,” 1999-present.

Michael D. Blechman, who concentrates in the fields of litigation, antitrust and international law, has been a Partner in Kaye Scholer LLP since 1975 and was a member of its Executive Committee from 1996 to 2003.

Michael Bleier is a member of Reed Smith's Financial Industry, Financial Services Regulatory, and Hedge Fund Groups. Mr. Bleier joined Reed Smith after serving for nearly 14 years as General Counsel for Mellon Financial Corporation and Mellon Bank, NA, and as manager of legal affairs. At Reed Smith, Mr. Bleier has counseled clients, filed expansion applications with the Federal Reserve, the Comptroller of the Currency and the FDIC, and also advised financial institution clients on an array of regulatory matters.

Bob Bloch is a Partner with Mayer Brown where his litigation practice focuses on the defense of major national corporations, non-profit entities, and corporate officials in criminal and civil investigations before the Antitrust Division of the U.S. Department of Justice and the Federal Trade Commission for price fixing, bid rigging, boycotts, pricing and marketing policies, and mergers. He also defends companies in private class action litigation in federal and state courts. He is the firm's Global Antitrust practice leader.

John Blum is a John J. Waldron Research Professor at Loyola University Chicago School of Law and a member of the advisory board of Bloomberg BNA's Health Law Reporter. He has held positions on the faculties of Penn State and Boston University, and was a teaching fellow at the Harvard School of Public Health. He was also a visiting professor at Osgoode Hall and the University of British Columbia Faculties of Law under the auspices of the U.S.-Canada Fulbright program.

David Z. Bodenheimer is a Partner in the Washington, D.C., office of Crowell & Moring where he handles Government Contracts, False Claims Act, Privacy, and Cybersecurity matters. For more than 30 years, Mr. Bodenheimer has found solutions for clients whenever and wherever problems arise in doing business with the Government.

Joseph S.U. Bodoff is the founder of Bodoff & Associates. His practice focuses on bankruptcy, creditors’ rights and commercial litigation. He has handled matters including complex Chapter 11 reorganizations, corporate governance issues, construction litigation and unfair trade practice claims.

John T. Boese is a member of the Litigation Department in Fried Frank's Washington, D.C., office. He joined the firm in 1977 after five years in the U.S. Department of Justice, and he became a partner in 1980. He was a Managing pPartner of the Washington, D.C., office and co-chair of the Washington, D.C., Litigation Department from 2001-05.

Dan Boston is President of Health Policy Source, Inc. and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. Prior to joining the firm, he was Senior Public Policy Advisor with Baker, Donelson, Bearman, Caldwell & Berkowitz's Washington Public Policy Group, where he founded the firm’s federal health policy practice, recruiting and servicing a diverse base of clients.

Dan Boston is Executive Vice President & Partner for Health Policy Source, Inc. Prior to joining the firm, he was Senior Public Policy Advisor with Baker, Donelson, Bearman, Caldwell & Berkowitz's Washington Public Policy Group, where he founded the firm’s federal health policy practice, recruiting and servicing a diverse base of clients.

Andrew S. Boutros is an Assistant U.S. Attorney in Chicago in the Office’s Financial Crimes Section. As a federal prosecutor, Mr. Boutros has conducted some of the Office’s largest and most complex, multi-district, international fraud investigations and prosecutions of business organizations and corporate executives.

Hildy Bowbeer has served as a Federal Magistrate Judge in the U.S. District Court for the District of Minnesota since June 2014. Judge Bowbeer previously served as Assistant Chief Intellectual Property Counsel and as Senior Counsel in the Office of General Counsel at the 3M Company.

Kevin Brady, Of Counsel at Redgrave LLP, has extensive experience representing clients in complex corporate, commercial, and products liability litigation in both federal and state courts. Mr. Brady also focuses his practice on providing advice and counsel on electronic discovery, electronic information management, data privacy, and data security issues.

John T. Brennan, Jr. is a Partner at Crowell & Moring LLP and Co-Chair of the firm's Health Care Group, and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. His practice primarily focuses on health care fraud and abuse matters. He defends clients in federal litigation, investigations and enforcement actions, especially relating to the federal False Claims Act and the anti-kickback and physician self-referral (Stark Law) statutes. He deals frequently with the U.S. Department of Justice and the Department of Health & Human Services, Office of the Inspector General.

John Briggs is Co-Chair of Axinn’s Antitrust Group and Managing Partner of the firm’s Washington, D.C., office. His practice is focused on antitrust (mainly mergers, acquisitions, joint ventures and private treble damage actions) and other complex civil litigation (mainly parent/shareholder liability, business torts and contracts).

Courtenay Brinckerhoff is a Partner and intellectual property lawyer with Foley & Lardner LLP. Ms. Brinckerhoff’s practice focuses on client counseling in all aspects of obtaining, licensing and enforcing patents and conducting freedom-to-operate and due diligence investigations.

Bernadette M. Broccolo is a Partner in the law firm of McDermott Will & Emery LLP based in the firm’s Chicago office and serves as a member of the advisory board of Bloomberg BNA's Health IT Law & Industry Report. Ms. Broccolo has been counseling health industry organizations for over 34 years on leading edge health industry relationship formation and realignments, with a recent focus on development of provider network strategies to respond to health reform; health information technology acquisitions; electronic health information network, "big data” strategy development and implementation to support innovations in care delivery and payment models; comprehensive programs for human subject, animal and bench research; and, conflict of interest compliance and overall corporate compliance programs. Her specialties include federal taxation of exempt organizations and not-for-profit corporate governance, privacy, human subject protection and technology contracting.

Michael F. Brockmeyer is a Partner in the Washington, D.C., office of Frommer Lawrence & Haug LLP. His practice concentrates on antitrust and consumer protection law. He spends substantial time on antitrust litigation, governmental investigations, and counseling a wide array of clients on mergers and acquisitions, joint ventures, distribution, consumer electronics, health care, insurance, and advertising.

Terry Brooks is a Senior Partner in the Washington, D.C., office of Polsinelli and a member of the advisory board of Bloomberg BNA's Medicare Report. With more than 35 years of experience in health and hospital law, Ms. Brooks now represents clients across the full spectrum of health care, including health care systems and institutions, physicians, specialty providers, pharmaceutical companies, managed care entities, health-related companies, financial institutions, units of government and trade associations, and public equity firms.

Lowell Brown is a Partner in the Los Angeles office of Arent Fox, is the national leader of the Health Care Practice Group, and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. Mr. Brown advises hospitals, medical staffs, health systems, long-term care facilities, medical groups, and other health care provider organizations in business, regulatory, and medico-legal matters, with an emphasis on laws relating to operational issues, including the design and implementation of compliance programs, practitioner credentialing, peer review, disciplinary hearings, Medicare certification, licensing and accreditation issues, and related policies and procedures.

Vickie Brown is a Member of Frost Brown Todd LLC and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. She concentrates her practice in health care, health insurance law, government affairs, informatics and mediation. In addition, Ms. Brown serves as Special Assistant to Dr. James Ramsey, President of the University of Louisville, advising in the areas of health, life sciences and research. She is also certified as a mediator.

Joan M. Brown is Associate General Counsel at CenturyLink Inc. in Denver. She has been with CenturyLink since 2003 as in-house ERISA counsel where she advises on compliance and with regard to transactions.  She has more than 25 years of experience with ERISA, employee benefits and HIPAA law.

Robert Brownlie is international Co-Chair of DLA Piper's Securities Litigation Practice and Managing Partner of the firm's San Diego office. He concentrates in the representation of corporations and their officers and directors in complex business, securities and corporate litigation, particularly class action and derivative litigation, and related Securities and Exchange Commission and criminal investigations and enforcement actions.

Arthur H. Bryant, Chairman of Public Justice, has won major victories and established new precedents in several areas of the law, including constitutional law, toxic torts, civil rights, consumer protection, and mass torts. Mr. Bryant first came to Public Justice in 1984 as its sole staff attorney, and was appointed Executive Director in 1987. Under his leadership, Public Justice grew from a staff of two, including him, to a staff of 30, and the organization has been involved in a broad range of cutting-edge, high-impact litigation.

Cathy L. Burgess is a Washington, D.C., Partner in Alston & Bird's Health Care Group and a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. Her practice focuses on regulatory compliance, product risk management, enforcement and policy matters affecting industries regulated by the Food and Drug Administration (FDA). Ms. Burgess advises clients on a range of matters affecting prescription and OTC drugs, biologics, medical devices, foods and cosmetics, and has extensive experience regarding current good manufacturing practice (CGMP) regulation.

James Burns is a Shareholder in the Washington, D.C. office of Baker Donelson PC, where he practices antitrust law and co-chairs the firm's healthcare antitrust initiative, and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. He has represented health-care providers and health-care insurers in numerous antitrust matters, including mergers, for over 25 years, and is a frequent contributor to publications on such issues

Patrick G. Burns is a founding shareholder at Greer, Burns & Crain in Chicago where he focuses on patent prosecution and opinions. Mr. Burns has handled litigation involving a variety of intellectual property disputes in the Federal Circuit, Federal District Courts, and the International Trade Commission.

Scott Burwell is an experienced intellectual property litigator with Finnegan, Henderson, Farabow, Garrett & Dunner, LLP and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. He focuses his practice primarily on Hatch-Waxman (ANDA) litigations, as well as other pharmaceutical and biotechnology-related disputes. He has broad experience in all facets of litigation, including bench and jury trials in federal district courts and appellate practice before the U.S. Court of Appeals for the Federal Circuit.

Under Elizabeth Cabraser's leadership, Lieff Cabraser has become one of the country's largest law firms serving clients seeking to redress for financial and consumer fraud, anti-competitive practices, harmful drugs and products, and illegal employment practices.

Rico Calleja is a legal know-how and marketing consultant to a number of U.K. firms and provides legal training to law firms including Reynolds Porter Chamberlain LLP, Speechly Bircham LLP and Michael Simkins LLP. Mr. Calleja also provides know-how and training services to a number of in-house legal departments, including Amazon, talkbackTHAMES and BSkyB. He specialises in IP, IT, media and communications.

Paul Calli is a Shareholder in the Miami office of Carlton Fields Jorden Burt, LLP who handles complex commercial litigation and white collar matters. Mr. Calli regularly represents law firms, lawyers, judges, physicians, professional athletes, sports agents, recording artists, and recording industry executives in sensitive civil and regulatory matters. He has tried over 125 cases to verdict in federal and state courts throughout the U.S. during the past 20 years, and has won a series of acquittals in high-profile trials since 2008.

Kerrie Campbell is a Partner in the Litigation Department of Chadbourne & Parke LLP and she is resident in its Washington, D.C. office. Over 27 years, Ms. Campbell has built a practice focused on all aspects of consumer product safety, risk management, regulatory compliance and related litigation, and on reputation protection, defamation, libel, product disparagement and First Amendment issues and litigation.

Neil Campbell is Co-Chair of the Competition and International Trade Law Groups and partner in the Energy Law Group in the Toronto office of McMillan LLP. His competition law experience includes over 250 merger clearances under the Competition Act and/or the Investment Canada Act; more than 25 domestic or international cartel cases and related class actions; multiple abuse of dominance and other unilateral conduct investigations and proceedings; and advising on marketing, distribution, grey marketing, joint venture and compliance issues.

Mary Devlin Capizzi is a Partner in the Government Relations & Regulatory Affairs Practice Group of Drinker Biddle & Reath LLP and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. Ms. Capizzi counsels a broad range of domestic and international clients on corporate compliance, with an emphasis on regulatory, legislative and policy issues affecting the life sciences industry. She has served as a Managing Partner of the firm and was the firm's first chair of its Professional Development Committee.

Garry Carneal, Founder of Schooner Strategies, is a leading expert in health care and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. Schooner Strategies is a consulting firm and incubator that identifies and implements business development solutions, leverages technology applications, engages in research and education initiatives, and manages health-related organizations. Today, Mr. Carneal serves as President and CEO of RadSite, LLC as well as continuing to supervise Schooner initiatives.

Elizabeth Carpenter is a Director at Avalere Health in Washington, D.C., where she helps clients anticipate the impact of regulations and legislation on business strategy, and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. Specifically, Ms. Carpenter focuses on issues related to the coverage expansions included as part of the Affordable Care Act, including health insurance exchanges, insurance market reforms and the Medicaid expansion. In particular, she has experience helping insurance carriers, private exchanges, technology vendors and states navigate the short- and long-term market shifts created by the law.

Fred Cate, the Distinguished Professor and C. Ben Dutton Professor of Law at Indiana University's Maurer School of Law, specializes in information privacy and security law issues. He has testified before numerous congressional committees and speaks frequently before professional, industry, and government groups.

David M. Certner is Legislative Counsel and Legislative Policy Director for Government Affairs at AARP Inc. in Washington.  He has been with AARP since 1982 and serves as counsel for the association’s legislative, regulatory, and policy efforts at the federal and state level, as well as for litigation opportunities before the courts. Prior to assuming his current role in 2007, Mr. Certner served as Director of AARP’s 25 person federal affairs group, where he headed up all federal legislative and regulatory activity.

Scott Chambers is a Principal of Porzio, Bromberg & Newman, P.C. and a member of the firm's Intellectual Property Department. Dr. Chambers advisers clients on complex intellectual property matters, focusing on utilizing the courts and government agencies, such as the U.S. Patent and Trademark Office (USPTO), to protect or defend clients’ rights. Dr. Chambers helps clients avoid and resolve problems associated with protecting intellectual property, including litigation at the appellate and district court levels, and before the International Trade Commission.

Robert P. Charrow is a Shareholder at Greenberg Traurig, LLP and serves as a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report. He focuses his practice on research, biotechnology and health care issues. Mr. Charrow represents health care providers, scientists, pharmaceutical companies, universities, research institutes and other entities with respect to legislative, regulatory and litigation matters arising under the Federal Food, Drug, and Cosmetic Act; research issues under the Public Health Service Act; licensing issues under the Federal Technology Transfer Act, the Bayh-Dole Act and related legislation; and reimbursement and regulatory issues under Medicare and Medicaid, the False Claims Act and other federal laws.

Sumi Chong is Senior Vice President, General Counsel and Chief Compliance Officer with the Federal Reserve System Office of Employee Benefits. Ms. Chong was previously a Senior Benefits Counsel with the the Campbell Soup Company, Corporate Counsel for Bristol-Myers Squibb and a Senior Consultant with Price Waterhouse Coopers.

Peter Church is a Solicitor in the London office of Linklaters LLP where he works in a number of areas where technology interfaces with the law, including data privacy, telecom regulation and technology contracts. Mr. Church graduated from the University of Cambridge and earned a PgDL from The Nottingham Trent University.

Alan L. Chvotkin is the Executive Vice President and Counsel of the Professional Services Council (PSC), the principal national trade association of the government professional and technical services industry, where he is responsible for the association’s legislative and regulatory policy activity. Prior to joining PSC, he was a Vice President of AT&T Government Services where he was responsible for managing key AT&T programs and opportunities.

Michael V. Ciresi is a name Partner and former Chairman of the Executive Board of Robins, Kaplan, Miller & Ciresi L.L.P. During his 43 years with the firm, he has driven the firm’s litigation practice. Mr. Ciresi’s trial practice and consulting is focused in the areas of product liability, intellectual property, business and commercial litigation. He has represented individuals, corporations, and governmental entities throughout his career and he has obtained nearly $12 billion in verdicts, awards and settlements on behalf of clients.

David Coar served as U.S. District Judge for the Northern District of Illinois for 16 years and as a U.S. Bankruptcy Judge for eight years. From 1979-82, he served as the first U.S. Bankruptcy Trustee in the Northern District of Illinois. As Associate Professor of Law at DePaul University College of Law, Judge Coar taught courses on ethics, corporations, corporate finance, constitutional law, labor law, and professional responsibility. As a practicing lawyer, Judge Coar represented private plaintiffs in the case that determined how Title VII impacted the merger of previously segregated lines of progression in the steel industry.

Jerry Cohen is a Partner with Burns & Levinson LLP in Boston who has more than 40 years experience as a lawyer dealing with patent, copyright, trademark, unfair competition, licensing/franchising, visual arts, software, databases and publication law, formation and operation of business enterprises and not-for-profit organizations, international trade, litigation/ADR, and legal ethics. Mr. Cohen handles acquisition, licensing and litigation of intellectual property rights. He has also served as an expert witness, arbitrator and mediator in intellectual property matters.

Peter Coll is a Senior Member of Orrick, Herrington & Sutcliffe LLP's Litigation Group in New York. He served as a member of the firm's Executive Committee from 2000-12. Mr. Coll has tried major, complex cases in New York state and federal courts and throughout the U.S., including Washington, the Virgin Islands, California and Arizona. During his 40 plus year litigation and trial career, he has argued appeals before the U.S. Supreme Court, the highest-level appellate courts of New York and New Jersey, and seven federal circuit courts of appeal.

Robert E. Colletti is a partner in Frommer Lawrence & Haug’s New York office and a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. He has extensive experience in all aspects of patent counseling and litigation. For over 15 years, Mr. Colletti has counseled pharmaceutical companies with regard to Hatch-Waxman patent infringement actions and also on related FDA and antitrust issues that arise during litigation.

Ann L. Combs is a Vanguard Principal and leads the firm's governmental relations activities as well as the strategic retirement consulting group. She is responsible for representing the interests of Vanguard and its shareholders in Washington, D.C., and has oversight responsibilities for Vanguard’s retirement policy, research, and plan consulting activities.

Gerald Connell retired from Baker & Hostetler LLP, where he was a partner, in 2001. He previously spent two decades at the Department of Justice's Antitrust Division, where he served as Trial Attorney, Assistant Section Chief and Section Chief. He was the Justice Department's lead counsel and chief trial lawyer in the AT&T antitrust litigation, which resulted in the breakup of the Bell System.

Dennis J. Connolly is a Partner in the Atlanta and New York offices of Alston & Bird LLP where his primary area of practice is in the representation of debtors and creditors' committees in large Chapter 11 bankruptcy cases. Mr. Connolly has been involved in cases across the country in a number of different industries, including manufacturing, transportation, finance, defense contracting and space and technology. He has appeared in courts in Delaware, North and South Carolina, Florida, Georgia, Alabama, Texas, California, Ohio, Louisiana, West Virginia and New York.

Mary Consalvi is a Partner in the Litigation Department of Proskauer Rose LLP, and a member of the Patent Law and Intellectual Property Groups, in the New York office, and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. Ms. Consalvi has more than 20 years of patent law experience in the biotech industry. She has represented start-up, emerging and mature public companies in a wide variety of intellectual property disputes and transactions. She has litigated patents on diagnostic assays and devices, amplification technologies, antibodies, genetic probes, viruses and drugs. In addition to U.S. trial experience, she has directed strategy and briefed counsel in multinational patent litigation, including before the U.K. House of Lords.

Alan Cooper is Of Counsel with Wiley Rein LLP in Washington, D.C., where he specializes in trademark and unfair competition law and related litigation. Mr. Cooper has represented trademark owners for more than 25 years, acting as lead counsel in numerous trademark infringement, trademark dilution, trade dress infringement, and false advertising actions in federal courts throughout the U.S., and in inter partes registration proceedings before the Trademark Trial and Appeal Board. These cases have involved many commercially important marks such as Lexus, Brinks, Toyota, AutoZone, Toshiba, Nike, Goodyear, and Godiva.

Greta Cowart is a Shareholder at the Dallas office of Winstead P.C. where she is a member of the Executive Compensation & Benefits practice. Ms. Cowart focuses her practice on employee benefits, health and welfare plans, tax-sheltered annuities, retirement and health law. She specializes in complex employee benefit plan issues and in resolving issues through voluntary compliance programs.

Tom Crane, a Member of Mintz Levin in the firm's Boston and Washington, D.C., offices, is nationally recognized for his experience with fraud and abuse, and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. Mr. Crane advises national and local clients on structuring complex strategic affiliation arrangements and transactions to comply with the applicable fraud and abuse laws as well as the variety of other regulatory requirements to meet today’s health reform challenges.

Stephen Crimmins, a Partner in the Washington, D.C., and New York offices of K&L Gates, defends clients in investigations, litigation, ADR and settlement negotiations involving the Securities and Exchange Commission (SEC) and other financial services regulators. Mr. Crimmins also litigates private securities and other commercial cases, leads internal investigations, and counsels on financial regulatory matters. In addition to client representation, he chairs securities bar groups and has testified twice before Congress on SEC-related issues. He writes, speaks on professional panels, and is widely quoted on securities law topics.

Malcolm Crompton is Managing Director of Information Integrity Solutions Pty Ltd (IIS), a global consultancy specializing in data protection and privacy strategies. Mr. Crompton is a Director of the International Association of Privacy Professionals Australia New Zealand (iappANZ), an affiliate of the International Association of Privacy Professionals (IAPP). He was founding President of iappANZ in 2008, a Director of IAPP from 2007-11 and is an IAPP Certified Information Privacy Professional. Mr. Crompton's global reputation and expertise in privacy was recognised when IAPP honoured Malcolm with the 2012 Privacy Leadership Award.

Conor Crowley is an internationally recognized expert in e-discovery. Mr. Crowley leverages almost 15 years of e-discovery experience as an attorney and a testifying expert to provide cost effective, practical advice to corporate and law firm clients in the areas of e-discovery readiness and responsiveness, defensibility, preservation, early case assessment, records and information management and international e-discovery. He has served as both an expert witness and a court-appointed special master on matters related to civil discovery.

James D. Crowne is the Director of Legal Affairs at the American Intellectual Property Law Association and was formerly the Managing Editor of Bloomberg BNA's Patent, Trademark & Copyright Journal.

Dawn R. Crumel is special counsel for Sheppard Mullin Richter & Hampton LLP in its Washington, D.C. office and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. Her practice focuses on faculty practice plans, academic affiliations, acquisitions, alliances, clinical research, health information contracting, managed care contracting and medical staff issues for teaching hospitals, academic medical centers, children's hospitals, community hospitals, and other health systems. For most of her career, she served as in-house counsel for hospitals, including as vice president and general counsel of Meritus Health and senior associate counsel for Children's National Medical Center. She started her career clerking for the New Jersey Supreme Court and as an associate at Buchanan Ingersoll.

Catherine Crump is a Staff Attorney with the ACLU's Speech, Privacy and Technology Project where her principal focus is representing individuals challenging the lawfulness of government surveillance programs.

Barry J. Cutler, who is Of Counsel in the Washington, D.C., office of Baker Hostetler, has focused his practice on providing clients with advice on compliance with consumer law requirements and defending companies that have been challenged by the Federal Trade Commission (FTC), a state attorney general, or a private party.

James Czaban is a Partner in Wiley Rein LLP's Washington, D.C., office, and serves as a member of the advisory boards of Bloomberg BNA's Health IT Law & Industry Report and Pharmaceutical Law & Industry Report. He has extensive experience in government regulation of pharmaceutical, biotechnology, food, medical device, and health care related companies and his practice focuses on counseling such clients on complex regulatory strategies and compliance matters, and representing clients in administrative and judicial enforcement actions and other proceedings involving the Food & Drug Administration (FDA), Federal Trade Commission (FTC), Drug Enforcement Administration (DEA), Department of Justice (DOJ), and other federal and state agencies.

Ron Daignault is a Shareholder in Polsinelli's New York office and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. He is an intellectual property litigator and trial attorney who has represented clients in patent, trademark, false advertising, trade secret and copyright cases across a broad spectrum of industries and technologies. He has developed particular expertise in pharmaceutical Hatch-Waxman litigation for generic and branded companies.

Susan Daley is a Partner in the Chicago office of Perkins Coie where she is a member of the Employee Benefits & Executive Compensation practice.  Ms. Daley has over 25 years of experience in the areas of executive compensation, securities and employee benefits. She is currently President of the Chicago Chapter of the National Association of Stock Plan Professionals.

Lucy A. Dalglish became Dean of the Philip Merrill College of Journalism at the University of Maryland on August 1, 2012. She served as executive director of the Reporters Committee for Freedom of the Press from 2000-12. Prior to assuming the Reporters Committee position, Ms. Dalglish was a media lawyer for almost five years in the trial department of the Minneapolis law firm of Dorsey & Whitney. From 1980-93, Ms. Dalglish was a reporter and editor at the St. Paul Pioneer Press. As a reporter, she covered beats ranging from general assignment and suburbs to education and courts. During her last three years at the Pioneer Press, she served as night city editor, assistant news editor and national/ foreign editor.

Thomas J. Daly, a Partner with Christie, Parker & Hale LLP, has over 25 years of experience in intellectual property law. Mr. Daly, who began his intellectual property law career as a litigator, utilizes this background in preparing patent applications that prevent or defend against subsequent disputes. He procures, licenses and enforces patent portfolios in the fields of medical devices, chemical processing, and pharmaceuticals, among others. He has represented clients in a large number of medical device, spinal implant and joint replacement implant intellectual property cases. He assisted a venture in early licensing of outer surface texturing of soft tissue implants that grew into a $47 million business.

Joel Davidow specializes in antitrust, patent and international litigation, as well as antitrust counseling with Cuneo Gilbert & LaDuca, LLP. Mr. Davidow has litigated unfair competition and antitrust issues at the U.S. International Trade Commission, Federal Trade Commission (FTC) and Federal Communications Commission, as well as before state utility commissions. He has advised enforcement officials of more than 50 countries on how to draft and administer their competition laws.

Chris Davis directs the Investor Program at Ceres, which promotes and supports sustainable investment policies, practices and strategies for institutional investors. He is Chief of Staff of the 100+ member Investor Network on Climate Risk (INCR). Mr. Davis works primarily with North American asset owners and and asset managers on climate change and other environmental, social and related governance issues that present material investment risks and opportunities.

G. Eric Davis serves as Senior Vice President, General Counsel and Secretary at BioMarin and serves as a member of the advisory board of Bloomberg BNA's Life Sciences & Industry Report. Mr. Davis previously worked in the San Francisco office of Paul Hastings Janofsky & Walker LLP, where he served on the firm's national securities practice committee. Mr. Davis has represented public and private companies and venture capital and investment banking firms in a wide range of corporate and securities matters, mergers and acquisitions, strategic alliance matters, and intellectual property-related business transactions. His experience involves a variety of industries, including biotechnology and life sciences.

Randy G. DeFrehn is Executive Director of the National Coordinating Committee for Multiemployer Plans in Washington. He has more than 35 years of experience working with multiemployer plans as the administrator of national pension and health benefit plans, an employee benefits consultant and a registered investment adviser.  Since 2000, he has been an advocate and spokesman on matters of public policy affecting plans, participants and their sponsoring organizations.

Jay R. Deshmukh is a Partner in Knobbe Martens Olson & Bear LLP's Washington, D.C., office and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. Mr. Deshmukh has more than 10 years of industry experience in the pharmaceutical area having worked as head lawyer for a top-10 generics company. He is highly experienced in the area of pharmaceutical litigation, as well as the Abbreviated New Drug Application (ANDA) process and the complexities of litigation involving pharmaceuticals under the Hatch-Waxman Act. He also has experience in obtaining and licensing pharmaceutical-related intellectual property.

Scott P. DeVries is a litigation Partner in Winston & Strawn LLP’s San Francisco office and chairs the Insurance Recovery Practice. In this capacity, he routinely represents firm clients throughout the country facing insurance recovery issues. He also focuses his practice on class and mass torts, product liability, and complex civil litigation at both the trial and appellate levels.

Q. Todd Dickinson is a Partner at Novak Druce Connolly Bove & Quigg LLP, and chairs the firm's Client Select Strategic Services Group. He was the Executive Director of the American Intellectual Property Law Association from 2008-14, and has more than 25 years of experience in all aspects of intellectual property law and public policy, including patents, trademarks, copyrights, and trade secrets. Mr. Dickinson previously served as Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO) during the Clinton Administration. At the USPTO, Mr. Dickinson was principal policy advisor to the President on all intellectual property matters. Moreover, he was responsible for all international intellectual property policy issues on behalf of the U.S. government.

Catherine T. Dixon, a member of Weil, Gotshal & Manges LLP's Public Company Advisory Group, is a recognized authority in the federal securities laws. Her practice encompasses a wide range of SEC disclosure and compliance matters, including those affecting corporate governance, as well as capital markets transactions (including public and private offerings) and mergers & acquisitions (domestic and cross-border).

W. Gordon Dobie is a partner in the Chicago office of Winston & Strawn LLP. He serves as lead partner in trial court and appellate cases throughout the United States with a focus on business torts and fraud, including contract, antitrust, unfair competition, RICO, and securities litigation matters.

William Dombi is the Vice President for Law at the National Association for Home Care and the Director of the Center for Health Care Law, and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. Mr. Dombi is also the Executive Director of the Home Care and Hospice Financial Hospice Managers Association. Mr. Dombi has over 30 years of experience in health care law and policy and has been involved in virtually all legislative and regulatory efforts affecting home care and hospice since 1975, including the expansion of the Medicare home health benefit in 1980, the formation of the hospice benefit in 1983, the institution on Medicare PPS for home health in 2000, and the massive health care reform legslation in 2010.

Dan Doonan is a Senior Pension Specialist at the National Education Association in Washington. Prior to joining NEA, Mr. Doonan was a labor economist for the American Federation of State, County and Municipal Employees. He was also the Assistant Director of Research for the National Association of Letter Carriers and served as a consultant actuary for Buck Consultants.

John D. Doran is a Shareholder in the Providence and Boston offices of Littler Mendelson P.C. and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. His practice focuses exclusively on representing management in labor and employment matters, including Department of Labor investigations, proceedings before the National Labor Relations Board, labor arbitrations and collective bargaining.

Patrick Doyle has a broad background in financial institution regulation and headed Arnold & Porter LLP's financial services practice group from 1993 to 2013. Mr. Doyle regularly counsels bank holding companies, foreign banks, savings institutions, insurance companies, securities firms, hedge funds, and private equity entities on a wide variety of regulatory matters, including strategic planning, complex regulatory issues, enforcement proceedings (particularly those involving allegations of violations of the "control" regulations), and legislation. In addition, he has represented firm clients on numerous mergers and acquisitions.

Alison L. Doyle, who joined McKenna Long & Aldridge LLP in 1984, is a member of the firm's Government Contracts Department. Ms.Doyle counsels clients on issues relating to contract formation, performance and disputes. Although well-grounded in the traditional government contracts practice areas of the firm, her practice today focuses in particular on issues relating to acquisition of commercial goods and services, particularly information technology hardware and software.

Ted Doyle is Vice President, Healthcare Markets for Performant Financial Corporation and serves as a member of the advisory boards of Bloomberg BNA's Health Care Fraud Report and Health Care Program Compliance Guide. Mr. Doyle has three decades of experience as a senior leader in health care administration and payment integrity for both the private and public health care sectors. He has worked to detect, investigate and prevent health care fraud, waste and abuse for U.S. and international health care payers.

Suzie Draper is Vice President of Business Ethics and Compliance at Intermountain Health Care in Salt Lake City and serves as a member of the advisory board of Bloomberg BNA's Health Care Program Compliance Guide. Ms. Draper has been with Intermountain for 23 years, and co-founded Intermountain’s Compliance Program in 1997. Ms. Draper is a member of the Presbyterian Health Care Services Compliance and Audit Committee in Albuquerque and chairs the Salt Lake Community Health Care Center Board of Directors.

Rochelle Cooper Dreyfuss is the Pauline Newman Professor of Law at New York University School of Law and the Co-Director of the Engelberg Center on Innovation Law and Policy. She is a member of the American Law Institute and served as a Reporter for its Project on Intellectual Property: Principles Governing Jurisdiction, Choice of Law, and Judgments in Transnational Disputes. She also sits on the National Academy of Science's Committee on Science, Technology and Law. Professor Dreyfuss was a consultant to the Federal Courts Study Committee, to the Presidential Commission on Catastrophic Nuclear Accidents, and to the Federal Trade Commission.

Donald Dunner, a Partner in the Washington, D.C., office of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, has worked in all phases of patent law, including prosecution, licensing, litigation, validity and infringement studies, and counseling. He has extensive technical experience in chemical engineering, chemistry, biotechnology, and pharmaceuticals.

Joseph G. Eaton is a Partner in the Indianapolis office of Barnes & Thornburg LLP. He is vice chairperson and co-administrator in the Litigation Department and chair of the firm’s Toxic Tort Practice Group. Mr. Eaton has represented chemical, petroleum and industrial manufacturers in complex litigation throughout the U.S. Mr. Eaton concentrates his practice in litigating matters involving chemical product liability actions, including plaintiffs’ personal injury and property damage litigation relating to alleged toxic products.

Henry C. Eickelberg is General Dynamics Corporation’s Vice President for Human Resources & Shared Services in Falls Church, VA. He is responsible for the design and administration of General Dynamics’ defined benefit pension plans, 401(k) plans, and health and welfare programs. He also oversees its General Dynamics’ Shared Services organization that performs the company’s payroll, travel expense reimbursements, accounting, and payroll tax compliance. In addition, Mr. Eickelberg has oversight of the company’s occupational health and work-safety programs. In the area of mergers and acquisitions, he has been directly responsible for negotiating benefits and administrative aspects of over 50 major acquisitions and divestitures that General Dynamics has conducted during his tenure.

Robert Eisenberg is a Director of Empire Discovery where he provides legally defensible eDiscovery consulting and legal technology services to clients. Mr. Eisenberg has over 30 years' experience in the practice of law and the rendering of consultative and technical services relating to the discovery of Electronically Stored Information (ESI), Computer Forensics, Records and Information Management (RIM) and traditional paper-based litigation support services. Mr. Eisenberg frequently conducts seminars, CLE courses, webinars and other presentations on the subjects of eDiscovery and Electronic Records Management.

Peggy Eisenhauer is the founder of Privacy & Information Management Services, and leader of the PIMS global privacy and information management practice. Ms. Eisenhauer's practice focuses on privacy, security and fair information practices. She works with companies in all industries to develop and implement policies and procedures governing the collection, use and distribution of consumer, customer and employee records. She also works with aggregators of public and non-public data.

Lannie Elderkin joined Computer Sciences Corporation (CSC) in 1991 following CSC’s acquisition of Analytics, where she was Vice President and General Counsel. Since joining CSC, she has held progressively responsible roles in CSC’s legal department. Today, she leads a combined legal and contracts team of 200 professionals serving the legal, compliance and contracting needs of CSC’s North American Public Sector (NPS).

Whitney C. Ellerman is head of Katten’s Washington, D.C., Litigation and Dispute Resolution practice and co-head of the office’s White Collar Defense, Internal Investigations and Compliance practice. Mr. Ellerman represents Fortune 500 companies, high-ranking public officials and corporate executives throughout the nation in complex criminal cases involving the Foreign Corrupt Practices Act, federal environmental statutes including the Clean Water Act and Clean Air Act, fraud and corruption, antitrust and other criminal statutes. He also assists clients in designing, customizing and implementing comprehensive compliance programs.

Charles Elson is the Edgar S. Woolard, Jr. Chair in Corporate Governance and Professor of Finance at the University of Delaware's Alfred Lerner College of Business & Economics. Professor Elson is a leading authority on corporate governance issues and his fields of expertise include executive compensation, corporate compliance, securities regulation, corporate legal matters and Delaware issues.

Fredric Entin is a Partner in the Chicago office of Polsinelli LLP and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. As the former general counsel of the American Hospital Association, Mr. Entin applies his in-house experience to meet the needs of his existing clients, which include hospitals, academic medical centers, physicians and medical groups, and health care trade associations. Mr. Entin offers domestic and international health care clients extensive knowledge of health care corporate, regulatory, and general counsel services.

Larry Espel founded Greene Espel PLLP with Cliff Greene in 1993. Mr. Espel's practice includes federal and state litigation in Minnesota and throughout the country. It has involved class actions and multi-district lawsuits, arbitration, and administrative proceedings to resolve commercial, environmental, construction, products liability, and telecommunications disputes.

Amor A. Esteban is a Partner of Shook, Hardy & Bacon LLP. where he has developed an expertise on e-discovery, records and information management and data privacy is widely known. Mr. Esteban represents national and international businesses in all aspects of e-data and information law and related litigation and government investigations.

Roger A. Fairfax, Jr. teaches courses in criminal law, constitutional and adjudicatory criminal procedure, criminal litigation, and seminars on the grand jury, white-collar criminal investigations, and criminal justice policy. He conducts research on discretion in the criminal process, the grand jury, prosecutorial ethics, and criminal justice policy and reform. His scholarship has been published or is forthcoming in his edited book, Grand Jury 2.0: Modern Perspectives on the Grand Jury, and in a number of leading journals including the Boston College Law Review, Cornell Law Review, U.C. Davis Law Review, Fordham Law Review, Iowa Law Review, Minnesota Law Review, and the Yale Law Journal.

Charles E. Falk has specialized for more than 25 years in the fields of corporate tax, international tax, tax litigation, real estate tax planning, bankruptcy taxation, gift and estate tax, and deferred compensation planning.

David Farer joined Greenbaum Rowe Smith & Davis LLP in January 2012 as Chair of the firm's newly established Environmental Department. A nationally-renowned environmental lawyer, Mr. Farer previously chaired the Environmental & Brownfields practice group at Farer Fersko, where he established that firm's environmental practice in 1984.

Jay N. Fastow is a Partner in Ballard Spahr’s Antitrust and Consumer Finance Groups. He has tried antitrust and financial services cases, as well as a recent international arbitration in the pharmaceutical industry, and has argued appeals in numerous federal and state courts. Mr. Fastow is a former adjunct lecturer in consumer finance law at Rutgers University School of Law.

Richard Faulk, a Partner in Hollingsworth LLP in Washington, D.C., concentrates his practice in complex toxic tort and environmental litigation, including class actions and other mass tort cases involving multiple plaintiffs and defendants. Mr. Faulk has defended claims for a variety of injuries and illnesses allegedly caused by exposures to asbestos, various solvents, coal tar pitch, gasoline additives, lead paint and pigments, and other toxic substances.

Karin Feldman is a Benefits and Social Policy Insurance Specialist at the AFL-CIO in Washington.  She joined the AFL-CIO in September 2006 as the policy specialist for health care and retirement security. She works on a range of issues affecting pension and health care benefits whether provided through employer-sponsored plans or federal programs including Social Security and Medicare. Since the passage of the Affordable Care Act, she has been responsible for coordinating the response of the AFL-CIO and its affiliates to the proposed rules implementing the Act issued by the Departments of Labor, Health and Human Services and Treasury.

James E. Felman has concentrated his practice of law with Kynes, Markman & Felman, P.A. in the defense of complex criminal matters and related civil litigation for over 25 years. Mr. Felman represents clients in federal and state matters in every phase of the criminal process -- investigation, trial, sentencing, appeal, and post-conviction proceedings. He has represented clients in a wide range of matters, including allegations of bank fraud, health care fraud, mail and wire fraud, securities fraud, public corruption, environmental crimes, antitrust violations, synthetic/illegal drugs, illegal gambling, child abuse/pornography, and murder.

Karen Ferguson is Director of the Pension Rights Center in Washington, a nonprofit consumer organization dedicated to protecting and promoting the pension interests of workers, retirees, and their families. Before starting the Pension Rights Center in 1976, Ferguson worked as an attorney for the law firm Bell, Boyd and Lloyd, the National Labor Relations Board, the Public Interest Research Group, and the United Mine Workers of America Health and Retirement Funds.

Ralph Ferrara concentrates his practice with Proskauer Rose LLP in Washington, D.C., on a range of litigation, business, regulatory and corporate governance matters. Mr. Ferrara represents corporations and individuals in complex securities class and shareholder derivative actions as well as contested mergers and acquisitions; advises corporate clients on Securities and Exchange Commission (SEC) reporting and disclosure requirements; represents corporations and individuals in government investigations and enforcement proceedings; conducts corporate internal investigations; handles consumer financial services issues; and counsels corporate officers and boards on all of these matters.

Barbara Fiacco, a Partner with Foley Hoag LLP in Boston, represents clients in complex intellectual property and patent litigation matters. Ms. Flacco's technology-related practice focuses on the biomedical field, including counsel to companies with activities focusing on recombinant DNA, monoclonal antibodies, small molecule compounds, drug delivery, molecular diagnostics, and medical devices.

Thomas G. Field Jr. fully retired in 2013, after helping launch Franklin Pierce Law Center in 1973. Before that, Professor Field examined patents (alkene polymers) in the U.S. Patent Office and taught and practiced briefly in Ohio. Professor Field’s curricular responsibilities included administrative process (emphasis on IP and technological regulation) and fundamentals of IP (for first year and other students lacking IP backgrounds). For a time, he was the school’s content webmaster. He also founded and, over a 10-year span, moderated a listserv for IP professors.

Jesse A. Finkelstein has extensive experience advising and representing corporations, directors and significant shareholders. He provides corporate governance, transactional, M&A and control dispute advice to clients, and represents both corporate and individual clients in complex or high-stakes litigation. A director in the Corporate Department, Mr. Finkelstein also represents special and standing board committees with regard to corporate investigations.

Robert Fishman, a member of Shaw Fishman Glantz & Towbin LLC in Chicago, focuses his practice on resolving his clients’ difficult financial issues. Whether representing a debtor or creditor, through an informal out-of-court workout or through the bankruptcy process, he partners with his clients to find the most efficient and beneficial solution for their situation.

Timothy B. Fleming is a Member of Wiggins, Childs, Quinn & Pantazis, where his practice is focused in civil rights and employment litigation.

Gary M. Ford is a Principal in the Washington office of Groom Law Group, where he practices before Congress, the federal agencies, the federal courts and arbitrators. He has represented both debtors and creditors in bankruptcy cases involving substantial benefit liabilities and assets.

Pamela Furman Forrest is a Partner in King & Spalding’s FDA & Life Sciences Practice Group and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. Ms. Forrest joined the firm in 2007, and has nearly 20 years of experience in advising clients on a broad range of U.S Food and Drug Administration (FDA) regulatory issues.

Eleanor Fox, the Walter J. Derenberg Professor of Trade Regulation at the New York University School of Law, is a prominent antitrust and comparative competition law scholar. Her recent work includes articles on antitrust, markets, developing countries, and global governance, and casebooks on U.S. antitrust law and European Union law.

Laurence Freedman is a Member of Mintz Levin in Washington, D.C. and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. He focuses his health care and life sciences litigation practice on defending clients against allegations and investigations of fraud and abuse involving governmental programs. In addition to enforcement defense, Mr. Freedman counsels clients through internal investigations, corporate compliance, investor due diligence reviews, and health care bankruptcies involving governmental liabilities. His clients include hospitals and health systems, dialysis providers, clinical laboratories, medical equipment companies, pharmaceutical and device manufacturers, and health care executives.

Jeremy D. Frey is a Partner in the White Collar Litigation and Investigations Practice Group of Pepper Hamilton LLP, resident in the Philadelphia and Princeton offices. Mr. Frey concentrates on corporate investigations, white collar criminal defense and complex civil litigation.

Bruce Merlin Fried is a Partner in Dentons' Health Care practice, managing partner of the firm's Washington, D.C., office, a former national chair of the firm's Health Care group and a leader of its global Health Care practice, and serves as a member of the advisory boards of Bloomberg BNA's Health IT Law & Industry Report, Health Insurance Report and Medicare Report. Mr. Fried counsels and represents health plans, physician organizations, hospital groups, consumer organizations, health care information technology companies, pharmaceutical and biotech companies and other health care organizations with regard to federal health care programs and policies.

Stewart Fried, a Principal Attorney with Olsson Frank Weeda Terman Matz PC, devotes his practice to litigation and dispute resolution matters, with an emphasis on the areas of agricultural, environmental, commercial, government contracts, and employment-related litigation. Mr. Fried is experienced in all aspects of pre-trial, trial, and appellate matters before the District of Columbia, Florida, and the Federal Courts, including class action litigation.

Michelle Fried Galvanek works for OptumRx in the Government Affairs and Policy Department and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. She has been a working in health care policy and government/regulatory affairs for more than two decades. Her specialties include health care reform implementation, Medicare Part D policy and regulations, liaison with senior officials at the U.S. Department of Health and Human Services, FDA (biosimilars and REMS).

Diane J. Fuchs is formerly of Womble Carlyle Sandridge & Rice PLLC, where, until her retirement, she headed the firm’s Employee Benefits Practice group in Washington. Ms. Fuchs has almost three decades of experience advising corporate clients on executive compensation and employee benefits matters. She has also served as President of the American College of Employee Benefits Counsel and as Chair of the ABA Tax Section’s Employee Benefits Committee.

Tony Fuller leads Baker Tilly's government contractor advisory services practice and has been with the firm since 2002. He has more than 20 years experience providing a broad range of accounting, pricing, contract compliance and dispute/litigation related consulting services to government contractors and their legal counsel.

T. Markus Funk is the founding Co-Chair of Perkins Coie's Supply Chain Compliance Practice. Mr. Funk has successfully tried 24 federal jury cases, argued and briefed dozens of federal appeals, directed hundreds of investigations, and on a daily basis advises public and private entities and individuals on challenging ethics and compliance matters. In private practice since 2010, Mr. Funk focuses on internal investigations, complex commercial litigation both at the trial and appellate levels, white collar criminal defense, corporate social responsibility and supply chain compliance, and corporate counseling.

Philip Furgang is a founding Partner of Furgang & Adwar, LLP, where he concentrates his practice in patent, trademark, copyright, franchising, entertainment, and unfair competition law. Mr. Furgang has lectured nationwide to bar associations and commercial groups on patent, trademark, copyright, and unfair competition law, intellectual property litigation tactics, licensing, and legal ethics.

Hal Fuson retired from the newspaper business in 2009 after negotiating the sale of The San Diego Union-Tribune, concluding 26 years as an employee of the Union-Tribune’s former owner, The Copley Press. Mr. Fuson was chief legal advisor of the family-held, San Diego-based company for more than two decades.

Michael M. Gaba is a Partner in the Washington, D.C., office of Holland & Knight where he is the federal policy leader of the firm’s national Healthcare & Life Sciences Team, and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. His regulatory and legislative life sciences practice includes counseling and representing medical device and biotech companies before the U.S. Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS) and the U.S. Congress.

Jane Galvin is the Managing Director, Regulatory Affairs, for the BlueCross and BlueShield Association in its Washington, D.C., Office of Policy and Representation and serves as a member of the advisory boards of Bloomberg BNA's Health Insurance Report and Medicare Report. Ms. Galvin works with Blue Plans on regulatory and other health care issues that impact Plan business and works directly with critical government agencies, such as the U.S. Departments of Labor, Health and Human Services, Treasury and also the Centers for Medicare and Medicaid Services (CMS) on the issues and concerns of Plans as they related to federal regulatory matters.

Jennifer S. Geetter is a partner in the law firm of McDermott Will & Emery LLP and is based in Firm’s Washington, D.C., office and serves as a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report. She routinely advises global life sciences and health care clients on legal issues attendant to biomedical innovation. Her clients include a broad range of pharmaceutical, device, health plan, institutional health care provider, and others. Her work on behalf of these clients focuses her practice on emerging biotechnology and safety issues, research design and compliance, research program structure and operational and compliance infrastructure, personalized medicine, formulary compliance, scientific review and research misconduct proceedings, and emerging issues in the future, unspecified use of biospecimens and data.

Daniel K. Gelb is a Partner at Gelb & Gelb LLP in Boston where he represents clients in federal and state court litigation, arbitration and regulatory proceedings. Mr. Gelb concentrates in the areas of business, securities, non-competition agreements, corporate raiding and trade secrets, accountants' liability and criminal law.

Laura Goldbard George is a Partner with Stroock in New York where she concentrates in trademark, copyright and unfair competition law, with particular expertise in consumer product-related matters. With her extensive litigation experience in the U.S. courts and abroad, as well as the U.S. Patent and Trademark Office’s Trademark Trial and Appeal Board, Ms. George routinely represents plaintiffs and defendants in the clothing, luggage, jewelry, health and beauty aid, food/beverages, snuff and other tobacco products, gasoline and lubricant products, publishing, textile, and family entertainment industries. She also provides similar counsel to financial institutions.

Gary G. Gerlach founded New West Newspapers, Inc., and serves as its President and Principal Owner. Mr. Gerlach has a professional background as a publisher, journalist, and lawyer with over 35 years of experience in the media. Mr. Gerlach served as President and Chief Executive Officer of Partnership Press, Inc., which he co-founded with two partners, and Publisher of the Ames Daily Tribune in Ames, Iowa.

Kenneth Germain, who is Of Counsel at Wood Herron & Evans LLP, has more than 35 years of varied experience in the trademark/unfair competition field and is a former full-time law professor. He focuses his practice on trademark counseling, consulting and litigation.

Charles (Chico) L. Gholz is a Partner in Oblon, McClelland, Maier & Neustadt, LLP's Litigation Practice Groups. Mr. Gholz represents a wide variety of domestic and foreign clients across a range of technologies including biotech, chemical, electronics, computers, and lasers. He regularly appears before the PTAB, the Federal Circuit, and various district courts. He also counsels on patent validity and patentability. He has appeared as an expert witness on patent issues; and he has acted as an arbitrator.

Karen A. Gibbs is Vice President at Applied Medical and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. He primarily overseeing litigation, intellectual property, competition-related and other legal matters. Ms. Gibbs has focused her career on strategic counseling, litigation and jury trials, domestic and international distribution, intellectual property, and certain compliance and personnel matters for a variety of biomedical and other technology-driven companies.

Mark Gidley chairs the White & Case Global Antitrust/Competition practice and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. His practice focuses on mergers, acquisitions, and cartel cases, frequently with a transnational focus. Mr. Gidley represents parties before the U.S. competition agencies — the Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice (DO) — as well as parties in criminal grand jury and civil investigations of pricing conduct, and other potential antitrust violations.

Anders Gilberg is Senior Vice President, Government Affairs for the Medical Group Management Association (MGMA) and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. Mr. Gilberg serves on MGMA’s executive leadership team and manages the Association’s office in Washington, D.C. With over 20 years of government and health policy experience, Mr. Gilberg is well known for his detailed understanding of federal health policy and its impact on physician group practices.

Dave Giles is Vice President, Deputy General Counsel and Chief Ethics Officer of The E.W. Scripps Company. Mr. Giles provides counseling and advice to the corporate office and the newspaper and broadcast divisions, including matters involving the First Amendment, the FCC, the FTC, litigation, intellectual property, contracts, mergers and acquisitions, and antitrust.

Ron Glancz is the Chair of Venable's Financial Services Group. Mr. Glancz represents financial institutions of virtually every type – banks, savings associations, bank and thrift holding companies, insurance companies, securities firms, and credit unions – and represents companies and investors seeking to become or acquire a bank. He also represents directors and officers of financial institutions. Mr. Glancz represented the U.S. Department of the Treasury in connection with the Capital Purchase Program.

Larry Goldberg is the Founder of Larry Goldberg Consulting and the Senior Adviser for Health Care Legislative and Regulatory Matters for Grant Thornton, LLP, and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. He brings nearly 40 years of health care experience and is a well-known expert in Medicare legislation and regulation. Mr. Goldberg’s primary role is to advise on health care issues at the federal level, and to monitor health care legislation and regulation for the firm’s rapidly growing Health Care Practice.

Mort Goldberg, Counsel at Cowan, Liebowitz & Latman, P.C., is known for his expertise in copyright, trademark and related intellectual property counseling, negotiation, litigation and legislation. He practices in both traditional intellectual property areas and the newer technologies of software, databases and the Internet.

Neil Goldberg, a Partner with Goldberg Segalla, has defended products liability, pharmaceutical, medical device, trucking, toxic tort, and other complex catastrophic cases across the U.S. for a number of New York Stock Exchange companies. He is past President of the Defense Research Institute (DRI), the largest organization of civil defense attorneys in the United States. He is the past president and board chairman of the Lawyers for Civil Justice. He is the past chair of DRI's Products Liability Committee as well as the past chair of the New York State Bar Association's Products Liability Committee.

Mr. Goldberg serves as Vice Chairman of the Board at Evercore Trust. Mr. Goldberg's previous affiliations include serving as the supervising attorney for the Office of the Solicitor of the Department of Labor, where he was responsible for overseeing most of the litigation initiated by the Department of Labor under ERISA between 1977 and 1985.

Sam Goldblatt, former chair of Nixon Peabody’s Litigation Department, represents manufacturing and service businesses in disputes in federal and state courts and before arbitration panels. Mr. Goldblatt represented manufacturers in a wide range of civil cases arising from alleged product defects and failures and have tried more than 25 cases to verdict in courts across the U.S. He also provides strategic counseling regarding dispute resolution and adaptation of project management discipline to legal cases and projects to maximize results while minimizing costs.

Cal Goldman is a partner in the Toronto office of Goodmans and co-head of the firm's Competition, Antitrust and Foreign Investment Group. His practice covers all aspects of Canadian competition law, with a particular emphasis on Canadian and international mergers, abuse of dominance, cartels, civil reviewable matters and counseling on trade practices. He also has extensive experience advising on a wide range of foreign investment matters under the Investment Canada Act.

Edward Goldman is an Associate Professor in the University of Michigan Department of Obstetrics and Gynecology where he works on issues of reproductive justice, and serves as a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report. He previously served as the Health Systems Attorney for the University of Michigan and was appointed Associate Vice President and Deputy General Counsel for the University. He is also an Adjunct Professor at the University of Michigan School of Public Health, where he teaches courses in health law and the legal and ethical aspects of research. Mr. Goldman is also President of the Michigan BioTrust for Health and Chair of the Michigan Certificate of Need Commission.

James Goodale is a leading First Amendment lawyer. He is the former General Counsel and Vice Chairman of The New York Times and has represented the Times in all four of its cases that have reached the U.S. Supreme Court. He has also been called “the father of the reporters’ privilege.”

Philip L. Gordon, who chairs Littler's Privacy and Data Protection Practice Group, has years of experience litigating privacy-based claims and counseling clients on all aspects of workplace privacy and information security. He has provided advice to businesses of all sizes on issues including surveillance of employees' electronic communications, workplace searches, location tracking and use of GPS-enabled devices, background checks, social media and other new technologies affecting the workplace, state data protection laws, how to respond to security breaches and cross-border transfers of human resources data.

John Gorman is the Chairman and Founder of Gorman Health Group, a leading professional services and solutions firm for government-sponsored health care, and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. Mr. Gorman's work focuses on government health programs strategy, cultural transformation within healthcare companies, governance, and turnaround of distressed health plans. He speaks at dozens of industry and investment community conferences each year, reaching thousands of senior health care executives with his predictions about the evolving government-sponsored managed care market.

Ilene Knable Gotts is a partner in the New York City law firm of Wachtell, Lipton, Rosen & Katz, where she focuses on antitrust matters, particularly relating to mergers and acquisitions. Ms. Gotts regularly recognized as one of the world's top antitrust lawyers.

David B. Graham heads the environmental practice of Kaufman & Canoles. Mr. Graham represents clients in litigation and regulatory matters throughout the country, currently in more than eight states. Prior to joining Kaufman & Canoles, Mr. Graham headed the environmental practices at Kaye Scholer and Howrey & Simon in Washington, D.C., and Baker & Hostetler in Cleveland.

Jeffrey J. Greenbaum, Chair of Sills Cummis & Gross P.C.’s Class Action Practice Group, is an active litigator and trial attorney in the federal and state courts with a specialty in complex business litigation and in defending class action litigation. Mr. Greenbaum has handled cases of national prominence, chaired the ABA Section of Litigation Class Actions and Derivative Suits Committee and is a frequent lecturer in the class action field. He has handled numerous matters involving securities, RICO and consumer fraud, class actions and derivative suits, professional liability, antitrust, banking, chancery practice, contracts, real estate, trade secrets and unfair competition.

Pamela Greenberg is the President and CEO of the Association for Behavioral Health and Wellness (ABHW) and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. She is Past-President of ACMHA: The College for Behavioral Health Leadership. She was the Chair of the Coalition for Fairness in Mental Illness Coverage, one of the leading Coalitions that helped develop and successfully advocate for the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008.

Nathan Greene is a Partner in the New York office of Shearman & Sterling LLP and Co-Practice Group Leader of the firm's Asset Management Group (which includes the firm’s Investment Funds Group), advising on regulatory aspects of fund and investment advisory operations. Mr. Greene's practice includes the formation and representation of U.S. and foreign investment companies, sponsors, advisers and directors, including Securities and Exchange Commission registration, exemptions, inspections and investigations; fund formation, distribution and marketing; fund board and governance matters; compliance manuals and testing; and corporate transactions involving asset management businesses.

Harry Greenspun, M.D., is a Director at the Deloitte Center for Health Solutions (DCHS), part of Deloitte LLP, and serves as a member of the advisory board of Bloomberg BNA's Health IT Law & Industry Report. He has held a diverse range of clinical and executive roles and is now responsible for helping Deloitte’s health care, life sciences and government clients address key health information technology (IT) and clinical transformation issues.

Hayden W. Gregory is the Legislative Consultant for the American Bar Association Section of Intellectual Property Law (ABA-IPL) where he keeps ABA-IPL apprised of emerging legislation, bills, and developments and advises on issues on which the Section may want to formulate policy. Mr. Gregory also assists the members to select matters to pursue in committees, where substantive work usually originates, and helps nurture the issues to Section Council, which takes action to adopt policy.

Virginia Greiman has published and lectured extensively on international law, economic development, project management and finance, and international business transactions. She is an internationally recognized expert on mega-project management and infrastructure development, privatization and project finance, corporate reorganizations, cyber-trafficking, and international commercial transactions.

Gerry Griffith is Partner in the Chicago office of Jones Day where he practices in the areas of health care transactions, tax-exempt organizations, and regulatory compliance, and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. Mr. Griffith also has served as borrower's counsel on several hospital and long-term care bond issues. Mr. Griffith's transactional practice focuses on significant transactions, with an emphasis on joint ventures and acquisitions. His tax-exempt organizations practice concentrates on defending major IRS audits, obtaining rulings in complex cases, and community benefit matters.

Linda L. Griggs is a Partner in Morgan Lewis's Securities Practice. Ms. Griggs's practice focuses on securities regulatory matters, including financial reporting and accounting and other disclosure requirements under the securities laws and public and private securities offerings. Ms. Griggs also handles corporate law matters, including advising with respect to the fiduciary duties of directors and corporate governance matters.

Karen Gross is the President of Southern Vermont College, a small, private, affordable, four-year college located in Bennington, Vermont. From January 2012–13, Dr. Gross was on leave from the College to serve as Senior Policy Advisor to the U.S. Department of Education in Washington, D.C. In that capacity, she served as the Department of Education’s representative on the interagency task force charged with redesigning the transition assistance program for returning service members and their families, working closely with the Departments of Defense, Veterans Affairs and Labor. She also was involved in implementing the President’s 2020 Initiative to increase college access and success.

Maura R. Grossman is Of Counsel at Wachtell, Lipton, Rosen & Katz. Ms. Grossman has represented Fortune 100 companies and major financial services institutions in corporate and securities litigation, including civil actions and white collar criminal and regulatory investigations. Her practice presently focuses on advising lawyers and clients on legal, technical, and strategic issues involving electronic discovery and information management, both domestically and abroad.

Carl E. Gulbrandsen is the Managing Director of the Wisconsin Alumni Research Foundation, the patent management organization for the University of Wisconsin-Madison, and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. He is also President of WiCell Research Institute. Dr. Gulbrandsen is an adjunct professor in the Department of Physiology at the University of Wisconsin, ­Madison and is on the faculty of the Masters of Biotechnology program that is resident in the Department of Physiology.

Keir D. Gumbs is a partner in the Washington, D.C., office of Covington & Burling LLP. He advises public and private companies, non-profit organizations, institutional investors and other clients in corporate, corporate governance, securities regulation, and transactional matters.

Sonali P. Gunawardhana is Of Counsel at Wiley Rein LLP, where she draws on her nearly 10 years’ experience as an attorney at the U.S. Food and Drug Administration (FDA) to offer clients detailed and practical guidance on how to avoid and resolve FDA regulatory challenges, and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report.

David Gustman is head of the Freeborn & Peters LLP's Litigation Practice Group, co-head of the firm’s Antitrust Practice Group and a member and former Chairman of the firm’s Executive Committee. For nearly 35 years, Mr. Gustman has handled and served as lead trial counsel on a variety of complex business litigation matters involving antitrust, accounting, banking, bankruptcy, construction, finance, insurance coverage and broker disputes, real estate and securities.

Steven M. Haines is Deputy General Counsel at Seagate Technology in Cupertino, Calif., responsible for managing and directing Seagate’s litigation and arbitration matters, including patent, trade secret, copyright, trademark, licensing, contracts, insurance, trade and antitrust cases, class actions, and other business disputes in both the U.S. and foreign jurisdictions. Prior to joining Seagate in 2008, he was a partner at Morrison & Foerster LLP.

Bill Hall, a Partner with Venable LLP in Washington, D.C., has practiced environmental law for over 30 years and has handled many environmental regulatory, legislative, policy, and litigation matters. Mr. Hall currently represents trade associations and individual companies in the vinyl flooring, paint and coatings, plastics, chemical, and utility industries.

Michael J. Halloran is a Partner in Pillsbury Winthrop Shaw Pittman LLP's Corporate & Securities practice. As a nationally-recognized authority on corporate and securities law, Mr. Halloran provides extensive insight on a wide array of business and legal issues concerning finance and corporate matters from a career advising top industry leaders and regulators.

Jim Halpert heads the U.S. Privacy & Security practice of DLA Piper U.S. LLP and Co-Chairs the firm's global Data Protection, Privacy & Security practice. Mr. Halpert advises clients regarding compliance strategies for and transactions relating to transnational, federal and state security and privacy regulations, industry best practices and self-regulatory initiatives, and has represented clients in major security and privacy cases in the federal courts and before the Federal Trade Commission.

Warren Hamel is the chair of Venable's Investigations and White Collar Defense Practice Group. Mr. Hamel represents clients in white collar criminal defense and environmental criminal defense and civil enforcement matters, conducting internal investigations, general civil litigation, and commercial and contract disputes.

Anne W. Hance is a Partner in the law firm of McDermott Will & Emery LLP and is based in the firm’s Washington, D.C., office, and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. She is a member of the Health Industry Advisory Practice Group and co-chair of the firm’s Insurance/Payors Affinity Group. Ms. Hance focuses her practice on advising health insurers, health maintenance organizations, pharmacy benefit managers and other industry stakeholders on federal and state regulatory matters.

Justine Handelman is Vice President, Legislative and Regulatory Policy, for the Blue Cross and Blue Shield Association (BCBSA) and serves as a member of the advisory board of Bloomberg BNA's Health IT Law & Industry Report. Ms. Handelman has more than 20 years of experience in providing strategic analysis, policy development, and federal representation on legislative, regulatory and federal policy issues pertaining to public and private healthcare.

P. Arley Harrel is a Member in the Seattle office of Williams Kastner. Mr. Harrel's practice emphasizes civil litigation, trust and estate litigation, and trial, real estate and commercial advice in the states of Washington and Oregon. His primary areas of civil litigation practice (in alphabetical order) include antitrust, banking, class action, commercial, condemnation/eminent domain, construction, employment, environmental, franchise, intellectual property, municipal, personal injury, products liability, professional liability, real estate, securities, trade regulation and transportation. His real estate and general business practice focuses on client counseling and advice.

Steve Harris is Chair of Baker & McKenzie’s North America Antitrust & Competition Group. Mr. Harris practices antitrust law, including litigation, cartel defense, merger control filings and administrative proceedings, before U.S. and international courts and agencies.

Jonathan Hart is NPR's Chief Legal Officer and General Counsel. He represents NPR in all legal matters and serves as legal advisor to the President and CEO, Board of Directors and Foundation Trustees, and NPR management. He also serves as NPR's Chief Ethics Officer and as Secretary to the NPR Board of Directors.

Judith A. Hasko is a Partner in the Corporate Department of Latham & Watkins' Silicon Valley office and the global Chair of the Life Sciences Licensing Group, and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. Ms. Hasko's practice focuses on representing companies developing biotechnology, pharmaceutical, medical device and diagnostic products, and investors in such companies, in a wide range of technology-based commercial transactions.

Doug Hastings is the Chair Emeritus of Epstein Becker & Green, P.C. and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. Mr. Hastings is a nationally recognized health care transaction lawyer and adviser on health system change. Mr. Hastings and his colleagues have designed, implemented, and successfully closed scores of complex health care transactions on behalf of hospitals, health systems, academic medical centers, post-acute providers, large medical groups, and health plans. He advises clients on the strategic considerations, corporate architecture, and regulatory compliance components of proposed transactions, including the payment and delivery reform, governance, antitrust, exempt tax, and fraud and abuse implications.

Ronald J. Hedges is the principal of Ronald J. Hedges, LLC. Mr. Hedge has extensive experience in e-discovery and in the management of complex litigation and has served as a special master, arbitrator and mediator. He was a U.S. Magistrate Judge in the U.S. District Court for the District of New Jersey from 1986 to 2007. While a magistrate judge, he was the Compliance Judge for the Court Mediation Program, a member of the Lawyers Advisory Committee, and both a member and reporter for the Civil Justice Reform Act Advisory Committee. From 2001-05 he was a member of the Advisory Group of Magistrate Judges.

Kate Gallin Heffernan is Counsel at Verrill Dana LLP and serves as a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report. Ms. Heffernan advises academic medical centers, hospitals, physician groups, universities and other research organizations and stakeholders on issues related to human subjects protection, research compliance and misconduct, research affiliations and contracting, investigator and institutional conflicts of interest, the creation of data, genomic, and tissue research repositories and downstream uses of stored materials, FDA requirements for clinical investigations, research involving human embryonic stem cells and induced pluripotent cells, multi-site global trials, and the privacy of research subjects’ information.

Rex S. Heinke is co-head of Akin Gump's Supreme Court and Appellate practice. Mr. Heinke has argued over 100 appeals in federal and state courts throughout the country involving many issues and has served as lead trial and appellate counsel on behalf of newspapers, magazines, television networks, motion picture studios, websites, and entertainment production and distribution companies in First Amendment, intellectual property, entertainment, media, and Internet disputes.

Clinton Hermes is Sidra Medical and Research Center’s inaugural General Counsel, responsible for assessing Sidra’s legal requirements and educating staff on critical areas such as compliance and legislation, and serves as a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report. Reporting to the Office of the CEO and to Board of Governors. Mr. Hermes’ responsibilities also includes management of a broad range of corporate and commercial matters including high value contracts and affiliation agreements.

Gary Herschman is a member of the firm in Epstein Becker Green's Health Care and Life Sciences practice in its Newark and New York offices, serves on the firm’s National Health Care and Life Sciences Steering Committee, and is a member of the advisory board of Bloomberg BNA's Health Law Reporter. Prior to joining the firm, Mr. Herschman was co-chair of the health care practice group of a large regional law firm. He advises and assists a diverse group of health care clients in strategically positioning themselves in the rapidly changing health care marketplace. This includes advising clients in regard to consolidations, affiliations, mergers and acquisitions, as well as, joint ventures, physician alignment, clinically integrated networks, ACOs, MSOs, IPAs, PHOs, and population health contracts.

Thomas Hill is the General Counsel for GE’s EHS operations. Mr. Hill supervises a team of lawyers and environmental specialists and represents the company in some its most complex litigations in the areas of environmental compliance, regulatory toxic tort litigation and risk management. This group also coordinates GE’s Employee health and safety compliance policies.

Bethany Hills is a Member of Epstein Becker & Green, P.C.'s Health Care and Life Sciences practice in the New York office and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. Ms. Hills counsels life science, medical device, and health care provider businesses on a broad range of reimbursement, regulatory, and compliance matters.

Jay L. Himes is Co-Chair of the Labaton Sucharow LLP's Antitrust & Competition Litigation Practice. Mr. Himes' practice includes all facets of the antitrust landscape, including investigations and case filings, merger transactions, trial and appellate litigation, and settlement.

W. Reece Hirsch is a Partner in Morgan Lewis's Healthcare Practice and a co-head of the firm's Privacy and Cybersecurity Practice, and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. He counsels and represents hospitals, health plans and insurers, physician organizations, health care information technology companies, pharmaceutical and biotech companies, and other health care organizations on transactional and regulatory matters, including Medicare, fraud and abuse, self-referral, and privacy issues.

Michael Hoenig is a Member of Herzfeld & Rubin, P.C. specializing in products liability and complex litigation. Mr. Hoenig has served as National, Regional and Local Defense Counsel for a number of foreign and domestic companies including all phases of product litigation; negotiations in complex or catastrophic injury cases; class actions; regulation matters; and preventive counseling. He heads a major litigation group engaged in product liability defense from inception of claims through trials and appeals.

Jake M. Holdreith is a Partner in Robins, Kaplan, Miller & Ciresi LLP's Minneapolis office and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. He counsels clients and tries complex lawsuits including intellectual property, regulatory and constitutional litigation and has tried a number of large cases to jury verdicts, has handled cases in the United States, Europe and Asia, and represents inventors large and small.

Lee Hollaar is an Emeritus Professor in the School of Computing at the University of Utah, where he taught software and hardware systems design as well computer and intellectual property law. Dr. Hollaar was on the faculty of the University of Illinois prior to joining the University of Utah in 1980.

William J. Hone is an invention and licensing consultant in Irvington, New York. He retired from the firm of Fish & Richardson P.C. in August of 2006. Prior to his retirement, Mr. Hone spent more than 10 years at Fish & Richardson's New York office, which he helped establish. He previously spent 20 years as a Partner and Associate with Davis, Hoxie, Faithfull & Hapgood and spent six years at the New York firm of Fish & Neave.

Michael E. Horowitz was confirmed as Inspector General for the U.S. Department of Justice by the U.S. Senate on March 29, 2012. He was sworn in as the fourth confirmed Inspector General on April 16, 2012.

Dale Hoscheit, who practices in the Washington, D.C., office of Banner & Witcoff, Ltd., concentrates in federal and U.S. International Trade Commission litigation, licensing, counseling on patent matters, and protection of intellectual property rights. Mr. Hoscheit was one of the lawyers representing Chakrabarty in the landmark U.S. Supreme Court decision, Diamond v. Chakrabarty, which held that life forms could be patented.

John J. Huber, an Affiliate of the FTI Consulting Forensic and Litigation Consulting practice in Washington, D.C., provides consulting services and expert witness testimony in the areas of securities offerings, strategic transactions, corporate disclosure, restatements, internal control over financial reporting and corporate governance. He also provides assistance to companies facing Securities and Exchange Commission (SEC) Staff comments, FCPA investigations and SEC enforcement actions, including deferred prosecution agreements and monitorships.

Darren J. Hunter is a Partner and member of the energy, environmental, health and safety, and litigation practice groups at Rooney Rippie & Ratnaswamy LLP (R3). Mr. Hunter's practice focuses on counseling and defending natural gas transmission, distribution and storage companies in a wide variety of matters, including pipeline safety, pipeline security, regulatory compliance, governmental investigations, major incident investigations, operating agreements, and property, storage and mineral rights issues.

Lawson Hunter, Counsel at Stikeman Elliott, is one of Canada's renowned regulatory and government relations counsel. Mr. Hunter draws on a wide range of experience in business, government and private practice. Formerly Canada's senior civil servant in charge of competition policy and enforcement, Mr. Hunter was primarily responsible for the drafting of the federal Competition Act.

R. William "Bill" Ide is a Partner in the Atlanta office of McKenna Long & Aldridge. He focuses on representing boards of directors, audit committees and management with special investigations, crisis management ethics and corporate governance. Mr. Ide currently chairs the Boards of MetaJure and Rimidi Diabetes. Mr. Ide previously served as a member of the Board of Directors of Albemarle Corporation where he chaired the Governance Committee and served on the Compensation Committee. He also served as a member of the Board of Directors of Popeyes Louisiana Kitchen, Inc. where he chaired the Governance Committee.

John Isbister, a Partner in the law firm of Tydings & Rosenberg, concentrates in two primary areas: defending corporations against products liability claims and representing plaintiffs in commercial litigation, especially class actions in the financial and technology sectors. Mr. Isbister leads the products liability, toxic tort, and environmental litigation practice at Tydings & Rosenberg.

John Isidor is the CEO and Counsel of Human Subject Protection Consulting, LLC, which provides consulting services to the medical research industry regarding the legal and ethical issues involving human subject protection, and serves as a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report. Mr. Isidor also provides educational presentations and programs about human subject protection.

Matthew G. Jacobs joined CalPERS as General Counsel in July 2014. He is responsible for the strategic direction and oversight of the CalPERS Legal Office and the CalPERS Office of Audit Services. Mr. Jacobs provides guidance on complex legal issues relating to pensions, health care, investments, and corporate governance. He advises the CalPERS Board of Administration, the Board committees, executive and senior management staff, and various CalPERS divisions. He also represents CalPERS in litigation.

James M. Jacobson is a Partner in Nutter McClennen & Fish LLP's Business Department and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. Mr. Jacobson's practice focuses on clients in the life sciences and health care industries, including pharmaceutical companies, medical device manufacturers, contract manufacturers, wholesale distributors, clinical research organizations, hospital systems, pharmacies, pharmaceutical benefits and disease managers, clinics, health plans and insurers, physician organizations, and long term care providers. He specializes in complex corporate, contractual, regulatory, and reimbursement transactions, including M&A, joint ventures, licensing, clinical trials, dispute resolution, and the full range of compliance and regulatory issues.

Helene D. Jaffe is a Partner in the Litigation Department of Proskauer Rose LLP, and head of the firm's Antitrust Group. Ms. Jaffe practice concentrates on the transactional, counseling and litigation aspects of antitrust law with a focus on mergers & acquisitions, joint ventures, single firm conduct and distribution matters.

Sarah Rouse Janosik is Corporate Intellectual Property Counsel at Onyx Pharmaceuticals and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. She is a registered patent attorney specialized in nano-enabled therapeutics with experience in both patent portfolio management and patent litigation.

Regina T. Jefferson is a Professor of Law at Catholic University’s Columbus School of Law in Washington where she teaches federal income taxation, partnership taxation, and ERISA: pensions. Prior to joining the law faculty at Catholic University in 1992, Ms. Jefferson was a tax law specialist at the national office of the Internal Revenue Service in the Employee Plans Division, where she specialized in qualified employee plans.   Ms. Jefferson was a teaching fellow in the Graduate Teacher Training Program for Future Law Professors at Georgetown University.

Kristin Jenkins is the President of the Dallas-Fort Worth Hospital Council Foundation and Senior Vice President of the Dallas-Ft. Worth Hospital Council, and serves as a member of the advisory board of Bloomberg BNA's Health Care Program Compliance Guide. Ms. Jenkins has been in the healthcare field since leaving her private law practice in 1997.

Steve Baughman Jensen is an attorney with Allen Stewart, P.C. in Dallas. After a year-long position as a briefing attorney for then-Texas Supreme Court Justice Lloyd Doggett, Mr. Jensen has devoted his career to toxic tort litigation. Mr. Jensen has worked on a wide variety of toxic injury cases involving such substances as asbestos, trichloroethlyne (TCE), lead, radiation, beryllium, benzene, mercury, arsenic, and dioxins.

Bruce E. H. Johnson, a veteran litigator, represents information industry clients on issues involving media and communications law as well as technology and intellectual property matters. His expertise includes advising on First Amendment law issues, particularly involving commercial speech, commercial transactions and consumer rights.

Bruce Joseph, Chair of the Wiley Rein LLP’s Copyright Practice, represents clients in connection with copyright litigation, music and sound recording licensing negotiations and litigation, copyright and digital content protection legislation, regulation and inter-industry activities, and copyright and trademark licensing and registration. He has been deeply involved in issues relating to the Internet, digital technology protection measures, and DRMs.

Timothy S. Jost holds the Robert L. Willett Family Professorship of Law at the Washington and Lee University School of Law and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. He is a co-author of a casebook, Health Law, used widely throughout the United States in teaching health law, and of a treatise and hornbook by the same name.

Mark A. Kadzielski is a Partner and head of the Health Care Services practice of Pepper Hamilton LLP, in the Los Angeles office, and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. Mr. Kadzielski represents hospitals, medical staffs, managed care enterprises, and institutional and individual health care providers throughout the U.S. His work includes government regulatory investigations, contracting issues, credentialing, peer review, licensing, medical staff bylaws, joint commission accreditation and Medicare certification.

Siegrun Kane is a Partner in Kane Advisors LLP. Ms. Kane has specialized in trademark and unfair competition law for over 40 years. She focuses on litigation, U.S. Patent and Trademark Office proceedings and counseling. Ms. Kane also acts as a consulting and testifying expert.

Allan Kanner founded the firm of Kanner & Whiteley, L.L.C. in 1981 and has since developed a national reputation in the fields of complex litigation, environmental law and consumer fraud. He currently represents the State of Louisiana in the Deepwater Horizon oil spill litigation, as well as the State of New Jersey against ExxonMobil in a major natural resource damages case. He also serves as Lead Plaintiffs’ counsel in a national MDL class action against the manufacturers of a generic formulation of Wellbutrin XL.

Alan S. Kaplinsky leads Ballard Spahr LLP's Consumer Financial Services Group, which has over 100 lawyers. Mr. Kaplinsky devotes his practice exclusively to counseling financial institutions on bank regulatory and transactional matters, particularly consumer financial services law, and defending financial institutions that have been sued by consumers in individual and class action lawsuits and by government enforcement agencies.

Roberta Karmel's area of expertise is international and domestic securities regulation, for which she is widely called upon to teach and lecture all over the world. She is a former Commissioner of the Securities and Exchange Commission, a former Public Director of the New York Stock Exchange, and was in private practice for 30 years. She was also a Fulbright Scholar studying the harmonization of the securities laws in the European Union.

Thomas Kaufman, who is based in Goulston & Storrs PC's Washington, D.C., office, counsels clients on matters including real estate investment trusts, capital markets, mezzanine and subordinated loans, loan workouts and commercial real estate transactions with a particular focus on the hospitality industry and management agreements. Finance, private equity and joint ventures related to real estate are at the core of Mr. Kaufman's experience. He also represents clients in their real estate-related corporate structuring transactions.

Peter Kazon is Senior Counsel at Alston & Bird, LLP and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. He has over 25 years of experience assisting companies and individuals in negotiating the complex legal and regulatory issues that health care providers routinely face and counsels providers on matters involving Medicare coverage, reimbursement, billing, fraud and abuse and Stark self-referral issues.

Don Kempf is a former Senior Advisor at Gleacher Partners, a leading independent investment bank, and Blaqwell Inc., independent consultants to the legal profession. He currently serves as an AAA- and CPR-certified arbitrator and mediator, an adjunct professor of law and a private practitioner.

Roy W. Kent is a partner in the firm of Kent & Wittner P.S. and has over 33 years experience representing individuals in bankruptcy court. Mr. Kent has served as a Chapter 7 trustee for 12 years.

R. Shyam Khemani, a Principal at Microeconomic Consulting & Research Associates, Inc. (MiCRA), specializes in providing applied economic analysis, litigation support and economic research services to law firms, corporations, government and trade associations on complex competition and regulatory matters. Until recently, Dr. Khemani was Advisor, Competition Policy, in the Financial & Private Sector Development Vice-Presidency of the World Bank Group, Washington, D.C.

Suyong Kim is a partner in Hogan Lovell's London office and is the Co-head of the firm's Antitrust, Competition and Economic Regulation practice. Ms. Kim advises clients on all aspects of U.K. and E.U. competition law including transactional matters (mergers, joint ventures and other commercial arrangements such as distribution and licensing) and contentious matters (including damages actions). She also advises on competition and regulatory issues in relation to regulated utilities.

Jonathan Kirshbaum is an Assistant Federal Defender in the Office of the Federal Defender, District of Nevada where he litigates federal habeas corpus cases. Mr. Kirshbaum was previously a lawyer at the Center for Appellate Litigation where he represented indigent criminal defendants in their direct appeals and served as an assistant adjunct clinical professor at Brooklyn Law School.

Lori Kettering Knauer is Corporate Counsel in the Employee Benefits practice group at E. I. du Pont de Nemours and Company in Wilmington, Delaware.

Jeffrey Kodroff, a Partner in the law firm of Spector Roseman Kodroff & Willis, P.C. in Philadelphia, concentrates his practice in complex antitrust, healthcare and consumer litigation. Mr. Kodroff was among the first attorneys to represent clients in litigation against national health maintenance organizations (HMOs).

Mike Koehler joined the faculty of the Southern Illinois University School of Law in 2012. His teaching expertise and interests include corporate law, corporate compliance and ethics, white collar crime, international business transactions, international trade and investment, and securities regulations and torts.

Peter Kongstvedt is a Senior Health Policy Faculty Member in the Department of Health Administration and Policy, School of Health and Human Sciences at George Mason University and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. He teaches a graduate course on the topic of Health Insurance and Managed Health Care. He is a national authority on the health care industry with particular expertise in health insurance and managed health care. Dr. Kongstvedt also is principal of the P.R. Kongstvedt Company, LLC, a firm advising health care executives on strategy, operations and effective decision making. In March of 2014, he was appointed by Virginia Gov. Terry McAuliffe to serve on Virginia's Board of Medical Assistance Services.

Shannah Koss is President of Koss on Care LLC and serves as a member of the advisory board of Bloomberg BNA's Health IT Law & Industry Report. She is a health policy and informatics expert and strategist who has successfully advanced program initiatives for federal and state government health agencies and private healthcare businesses and organizations for over 20 years.

Victor Kovner is a Partner in the New York office of Davis Wright Tremaine LLP. Mr. Kovner represents national and regional broadcast and print media clients in all aspects of communications law, in addition to his work in intellectual property and commercial litigation. He advises clients in cases of alleged defamation, privacy, copyright, press access, and reporter’s privilege and other First Amendment issues.

Jennifer Kowalski is Vice President at the Anthem Public Policy Institute and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. She provides strategic advice and analysis to help clients assess and respond to health insurance market reform, including the implementation of the Affordable Care Act. Ms. Kowalski advises a range of managed care clients, including national and local health insurance companies, in the development of advocacy and policy positions to further their business objectives.

Daniel Kracov heads the FDA and healthcare practice at Arnold & Porter LLP and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. He assists clients, including start-up companies, trade associations, and large manufacturing companies, in negotiating the challenges relating to the development, approval and marketing of drugs, biologics, and medical devices.

Wendy Krasner is Vice President of Regulatory Affairs for the Pharmaceutical Care Management Association (PCMA) and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. In this role, she leads PCMA's federal regulatory activities, with a focus on health care reform implementation and Medicare.

Steve Kraus is a Partner at Carlton Fields Jorden Burt based in Washington. He advises clients on a broad range of tax and ERISA matters relating to qualified and nonqualified retirement plans, IRAs and IRA annuities, health and other welfare benefit plans. He also advises life insurance company clients on the tax qualification of annuities and life insurance contracts. Mr. Kraus has experience dealing with the issues surrounding synthetic annuities, including securing private letter rulings for clients, advising clients with regard to issues surrounding Bank-Owned Life Insurance and advising clients regarding mutual fund taxation issues. He has represented clients on numerous matters before both the Internal Revenue Service and the Department of Labor.

Steven R. Kronheim is Managing Director and Associate General Counsel at TIAA-CREF in New York. Previously, he worked as Vice President, Compensation & Benefits at Alcatel-Lucent, Assistant General Counsel, Compensation & Benefits at AlliedSignal and Partner at Rogers & Wells, now Clifford Chance. While at Rogers & Wells, he was the partner in charge of the firm’s Employee Benefits, ERISA and Executive Compensation practice.

John Kropf is Foundation Senior Scholar at the Information Accountability Foundation working on issues of global accountability and strategic privacy. Prior to joining the foundation, he was deputy counsel for privacy and information governance at Reed Elsevier.

Bob Krupka, who currently practices with the Krupka Law Group, P.C., has tried over 75 cases to judgment, including 18 jury trials to verdict, during his 39-year career at Kirkland & Ellis LLP. Teams he led obtained verdicts totaling over $1 billion and recovered over $3 billion in settlements, including one of the largest patent settlements in history - $1.35 billion.

Eckhard H. Kuesters, a Partner in the law firm of Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P., is a registered patent attorney and former design engineer, and a Senior Partner in the firm's Electrical Patent Prosecution group. Mr. Kuesters' practice includes client counseling, all phases of patent prosecution, patent infringement and validity opinion preparation, reexamination, and litigation support. He also advises clients on licensing arrangements and negotiates the full range of licensing matters and joint research agreements.

Herb B. Kuhn is the President and CEO of the Missouri Hospital Association, the trade association serving the state’s 167 hospitals and health systems, and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. Mr. Kuhn also serves as a Commissioner on the Medicare Payment Advisory Commission (MedPAC), as well as on the boards of the Healthcare Services Association and Missouri Health Plan, Missouri Health Connection, Excellence in Missouri Foundation and on an advisory panel to the Healthcare Financial Management Association board.

Christopher Kuner is Senior Of Counsel in the Brussels office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on European and international data protection and privacy compliance. Mr. Kuner has represented clients in their dealings with the European Commission, the Article 29 Working Party, and European and national data protection authorities.

Areta L. Kupchyk is the chair of the FDA practice group at Foley Hoag LLP and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. She focuses on counseling clients on U.S Food and Drug Administration (FDA) regulation of drug, medical device, biotechnology, and biologic products. Ms. Kupchyk represents drug, device, and biotechnology companies, as well as healthcare IT companies and wholesale distributors, in the U.S., Europe, and Australia.

Richard Kusserow is CEO and founder of Strategic Management, which has since specialized in developing, implementing and measuring effective compliance operations and programs, and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. He has assisted organizations by providing interim and designated compliance officer services. He provides specialized expertise on fraud and abuse, sanctions, exclusion, and debarment processes, as well as regulatory issues arising from the Centers for Medicare & Medicaid Services (CMS).

Dick Kuyath is Counsel at 3M. He was previously a Manager of Contract Counsel at FMC, Naval Systems Division. Mr. Kavath earned a B.A. from the University of Minnesota-Twin Cities and a J.D. from William Mitchell College of Law.

Laura Laemmle-Weidenfeld is a Partner at Jones Day in Washington, D.C. and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. She defends clients against civil and criminal government investigations and litigation relating to allegations of fraud and abuse, particularly under the civil False Claims Act and in the health care and life sciences industries. She has defended against investigations brought by the Department of Justice (DOJ), including U.S. Attorneys' Offices, the U.S. Department of Health and Human Services (HHS) Office of Inspector General, state attorneys general, and other state and federal agencies.

Dave Laigaie is a Member of Eckert Seamans Cherin & Mellott, LLC in Philadelphia and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. He focuses his practice on internal corporate investigations, health care litigation, and complex civil litigation and handles cases involving health care fraud, securities fraud, tax fraud, export violations, pharmaceutical marketing fraud, municipal corruption, defense procurement fraud, and public finance fraud.

Brian Lane, a Partner with Gibson, Dunn & Crutcher in Washington, D.C., is a corporate securities lawyer with extensive expertise in a wide range of SEC issues. Mr. Lane counsels companies on the most sophisticated corporate governance and regulatory issues under the federal securities laws. He is a nationally recognized expert in his field as an author, media commentator, and conference speaker.

Mark B. Langdon is a Partner with Sidley Austin LLP who practices in the Healthcare group out of the firm’s Washington, D.C., office, and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. Mr. Langdon has represented a diverse array of healthcare industry clients on numerous regulatory, compliance, fraud and abuse, and reimbursement matters. His clients have primarily included pharmaceutical and device manufacturers, durable medical equipment companies, and imaging companies.

Robert M. Langer is a Partner in Wiggin and Dana LLP's Litigation Department and head of the firm's Antitrust and Consumer Protection Practice Group. Mr. Langer is involved in all aspects of antitrust, consumer protection and trade regulation counseling and litigation, including class actions. He represents clients in both federal and state courts, and before the Federal Trade Commission, the Antitrust Division of the U.S. Department of Justice, as well as offices of state attorneys general throughout the United States.

Marilee P. Lau is an accountant based in the San Francisco Bay area. Before her retirement from KPMG LLP, she was the National Partner in Charge of KPMG’s employee benefit assurance practice. Ms. Lau was the American Institute of Certified Public Accountants’ representative to the ERISA Advisory Council for three years. She was the chairperson for the 1998 Council.

Tom Leary is Vice President, Government Relations, at the Health Information Management Systems Society (HIMSS), a global, cause-based, not-for-profit organization focused on better health through information technology (IT), and serves as a member of the advisory board of Bloomberg BNA's Health IT Law & Industry Report. Mr. Leary leads the organization’s public policy initiatives and outreach to Congress and Federal agencies.

Henry W. Leeds practiced trademark and copyright law from 1956 until his retirement in 2003. His expertise was in trademark practice before the U.S. Patent and Trademark Office. At the time of his retirement, he was – and remains – Of Counsel to the firm of Drinker Biddle & Reath LLP.

Ira Leesfield is founder and Managing Partner of Leesfield & Partners, P.A., with offices in Miami, Key West, South Beach and Central Florida. Mr. Leesfield is a past President of the Florida Justice Association, formerly known as the Academy of Florida Trial Lawyers; an EAGLE Patron; and now serves as Senior Florida Governor of the American Association for Justice, serving over 20 years.

Norman Lefstein served as Dean of the Indiana University McKinney School of Law from January 1, 1988 until June 30, 2002. During his tenure, he enhanced financial support for faculty research and scholarship and promoted the expansion of a number of the school’s activities, including international programs, clinics, internships, and pro bono opportunities for students. He also spearheaded the fundraising and planning for the school’s $37 million building, Lawrence W. Inlow Hall, which was dedicated in 2001.

Alain Leibman is a Partner in the Litigation Department of the Fox Rothschild’s Princeton office. He focuses his practice on litigation and white-collar compliance and defense. He has represented companies and individuals in a wide array of civil litigation in both federal and state courts, including defense of RICO lawsuits and the prosecution of copyright and trademark infringement cases.

Arthur N. Lerner is co-chair of Crowell & Moring LLP's Health Care Group and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. He focuses his practice on antitrust, health reform, transactions and fraud and abuse issues for health plans, hospitals, and other health care entities. Mr. Lerner handles mergers and acquisitions, joint ventures, antitrust investigations by the U.S. Department of Justice and the Federal Trade Commission (FTC), government program fraud and abuse compliance, health reform initiatives and compliance under the Affordable Care Act (ACA) accountable care organization (ACO) transactions and other complex regulatory and competition law counseling and litigation matters.

Laurie L. Levenson is Professor of Law and the David W. Burcham Chair in Ethical Advocacy at Loyola Law School, Los Angeles. Professor Levenson currently leads the following programs at Loyola Law School: Capital Habeas Litigation Clinic, The Fidler Institute annual symposium, and the Project for the Innocent.

Marsha Levick, Deputy Director and Chief Counsel, co-founded the Juvenile Law Center in 1975. Ms. Levick oversees Juvenile Law Center’s litigation and appellate docket. She has successfully litigated challenges to unlawful and harmful laws, policies and practices on behalf of children in both the juvenile justice and child welfare systems.

William E. Levin was the founding Partner and attorney in Levin & Hawes, Levin & O’Connor, and Levin Intellectual Property Group. Mr. Levin was also a Partner in the firms Cooper, White & Cooper in San Francisco and Flehr, Hohbach, Test, Albritton & Herbert, was Of Counsel to Hawes & Fischer and Goldstein & Phillips and was Senior Litigation Attorney with Brookstone Law PC.

Lee Levine has represented media clients in libel, invasion of privacy, reporter’s privilege, access, copyright, and related First Amendment cases for more than three decades. In the U.S. Supreme Court, he has argued for the media defendants in Harte-Hanks Communications, Inc. v. Connaughton and Bartnicki v. Vopper. Mr. Levine also has litigated in the courts of more than 20 states and the District of Columbia, and has appeared in most federal courts of appeal and in the highest courts of 10 states.

Greg Levine is co-chair of the Life Sciences Practice Group at Ropes & Gray, LLP and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. He focuses his practice on FDA regulation of pharmaceuticals, biotechnology and medical devices and also counsels his pharmaceutical and medical device clients on compliance with health care fraud and abuse laws. Mr. Levine regularly represents clients before state and federal regulators on all phases of product life cycle and assists clients with both internal and government compliance investigations and enforcement actions.

John Liftin is a Managing Director of D. E. Shaw & Co., L.P. and serves as the D. E. Shaw group’s General Counsel. He is also responsible for general oversight of the firm’s compliance function.

Alfred R. Light has been a member of the law faculty at St. Thomas University since 1989. Professor Light currently teaches Civil Procedure, Federal Courts, and Environmental Law courses. He also served as Interim Dean at St. Thomas Law from 1993-94. He previously taught in the Center for Public Service at Texas Tech University.

Dr. Nancy Linck, a Partner in Rothwell, Figg, Ernst & Manbeck, P.C., specializes in intellectual property law, particularly in the biotechnology and pharmaceutical areas. She has a wide range of experience in private and corporate practice, including consulting and litigation at both trial and appellate levels and inter partes matters before the U.S. Patent and Trademark Office (USPTO).

Scott Lipkin is a Managing Director FTI Consulting and serves as a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report. Dr. Lipkin is part of the Health Solutions practice and in the research and compliance group. He focuses his practice in research compliance, research ethics, human subject protections, IRB operations and administration, scientific misconduct, conflicts of interest, research clinical operations, physician compensation, and research financial administration. Dr. Lipkin’s clients include academic medical centers, health systems, hospitals, and pharmaceutical and biotechnology companies.

Tad Lipsky is a Partner in the Washington, D.C., office of Latham & Watkins. Mr. Lipsky is internationally recognized for his work on both U.S. and non-US antitrust and competition law and policy and has handled antitrust matters throughout the world. Having served as chief antitrust lawyer for The Coca-Cola Company from 1992-2002, Mr. Lipsky has extensive experience with antitrust in the U.S., E.U., Canada, Japan and other established antitrust-law regimes, as well as in new and emerging antitrust-law regimes in scores of jurisdictions that adopted free-market policies following the 1991 collapse of the Soviet Union.

Richard Lockridge is a Partner in Lockridge Grindal Nauen P.L.L.P. and heads the firm's class action practices  During the past 30 years, Mr. Lockridge has focused his practice on securities and antitrust class action litigation. He has led litigation teams in a number of high profile complex class action matters.

Amy Jane Longo is a Senior Trial Counsel for the U.S. Securities and Exchange Commission. She was previously a partner at O'Melveny & Myers, LLP where her practice included extensive experience as litigation and/or discovery counsel in a variety of complex class actions, with a focus on securities and ERISA litigation. She also co-founded the firm's electronic discovery practice and was one of the leaders of the group of attorneys dedicated to the electronic discovery needs of the firm's clients and its litigators.

Gaby L. Longsworth is a Director in the Biotechnology/Chemical Group of Sterne, Kessler, Goldstein & Fox P.L.L.C. in Washington, D.C. and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. Dr. Longsworth is sought out by both innovator and generic pharmaceutical companies for her insights and knowledge of IP and brand product lifecycle management strategies. She counsels innovator pharmaceutical clients from around the world in all areas of patent procurement, including domestic and foreign patent preparation, and lifecycle management strategies.

Mr. Lothstein is an experienced DUI defense lawyer and criminal lawyer in New Hampshire whose victories have been widely reported in publications such as the Boston Globe, the Concord Monitor, the Nashua Telegraph, and the national Criminal Law Reporter. A former Assistant Appellate Defender and Public Defender, Mr. Lothstein has litigated over 80 appeals in the New Hampshire Supreme Court and U.S. Court of Appeals for the First Circuit.

Karen Lovitch is the Practice Leader of Mintz Levin's Health Law Practice and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. She counsels health care clients on regulatory, transactional, and operational issues, including Medicare coverage and reimbursement, the development and implementation of health care compliance programs, and licensure and certification matters. In addition, Karen advises clients on the legal, practical, and fraud and abuse implications of business arrangements and sales and marketing practices. Her experience includes matters related to the anti-kickback statute, the Stark law, state statutes prohibiting kickbacks and self-referrals, and the federal Physician Payments Sunshine Act.

James A. Lowe, who is affiliated with Lowe Eklund Wakefield Co., LPA in Cleveland, is a nationally recognized trial lawyer in products liability, automobile product safety, and other complex cases. He is the author of multiple texts and treatises and frequent national and international lecturer on products liability and motor vehicle defect cases.

Deborah L. Lu, is a Shareholder in the New York office of Vedder Price and a member of the firm’s Intellectual Property group, and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. Dr. Lu obtains and evaluates intellectual property protection, manages complex patent portfolios and counsels clients regarding validity, freedom-to-operate and patentability in biotechnology and pharmaceuticals. In particular, she prepares and prosecutes patent applications.

Alice Neff Lucan advises news client on a variety of issues affecting their operations, including libel, copyright and access issues, plus business issues, such as contract review and employment law. Her work for clients includes pre-publication counseling, responses on demands for correction, advice on gaining newspaper distribution access and on access to records and meetings, working with freelance contracts, copyright and trademark issues, defending against administrative agency actions, advocacy on remote access to public court records, avoiding unneeded demands for reporter evidence and testimony, and pursuing refused requests for access to meetings or to public government and public court records.

Gene Lucero is Of Counsel in the Los Angeles office of Latham & Watkins LLP and is a Member of the Environment, Land and Resources Department. He joined Latham as a Partner in December 1992 and retired from the Partnership on December 31, 2011. Mr. Lucero is a former Chair of the firm's Global Environment, Land and Resources Department.

Mark E. Lutes is a Member of the Health Care and Life Sciences practice of Epstein Becker Green and the Chair of the firm's Board of Directors, and serves as a member of the advisory board of Bloomberg BNA's Health IT Law & Industry Report. He was previously a legislative adviser to the Federal Trade Commission (FTC).

Michael Lutz is a Director in Avalere’s Health Reform Practice and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. He provides strategic advice and analysis to help clients assess and respond to insurance market reform, including the implementation of the Affordable Care Act. He regularly guides clients in the development of advocacy and policy positions that align with their business objectives. He also leads research and analysis to inform clients’ strategic initiatives and product planning. His areas of expertise include Medicare Advantage, Medicaid managed care, Medicare Part D, behavioral health integration, and Dual Eligible programs.

Gary G. Lynch is Global General Counsel and head of Compliance and Regulatory Relations for Bank of America, responsible for overseeing the company’s legal and compliance functions and its relationships with regulators and law enforcement authorities around the world. Based in New York, Mr. Lynch is also a member of the bank’s executive management team.

John E. Lyncheski is a director and one of the founding members of Cohen & Grisby, P.C., where he focuses his practice in management labor relations law and healthcare, and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. Mr. Lyncheski counsels and represents private and public sector management on labor board proceedings, negotiations, personnel decisions, mergers, acquisitions, consolidations and divestitures, discrimination claims, employee and union litigation and advises clients in labor disputes and resistance of union organizational efforts.

Christine Lyon’s practice focuses on privacy and employment law. Ms. Lyon assists clients in developing global strategies to comply with laws regulating the collection, use, disclosure, and transfer of personal information about their customers and employees. She also advises clients about privacy issues in cloud computing and social media, security breach notification requirements, laws regulating the use of personal data for direct marketing purposes, and workplace privacy issues.

Scott Macey is the past President and Chief Executive Officer of The ERISA Industry Committee. Mr. Macey has advised clients on ERISA, labor, tax, general corporate and related laws regarding the design, establishment, amendment and administration of employee and executive benefit plans and trusts. He also has negotiated extensively with banks, insurance companies, investment advisers and others providing services to or having a relationship with benefit plans or trusts. He has more than 30 years of experience in compensation and benefit consulting in health care, pensions and executive compensation.

Marcia G. Madsen is a Partner in the Washington, D.C., office of Mayer Brown where she focuses on Government Contracts and Litigation. Ms. Madsen advising clients on contract formation, teaming and strategic alliances, contract and subcontract negotiations, performance disputes, audits, terminations, cost accounting and allowability, technical data rights and trade secrets, and fraud/false claims investigations.

Terry Maguire is a media lawyer and consultant with more than 35 years of experience in a wide variety of media sectors and issues. He worked as a consultant for newspapers in the U.S. and for many overseas, including the Nation (Nairobi) and The Irish Times (Dublin). He helped both newspapers with their strategic planning, especially as it related to new media.

Terry G. Mahn is Managing Principal of Fish & Richardson's Washington, D.C., office, and the Regulatory and Government Affairs Practice Group Leader, and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. His practice is primarily before the Federal Communications Commission (FCC) and U.S. Food and Drug Administration (FDA) with emphasis on complex product authorizations.

Bill Mahon is President of The Mahon Consulting Group LLC and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. Mr. Mahon helps health plans and other medical-claim payers to assess their relative vulnerability to fraud and abuse and to increase the effectiveness of existing anti-fraud functions or to establish appropriate and effective anti-fraud functions.

David C. Main is a Partner in Nelson Mullins Riley & Scarborough LLP's Washington, D.C., office and serves as a member of the advisory board of Bloomberg BNA's Health IT Law & Industry Report. Mr. Main concentrates on healthcare transactional work, including corporate formations; mergers and acquisitions (and attendant regulatory issues); restructurings and reorganizations; financings; contractual arrangements; regulatory, operational and litigation matters; and health policy and government relations issues.

John R. Manthei is a Partner in the Washington, D.C., office of Latham & Watkins, serves as global Co-chair and Washington, D.C., Chair of the Healthcare and Life Sciences Practice, and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. His practice focuses on regulatory matters involving the Food and Drug Administration (FDA) for the medical device, pharmaceutical, biotechnology, food and dietary supplement industries.

Renzo Marchini, who is Special Counsel in the London office of Dechert LLP, handles all types of commercial and intellectual property issues, in particular in relation to information technology, e-commerce, data protection and international trade/licensing. Mr. Marchini deals with supply, licensing and support, consultancy, development and outsourcing agreements, standard terms and conditions, distribution and agency, liability and consumer protection issues, and the full range of commercial transactions and advisory work in these and general intellectual property and commercial areas.

Professor Richard Marcus' teaching has focused on litigation-related areas such as civil procedure, complex litigation, conflicts of law, and evidence, and he has also taught contracts, corporations and remedies. He is a lead author of the West casebooks Complex Litigation (5th ed. 2010) and Civil Procedure: A Modern Approach (6th ed. 2013).

Kenneth R. Marcus is a Partner in the Detroit office of Honigman Miller Schwartz and Cohn LLP and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. He is nationally recognized in hospital Medicare and Medicaid payment appeal issues. Mr. Marcus has nearly three decades of successful representation of numerous hospitals in individual and group appeals before the Provider Reimbursement Review Board, the federal district courts and federal courts of appeals.

John Markus is a member of the Bradley Arant Boult Cummings LLP's Health Care Group and serves as a member of the advisory board of Bloomberg BNA's Health Care Program Compliance Guide. He specializes in healthcare regulatory law and assists clients in the design and assessment of internal compliance programs. Mr. Markus previously served as Executive Vice President and Chief Compliance Officer for HealthSouth Corporation, a leading providers of rehabilitation, surgery, and diagnostic services, where he directed the development of a regulatory compliance program as part of a comprehensive restructuring initiative at the Company. He also negotiated and directed the implementation of a Corporate Integrity Agreement between the Company and the Office of Inspector General for the Department of Health and Human Services.

David B. H. Martin is co-head of Covington & Burling LLP's securities practice and advises corporations and other entities, directors, financial professionals, investors and other clients in corporate, corporate governance, securities regulation and transactional matters. He has led teams of lawyers in corporate finance, business combination and other change of control transactions, including public offerings, spin-offs, proxy contests, and tender offers.

Arvin Maskin is Chair of Weil, Gotshal & Manges LLP's Product Liability and Mass Tort Practice Group. He has served as Lead Counsel in some of the largest mass tort and product liability litigation's in the country. Formerly with the U.S. Department of Justice in Washington, D.C., he was the government’s lead counsel in such seminal matters as the “Agent Orange” litigation.

Kent Mason is a Partner in the law firm of Davis & Harman LLP in Washington where he primarily works with major employers, large plans and national vendors of retirement plan services. Mr. Mason advises on the full range of employee benefits issues, including all types of retirement plans, deferred compensation arrangements, health and life insurance for employees and retirees, COBRA, VEBAs, and cafeteria plans. In his practice, Mr. Mason frequently represents clients before the IRS, Treasury, the Department of Labor, and the Pension Benefit Guaranty Corporation. He also works extensively for trade associations on legislative and administrative issues affecting retirement plans and other employee benefits.

Mike Mason, a Partner in the Washington, D.C., office of Hogan Lovells, practices principally in the area of federal, state, and local government contracts with an emphasis on representing clients in matters involving litigation, contract disputes and claims, investigations of alleged misconduct and fraud, government compliance requirements, and complex transactions.

Gary E. Mason is a founding Partner at Whitfield Bryson & Mason LLP in Washington, D.C. Focusing on consumer class actions and mass torts, Mr. Mason has recovered more than $1.5 billion in the 22 years he has represented plaintiffs. He is nationally known for representing consumers in class actions involving a wide range of defective products, including Chinese drywall, fire retardant plywood, polybutylene pipe, high-temperature plastic venting, hardboard siding, pharmaceutical products, consumer electronics and automobiles.

Mitsuo Matsushita is a Professor Emeritus of Tokyo University and a counsel to Nagashima, Ohno & Tsunematsu, a leading international law firm in Tokyo. He is an internationally-acknowledged expert in the field of competition law and international economic law.

Joanne M. Mattiace has more than 30 years of active work in the area of consumer product safety regulation. She previously served as Legislative Counsel for the Sears Roebuck & Co. Upon leaving Sears, Ms. Mattiace co-founded the Washington, D.C., area law firm of Mattiace, Craib & Carrico, P.C. That law firm was later dissolved and Ms. Mattiace organized her own law firm, which represents manufacturers, distributors (including importers), and retailers.

Thomas Mayo is an Associate Professor of Law at Southern Methodist University Dedman School of Law and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. He teaches Bioethics & Law, Health Care Law, Law, Literature & Medicine, Nonprofit Organizations, Legislation, and Torts.

Judith F. Mazo is a Washington attorney formerly with Segal Co. where, before her retirement, she was Senior Vice President and Director of Research. While at Segal, Ms. Mazo was responsible for providing guidance on public policy and legislative and regulatory issues. She served on Segal’s senior management team and chaired its National Practice Council.

Kevin McAnaney recently returned to private practice, concentrating on health care fraud and abuse matters, including compliance reviews, transactional work, and civil and administrative litigation and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. For over 25 years, Mr. McAnaney has practiced health care law including as in-house counsel to a major teaching hospital, as a partner in a major law firm, and in government service at the state and federal levels.

Andrew McBride is a Partner in the Washington, D.C., office of Wiley Rein LLP. Mr. McBride specializes in legal issues surrounding wireless technologies, the Internet, and all forms of new media, including copyright, patent, federal preemption defenses, class action defense, enforcement of arbitration clauses, and First Amendment protection for commercial speech.

David M. McConoughey, Of Counsel with Miskin & Tsui-Yip LLP in New York, is a registered patent attorney with extensive experience in the private practice of intellectual property law as well as experience as senior level in-house patent counsel. Mr. McConoughey's practice focuses primarily on the creation and development of the intellectual property assets of entrepreneurs and embryonic and growth stage businesses.

Brian McCormick is Executive Counsel of Regulatory/LCM for Teva Pharmaceuticals, where he is responsible for the lifecycle management of specialty pharmaceutical products, and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. Mr. McCormick also provides legal support to project teams including the U.S. business, Business Development, and Global Intellectual Property teams on Hatch Waxman, exclusivity, technical, and regulatory issues.

Janet McDavid is a Partner in the Washington, D.C., office of Hogan Lovells where she focuses on antitrust, competition, and trade regulation, with a particular emphasis on government investigations, litigation, and antitrust policy issues. She is a Past Chair of the ABA Antitrust Section, a Vice-Chair of the IBA Antitrust Committee, and provided antitrust transition advice to the Obama, Bush, and Clinton Administrations/

Janet McDavid is partner in the Washington, D.C., office of Hogan Lovells where she focuses on antitrust, competition, and trade regulation, with a particular emphasis on government investigations, litigation, and antitrust policy issues.  Ms. McDavid is a Past Chair of the ABA Antitrust Section, a Vice-Chair of the IBA Antitrust Committee, and provided antitrust transition advice to the Obama, Bush, and Clinton Administrations.

Kathleen McDermott is a Partner in the Washington, D.C., office of Morgan Lewis and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. She has served as an Assistant U.S. Attorney and Health Care Fraud Coordinator in the Department of Justice, and is a recipient of the HHS-OIG Inspector General's Integrity Award for her work in government healthcare fraud matters.

Peter McDonald is a former Director of BDO USA, LLP. Mr. McDonald retired in 2014 after more than 30 years of government contracting and consulting experience. He served as a Director at McGladrey and a Senior Manager at KPMG, PriceWaterhouseCoopers and Deloitte.

Deven McGraw became Deputy Director for Health Information Privacy at the Office for Civil Rights at HHS, and serves as a member of the advisory board of Bloomberg BNA's Health IT Law & Industry Report. Ms. McGraw, a well-respected privacy expert has a wealth of experience in both the private sector and the non-profit advocacy world. In addition to having written extensively on various issues relating to the Health Insurance Portability and Accountability Act (HIPAA), McGraw has been invited to testify before Congress multiple times. In 2009, she was appointed by former HHS Secretary Kathleen Sebelius to the federal Health IT Policy Committee, for which she chaired the Committee’s Privacy and Security Workgroup.

William McLucas is a Partner in the Washington, D.C., office of Wilmer Cutler Pickering Hale and Dorr LLP and Chair of the firm's Securities Department. Mr. McLucas is a sought-after advisors to public companies, boards of directors, audit committees and special committees dealing with corporate crises and related issues.

Ed McNicholas, a co-leader of Sidley’s Privacy, Data Security, and Information Law practice, has an extensive practice representing clients facing complex information technology, constitutional and privacy issues in civil and white-collar criminal matters. Mr. McNicholas focuses on trial and appellate representations of technologically-sophisticated clients facing complex personal information and cybersecurity issues.

Jerry A. Menikoff is Director, Office for Human Research Protections (OHRP), part of the Office of Public Health and Science, in the Office of the Secretary, U.S. Department of Health and Human Services (HHS), and serves as a member of the advisory board of Bloomberg BNA's Medical Research & Policy Report. Dr. Menikoff's office is responsible for protecting the rights, welfare, and well-being of subjects involved in research conducted or supported by HHS. In addition, OHRP provides leadership in the protection of human subjects participating in such research by providing clarification and guidance, developing educational programs and materials, and maintaining regulatory oversight.

Judith K. Meritz is Associate General Counsel at Covidien, a manufacturer of medical devices, medical supplies and pharmaceuticals, and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. Ms. Meritz concentrates her practice in Food and Drug Administration (FDA) compliance counseling in the areas of drugs, devices, biologics and dietary supplements.

James L. Michalowicz is a Managing Director in the Huron Consulting Group's legal practice. At Huron Legal, Mr. Michalowicz implements cost control programs for law department and law firm clients using business analytics and performance metrics.

Paul R. Michel stepped down from the U.S. Court of Appeals for the Federal Circuit in May 2010 after serving more than 22 years on the court. Judge Michel heard thousands of appeals and wrote over 800 opinions, approximately one-third of which were in patent cases. He also served as Chief Judge and as a member of the Executive Committee of the Judicial Conference of the United States.

Brent V. Miller is the Director of Federal Government Relations for the Marshfield Clinic and serves as a member of the advisory board of

Rebecca (Becky) J. Miller is a Managing Director in McGladrey LLP’s national tax office in Minneapolis.  Ms. Miller’s responsibilities include firm wide assistance on tax, consulting and financial reporting issues for all kinds of employee benefit plans, as well as tracking and anticipating industry developments. Her area of service covers employee stock ownership plans, qualified and non-qualified retirement and other deferred compensation plans, management compensation plans and total compensation planning.

William H. Minor is a Partner in the Washington, D.C. office of DLA Piper. Mr. Minor counsels corporations, associations, professional firms, nonprofits and individuals on federal and state lobbying, campaign finance, and government ethics laws and rules. Prior to joining DLA Piper, Mr. Minor served as legislative assistant to U.S. Representative Edward J. Markey. He has also worked for Marttila & Kiley, a political consulting firm, and previously held positions with the American Civil Liberties Union, U.S. Representative Joseph P. Kennedy and the Democratic Congressional Campaign Committee.

Joel M. Mitnick is a litigation partner in Sidley Austin LLP's New York office. Mr. Mitnick is a global coordinator of the firm’s Antitrust and Competition practice and former head of the firm’s electronic discovery program. His practice focuses on antitrust and securities matters on behalf of a wide array of financial market, service industry and industrial clients.

MJ Moltenbrey is a partner in the Antitrust and Competition practice of Paul Hastings and is based in the firm’s Washington, D.C., office. She represents clients before the Department of Justice and Federal Trade Commission, state attorneys general, and in federal courts on a wide array of issues, including mergers, civil and criminal conduct cases, and administrative proceedings.

H. Laddie Montague, Jr. is the President and Shareholder of Berger & Montague, P.C. and is Chairman of the Antitrust Department. He has been with the firm since its inception in 1970. Mr. Montague focuses his practice on antitrust and class action litigation. Mr. Montague was one of the courtroom trial counsel for plaintiffs in In re Exxon Valdez Oil Spill Litigation, which culminated in a record-setting punitive damage award against Exxon.

Thomas D. Morgan is the Oppenheim Professor of Antitrust and Trade Regulation Law. He teaches antitrust law and professional responsibility. He is an author of articles and widely-used casebooks in both subjects, as well as administrative law, economic regulation, and legal education. He also lectures and serves as a consultant to law firms on questions of professional ethics and lawyer malpractice.

Lewis Morris is an attorney with LeClairRyan in Annapolis, M.D. and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. He entered private practice in 2012 after retiring from the Department of Health and Human Services, Office of Inspector General (OIG) with 25 years of service. He served as Chief Counsel to the OIG for ten years, during which time his office crafted compliance guidance for the health care industry, issued resource materials for health care boards of directors, and implemented the OIG self-disclosure protocol.

Helen Morrison is a Principal in the National Tax Department of Ernst & Young LLP in the Washington, D.C office. As a member of the Compensation and Benefits practice, Ms. Morrison assists clients in addressing compliance and management of health care reform, executive compensation, and other key employee benefits tax-related matters.

I. Leo Motiuk, Special Counsel with Windels Marx Lane & Mittendorf, LLP in New Brunswick, N.J., focuses on transactional, regulatory and litigation matters in the environmental area. He has been Special Litigation Counsel in a number of major matters, including a successful challenge to a water discharge fee permit system devised by the State of New Jersey and a successful defense all the way to the U.S. Supreme Court against the City of Philadelphia and others in regard to solid waste flow orders.

Lateef Mtima is a Professor of Law and the Founder and Director of the Institute for Intellectual Property and Social Justice at the Howard University School of Law (HUSL). A member of the HUSL law faculty since 1998, Professor Mtima teaches and writes in the areas of bankruptcy and debtors and creditors' rights, commercial law, torts, and intellectual property law, with emphases in the areas of software and Internet issues, and the digital divide.

Linda S. Mullenix holds the Rita and Morris Atlas Chair in Advocacy at the University of Texas School of Law. Professor Mullenix has been a professor since 1974, teaching federal civil procedure, mass tort litigation, current issues in class action litigation, aggregate and class action litigation in a global context, and state class action procedure. She also has taught complex litigation, federal courts, conflicts, professional responsibility, and civil justice reform.

Timothy J. Muris, a George Mason University Foundation Professor of Law, served from 2000-04 as Chairman of the Federal Trade Commission (FTC). During his tenure at the FTC, he created the highly popular National Do Not Call Registry that has allowed millions of consumers to block unwanted telemarketing calls.

Lisa Murtha is a Senior Managing Director at FTI Consulting where she is part of the Health Solutions practice and serves as a member of the advisory boards of Bloomberg BNA's Medical Research & Policy Report and Health Care Program Compliance Guide. She focuses her practice in corporate ethics and compliance programs, and in both sponsor and research site clinical research compliance, which includes Physician Sunshine Act compliance, aggregate/promo spend issues, off-label use issues, issues related to payments to health care professionals, human subject protections, effort reporting/grant accounting, scientific misconduct, conflicts of interest, internal auditing and monitoring, and clinical trial billing and process improvement.

David Mustone is a Partner with Hunton & Williams in the firm’s McLean, Va., office.  Mr. Mustone’s practice includes advising employers and third-party administrators on all tax and ERISA aspects of employee benefits law and related labor and employment law. His clients include publicly traded and privately held for-profit employers, as well as a wide variety of nonprofit and governmental employers.

Jim Myers, a Partner at Ropes & Gray LLP, works with clients on complex civil litigation, especially patent litigation involving a wide range of technologies, particularly financial services, insurance, banking and computer systems software patent litigation. Starting on September 16, 2012—the first day the Patent Trial and Appeal Board (PTAB) permitted filings under the American Invents Act—his clients began filing patent invalidity challenges before the PTAB as part of coordinated patent litigation strategies. Final Written Decisions by the PTAB cancelled all challenged claims in all five patents.

Donald J. Myers is a retired Partner in Morgan Lewis’s Washington D.C. office Employee Benefits and Executive Compensation practice. He focused his practice on the fiduciary responsibility provisions of ERISA and ERISA compliance issues. He regularly represented clients before the U.S. Congress; government agencies such as the Department of Labor, the Pension Benefit Guaranty Corporation, the Internal Revenue Service, and the Securities and Exchange Commission; and federal and state banking regulators.

Kirk J. Nahra, a Partner with Wiley Rein LLP, specializes in privacy and information security litigation and counseling, along with a variety of health care, insurance fraud, and compliance issues, and serves as a member of the advisory boards of Bloomberg BNA's Health Law Reporter and Health Care Fraud Report. Mr. Nahra assists companies in a wide range of industries in analyzing and implementing the requirements of privacy and security laws across the country and internationally. He also works with insurers and health care industry participants in developing compliance programs and defending against government investigations into their practices.

Wim Nauwelaerts is a Belgian-qualified attorney and Partner in the Brussels office of Hunton & Williams. Mr. Nauwelaerts advises and counsels clients on all aspects of E.U. and international data protection and privacy compliance, including compliance training, data protection notifications, data transfer strategies, implementation of data security measures, Privacy Impact Assessments, privacy implications of cross-border M&A transactions, representations before data protection authorities and reviews of websites and online privacy policies.

Richard Neely, a Partner at Neeley & Callaghan in Charleston, West Virginia, is a retired Chief Justice of the West Virginia Supreme Court of Appeals. He was elected to the court for two 12-year-terms in 1972 and 1984. He had previously served as a member of the West Virginia House of Delegates.

Kevin E. Noonan is a Partner with McDonnell Boehnen Hulbert & Berghoff LLP and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. An experienced biotechnology patent lawyer, Mr. Noonan brings more than 20 years of extensive work as a molecular biologist studying high-technology problems in serving the unique needs of his clients. His practice involves all aspects of patent prosecution, interferences, and litigation.

James L. Oakes is a Principal at Health Care Information Consults and serves as a member of the advisory board of Bloomberg BNA's Health IT Law & Industry Report. His career spans over 35 years in healthcare information systems and management engineering, with extensive experience as an operating manager, vendor executive and consultant. He specializes in helping healthcare providers plan and optimize their use of information resources, systems, and technology to improve clinical, operational, and financial outcomes. He has assisted numerous health organizations with meaningful use compliance and with improving oversight of their EHR environment.

James P. O' Brien chairs Baker & McKenzie LLP's Global Energy, Mining & Infrastructure Practice Group. He serves as Counsel in major project and infrastructure transactions such as power generation and waste recycling facilities. Both on behalf of project sponsors and lenders, Mr. O'Brien has led moving complex projects through development, project financing and operation.

Kirk Ogrosky, a Partner in Arnold & Porter LLP's Washington, D.C., office, defends business entities and individuals in government investigations, prosecutions, qui tam litigation, and trials, and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. Prior to joining Arnold & Porter LLP, Mr. Ogrosky served as deputy chief of the Fraud Section within the Criminal Division of the U.S. Department of Justice (DOJ), and is recognized as the key architect behind DOJ's modern criminal health care fraud enforcement programs. At the Fraud Section, Mr. Ogrosky was responsible for overseeing healthcare investigations and prosecutions, and for supervising teams of federal prosecutors with respect to a wide variety of crimes including FCPA violations, securities fraud, money laundering, and mail and wire fraud. Mr. Ogrosky also had significant policy responsibilities including serving on committees of the President's Healthcare Fraud Prevention and Enforcement Action Team (HEAT).

Regina Olshan is the Global Head of Skadden, Arps, Slate, Meagher & Flom LLP’s Executive Compensation and Benefits group in New York. Her practice focuses on advising companies, executives, and boards on navigating the regulatory complexities of executive compensation and benefits. This includes tax laws (including laws governing deferred compensation, golden parachute arrangements and deduction limitation rules), securities laws (including reporting and disclosure requirements and registration issues) and compensation-related litigation matters.

John F. Olson is a founding Partner of Gibson, Dunn & Crutcher's Washington, D.C., office. Mr. Olson represents business organizations in corporate governance, corporate securities, corporate finance and merger and acquisition matters. He has counseled many boards of directors and board committees on governance issues and in assessing shareholder litigation, responding to business combination proposals and conducting internal investigations. He has represented firms and individuals before the Securities and Exchange Commission and other federal agencies in both regulatory matters and enforcement investigations.

Ralph Oman practices and teaches copyright law at The George Washington University Law School as the Pravel Professorial Lecturer in Intellectual Property and Patent Law. He also serves as a Fellow on the faculty of the law school’s Creative and Innovative Economy Center. He has taught at The George Washington University Law School since 1993. From 1994 to 2008, he was Counsel to the international law firm, Dechert LLP. He has more than 36 years of experience in intellectual property law and legislation.

David Orbuch is the Executive Vice President at Optum where he leads the company’s ongoing focus on building optimal collaboration and service experiences for its clients, and serves as a member of the advisory board of Bloomberg BNA's Health Care Program Compliance Guide. Mr. Orbuch has more than 15 years of experience helping health care organizations meet the needs of the people and communities they serve.

Andrew L. Oringer is a Partner and Co-Chair of the ERISA and Executive Compensation Group at Dechert LLP, and leads the firm’s national fiduciary practice in New York. He counsels clients on their employee benefit plans and programs, benefits-related tax matters, and fiduciary issues arising in connection with the investment of employee benefit plan assets.

Charles D. Ossola, a Partner in Vinson & Elkins LLP's Washington, D.C., office, is a trial lawyer whose practice has spanned a broad spectrum of intellectual property litigation for more than 25 years, and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. Mr. Ossola has served as lead counsel in numerous patent, trademark, false advertising, unfair competition, copyright, and trade secret lawsuits in federal and state courts throughout the U.S. In addition, he has litigated antitrust counterclaims in patent litigation as well as independent antitrust claims arising from the use or enforcement of intellectual property rights.

John S. Pachter is a Member of Smith Pachter McWhorter PLC in the firm's Tysons Corner office. A practitioner of government contract law for more than 40 years, Mr. Pachter has engaged in substantial litigation before the Boards of Contract Appeals, the U.S. Court of Federal Claims, Federal District Courts, and the U.S. Court of Appeals for the Federal Circuit.

Deryck Palmer is a Partner in Pillsbury Winthrop Shaw Pittman LLP's Insolvency & Restructuring practice. Mr. Palmer has extensive experience advising domestic and multinational clients on out-of-court workouts, corporate restructurings and bankruptcy cases in a broad range of industries including financial services, healthcare, construction, real estate, energy, and manufacturing.

Michael Pasano, a Shareholder in the Miami office of Carlton Fields Jorden Burt, is a seasoned trial attorney who focuses his practice primarily on complex criminal and civil litigation in both federal and state court. He also handles appeals. Mr. Pasano's areas of concentration include the defense of a wide variety of white collar matters, including fraud and money-laundering; forfeitures; tax issues; FDA, FTC and SEC cases; antitrust and environmental issues; and others.

R. Hewitt Pate is Vice President and General Counsel for Chevron Corporation, a position he has held since 2009. As Chevron's chief legal officer, Pate directs the company’s worldwide legal affairs and serves on the company’s Executive Committee. Mr. Pate, a long-time partner at Hunton & Williams in Washington, D.C., headed the firm's Global Competition practice prior to joining Chevron.

Don J. Pelto is a Partner practicing intellectual property and patent litigation in the Washington, D.C., office of Sheppard Mullin, Richter & Hampton LLP, and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. Mr. Pelto serves as co-leader of the firm's Intellectual Property Practice Group and Life Sciences team.

Michael W. Peregrine is a Partner in the law firm of McDermott Will & Emery LLP based in the firm’s Chicago office and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. He represents corporations (and their officers and directors) in connection with governance, corporate structure, fiduciary duties, officer-director liability issues and charitable trust law. Mr. Peregrine is recognized as one of the leading national practitioners in corporate governance law.

Marybeth Peters, the eleventh Register of Copyrights of the United States, serving from 1994 through 2011, joined Oblon, McClelland, Maier & Neustadt, LLP’s Trademark and Copyright practice groups as Senior Counsel. She spent almost 45 years in the Copyright Office, first as a music examiner, later as attorney-adviser in the Office of the General Counsel and chief of both the Information and Reference and Examining Divisions.

Kevin L. Petrasic is a Partner in the Global Banking and Payments Systems practice of Paul Hastings and is based in the firm’s Washington, D.C., office. He advises banks and financial services firms on a wide array of regulatory, legislative, transactional, and compliance issues under federal and state banking laws, as well as federal securities and commodities laws.

Marvin Petry, a Member of Stites & Harbison PLLC in Alexandria, Va., has litigated 40-plus infringement actions and prosecuted patents and trademarks before the U.S. Patent and Trademark Office (USPTO) for international, Fortune 500, and midsized U.S. clients, including many patents of major economic significance.

Stephanie Philbin is Counsel in the law firm of Goodwin Procter LLP, in Washington, D.C., and a member of the firm's Life Sciences Practice, and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. Ms. Philbin focuses on Food and Drug Administration (FDA) laws, advising clients on regulatory and compliance issues including those related to testing, pre-market submissions, the Quality System Regulation, Medical Device Reporting, recalls, product importing and exporting, and product promotion.

Richard M. Phillips is a Senior Partner in the San Francisco office of K&L Gates LLP. Mr. Phillips concentrates his practice in securities regulation, particularly investment management, broker/dealer and Securities and Exchange Commission (SEC) enforcement. He previously held various positions on the SEC staff, including Assistant to the Chairman, Assistant General Counsel, and Staff Director of SEC Corporate Disclosure and Investment Company Studies.

Thomas A. Piraino, Jr. was Vice President, General Counsel, and Secretary for Parker Hannifin Corporation before his retirement in 2014. At Parker, he was responsible for managing the company’s legal and government contract compliance affairs. He oversaw all of Parker’s domestic and international legal operations.

Robert Pitofsky is Professor and Dean Emeritus of the Georgetown University Law Center. Professor Pitofsky has served as a Commissioner of the Federal Trade Commission (FTC), the Director of the Bureau of Consumer Protection of the FTC, Counsel to the American Bar Association Commission to Study the FTC, and Chair of a Department of Defense Task Force on downsizing the Defense Industry.

Irving Pollack is a former Commissioner and Director of the Divisions of Enforcement and Market Regulation for the U.S. Securities and Exchange Commission. Mr. Pollack has consulted for numerous governmental and private institutions, including the World Bank, the International Finance Corporation (World Bank affiliate), the International Organization of Securities Commissions (IOSCO), the National Association of Securities Dealers, the Ontario and Quebec Securities Commissions and Merrill Lynch Pierce Fenner & Smith, Inc., Edward Jones, and the U.S. Synthetic Fuels Corporation.

Suniti Ponkshe is a Senior Healthcare Executive with Accenture, LLC, where she provides expert consultation to clients in strategic planning, operations management and technology services in all aspects of health information technology including electronic health records and health information exchanges, and serves as a member of the advisory board of Bloomberg BNA's Health IT Law & Industry Report.

Michael A. Pope is a Partner in the law firm of McDermott Will & Emery LLP based in its Chicago office. He heads the firm's international Product Liability Practice Group. He is currently representing numerous Blue Cross Blue Shield plans in an ERISA class action in Chicago, and Syngenta Crop Protection in two class actions filed in Central Illinois. He has also represented McDonald’s in an MDL action involving the marketing of its french fries, as well as Coca-Cola, ExxonMobil and State Farm in commercial class actions in Illinois.

Laurence Popofsky, a Senior Counsel in Orrick’s San Francisco office, is a member of the firm's Litigation Group. Mr. Popofsky focuses his practice on a variety of antitrust and intellectual property matters, encompassing all aspects of antitrust jurisprudence, both state and federal court and agency alike.

Mark S. Popofsky, a veteran of the landmark Microsoft trial, chairs Ropes & Gray’s Antitrust Practice Group. A first-chair trial lawyer, Mr. Popofsky litigates antitrust, intellectual property and other complex business litigation matters. Mr. Popofsky’s litigation practice includes jury trials, class actions, arbitrations and appeals throughout the federal and states courts.

Andrew F. Popper teaches torts, administrative law, government litigation (a seminar), and advanced administrative law at American University’s Washington College of Law. He was Associate Dean of the law school between 1988 and 1995. He is the recipient of the American Bar Association (ABA) Robert B. McKay Award for Excellence in Tort Law and of a number of university-wide awards.

Carol Pratt is a Partner in K&L Gates’ Portland office where her practice focuses on regulatory issues associated with research, development and FDA requirements that apply to bio-medical and health products, and serves as a member of the advisory boards of Bloomberg BNA's Life Sciences Law & Industry Report and Medical Research Law & Policy Report. Dr. Pratt holds a Ph.D. in neuroscience and has an extensive background in medical research.

Timothy Pratt is Executive Vice President, Chief Administrative Officer, General Counsel and Secretary for Boston Scientific and a member of its Executive Committee, and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. In this role, he is responsible for worldwide management of Boston Scientific’s legal functions, global regulatory affairs, government affairs, enterprise strategy and marketing, health economics and reimbursement, corporate communications, and aviation.

The Honorable George C. Pratt, an arbitrator, mediator and consultant in national and international disputes, serves as Special Counsel to Farrell Fritz's litigation department in major federal and state trial and appellate cases. Mr. Pratt is a former judge on the U.S. Court of Appeals for the Second Circuit and a former U.S. District Court Judge in the Eastern District of New York. He rejoined Farrell Fritz, the firm he helped found prior to his judicial appointments, in 2001.

Ernest D. Prentice is the Associate Vice Chancellor for Academic Affairs at University of Nebraska Medical Center (UNMC) and serves as a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report. He is also Professor of Genetics, Cell Biology and Anatomy. Dr. Prentice is the Institutional Official (IO) for both the UNMC Human Research Protection Program (HRPP) and the UNMC Animal Care and Use Program (ACUP).

Ted Prince is a Senior Counsel in Alston and Bird LLP's Intellectual Property Group with more than 48 years of experience litigating and prosecuting trademark cases before the U.S. Patent and Trademark Office and in federal and state courts. Mr. Prince also has extensive experience in counseling clients on how to protect their intellectual property and in negotiating settlements of disputed matters.

Gray R. Proctor is the principal in the Law Office of Gray R. Proctor where he focuses on the post-conviction needs of criminal defendants, from appeals and habeas to prisoner civil rights/civil liberties and pardons, expungements, and restoration of civil rights.

Phil Proger, a Partner in Jones Day's Washington, D.C., office, practices antitrust law with emphasis on matters before U.S. and international enforcement agencies, including mergers and cartel investigations, as well as antitrust litigation. He has extensive experience advising on antitrust issues in a broad range of industries, including health care, chemicals, insurance, media, pharmaceuticals, software, and retail.

Gerard Prud'homme is a Partner in the Washington, D.C., and Baltimore offices of Hogan Lovells and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. Mr. Prud'homme's practice is primarily focused on the regulation of medical devices and pharmaceuticals, where he represents both small and large manufacturers with matters before the Food and Drug Administration (FDA).

Tom Quinlan is a Partner at Reed Smith representing companies in corporate, intellectual property and finance transactions, and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. Many of Mr. Quinlan's clients are technology, health care or life science companies. He also advises Boards and management on corporate governance and other matters relating to the duties of officers and directors.

Yvonne Quinn is a Member of Sullivan & Cromwell LLP's Litigation Group and one of two partners in charge of coordinating the firm’s Antitrust Group. Ms. Quinn practice focuses on antitrust litigation, merger analysis and review, and counseling work. Ms. Quinn’s clients include leading commercial banks, equity funds, investment banks, insurance companies, cable television operators, television programming suppliers, newspapers, publishers, sports franchise owners, advertising sales and healthcare companies, pharmaceutical and chemical companies, and many others.

Paul H. Raab is an economic consultant with a focus on the energy utilities industry. His experience includes mathematical and economic analyses and system development and his areas of expertise include regulatory change management, load forecasting, supply-side and demand-side planning, management audits, mergers and acquisitions, costing and rate design, and depreciation and life analysis.

Jani K. Rachelson is a Partner at Cohen Weiss and Simon LLP in New York, where her practice focuses on employee benefits law. She represents multiemployer employee benefit plans, as well as plans sponsored by unions for their internal staff. She provides compliance advice to plan clients with respect to a wide variety of laws, including ERISA and the tax code. She also advises them on plan design and administration, withdrawal liability, delinquency collection, benefit claims and fiduciary issues.

Per Ramfjord is a Partner of Stoel Rives LLP and the former Chair of the Litigation Practice Group. Mr. Ramfjord represents clients in complex civil and criminal litigation, with an emphasis on environmental, energy and white-collar criminal matters. He is also active in the firm's Property Tax section.

Carey Ramos is Partner in the Hong Kong office of Quinn Emanuel Urquhart & Sullivan LLP and Co-Chair of the firm’s National Media & Entertainment Practice. He has a broad practice that concentrates on cross-border disputes and media and technology matters. Mr. Ramos has represented prominent clients in widely publicized patent, copyright and trademark actions involving music, motion pictures, computer technology, telecommunications, and consumer electronics.

Joshua Raskin is managing director at Barclays Capital specializing in the health sector and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. He was previously managing director at Lehman Brothers.

Richard D. Raskin is co-chair of Sidley Austin LLP's global Healthcare practice team and head of the Chicago Healthcare group and serves as a member of the advisory of Bloomberg BNA's Health Law Reporter. For over 25 years, his practice has focused on complex healthcare litigation involving antitrust, fraud and abuse, and reimbursement issues.

James Ravitz is practice group leader for Arent Fox LLP's FDA Practice (Food & Drug) and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. He also is a member of the firm's life sciences and advertising groups, with a well-rounded practice focused on food and drug law, healthcare, consumer product safety, and advertising. Mr. Ravitz serves as vice chair of the firm's consumer product safety committee. Mr. Ravitz's FDA practice assists clients in navigating regulatory requirements impacting medical device combination products and medical technologies. He also helps clients through all regulatory phases of the approval, manufacture, marketing and retail process.

Andrew E. Rawlins is a Partner and patent lawyer with Foley & Lardner LLP and is Vice Chair of the firm’s Intellectual Property Department, and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. Mr. Rawlins has over 25 years of experience in the patent field. Before joining the firm, he served as a patent examiner at the U.S. Patent and Trademark Office.

Teresa Stanek Rea is a Partner in Crowell & Moring's Intellectual Property Group and a director with C&M International, Ltd. (CMI), the international trade and investment consulting firm affiliated with the firm, and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. Ms. Rea is the former Acting and Deputy Director of the U.S. Patent and Trademark Office (USPTO), as well as Acting and Deputy Under Secretary of Commerce for Intellectual Property.

Bob Reder had over 33 years of experience in transactional practice as a New York-based partner of Milbank Tweed Hadley & McCloy, where he practiced in the firm's mergers and acquisitions and corporate groups from 1978 until his retirement in 2011. He became a partner in the firm in 1987 and was co-leader of the firm's global corporate practice group from 2005-09. Professor Reder represented clients from a variety of industries, including financial services, healthcare, manufacturing and technology, in M&A and capital market transactions, and advised them on a variety of corporate governance matters.

Jonathan Reichman, a Partner in Kenyon & Kenyon LLP's New York office, has 30 years' of experience in litigation, licensing and counseling matters in copyright, trademark, unfair competition and right of publicity law, particularly for clients in the entertainment industry. He is co-author and contributing editor of the book Right of Publicity 2013, which addresses critical issues in publicity rights around the world.

Benjamine Reid, a Shareholder in Carlton Fields Jorden Burt's Miami office, represents a corporate clientele in a broad range of litigation and appellate matters. Mr. Reid has extensive jury trial and appellate experience in both state and federal courts in over 20 states. A substantial portion of his practice has involved class actions.

Alan Reider is a Partner in Arnold & Porter LLP's FDA and Healthcare practice group with more than 30 years of experience representing national healthcare corporations, pharmaceutical and medical device companies, institutional providers and individual practitioners and suppliers, and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. His practice focuses on compliance and fraud and abuse counseling, reimbursement and coverage and certification issues, and relationships with third party payors.

Ellen Relkin, Of Counsel with Weitz & Luxenberg P.C. in New York, focuses her practice on pharmaceutical and medical device product liability and toxic tort matters. Ms. Relkin has represented plaintiffs injured by the birth control patch Ortho Evra, the acne drug Accutane, the oral contraceptives Yaz, Yasmin and Ocella, Hydroxycut dietary supplement products, defective Zimmer Durom Cup hip implants, and those who suffered serious health problems related to their mother’s use of the drug DES during pregnancy, among other defective medical products.

Michael J. Remington, a Partner with Drinker Biddle & Reath LLP in Washington, D.C., has over 35 years of experience in intellectual property law (copyrights, trademarks, patents and semiconductor chip mask works), legal reform, government relations and lobbying.

Michael Reynolds is a Partner in the Brussels office of Allen & Overy where he has more than 30 years experience in European Antitrust law. Mr. Reynolds has represented a large number of corporations from the U.S., Japan and Brazil and other international clients before the European Commission in merger control, cartel and unilateral conduct cases.

Paul D. Rheingold is the founder of Rheingold, Valet, Rheingold, McCartney & Giuffra LLP and has been in practice since 1958. He has been active in mass tort work, including leadership and educational roles in over 20 drug and devices mass torts. Mr. Rheingold has handled depositions of company witnesses and defense experts in many of these mass tort cases and has represented bellwether clients in many of these same cases, including Yaz/Yasmin.

Lori S. Richardson Pelliccioni is a Partner and litigation attorney with Foley & Lardner LLP and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. She focuses her practice on health care regulatory compliance, health care fraud and abuse, and health care fraud litigation.

Max Richtman is President and CEO of the National Committee to Preserve Social Security and Medicare (NCPSSM) and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. Mr. Richtman also serves as Chair of the National Committee's Political Action Committee (PAC) board. Mr. Richtman has testified before House and Senate committees, participated in hundreds of Congressional Town Hall meetings across the country and has been a featured speaker during numerous national and state conferences on aging.

Thomas L. Riesenberg is Deputy General Counsel for Ernst & Young LLP, where he is responsible for the firm’s regulatory matters, primarily involving the SEC and the PCAOB. Mr. Riesenberg has worked at Ernst & Young for nearly 20 years. He previously served as an Assistant General Counsel at the Securities and Exchange Commission, where he handled appellate litigation and other matters.

Larry Riff is a Partner in Steptoe & Johnson LLP's Los Angeles office, where he serves as Managing Partner. He is a member of the Litigation Department and Practice Group Leader of the Firm's 40+ lawyer Mass, Toxic and Environmental Litigation Practice Group. Mr. Riff focuses on the defense of the petroleum, energy and chemical industries in toxic substance personal injury, death, environmental and property damage claims in state and federal courts.

James Rill, Senior Counsel at Baker Botts in Washington, D.C., is one of foremost antitrust attorneys in the United States. Mr. Rill has served as Assistant Attorney General in charge of the U.S. Department of Justice’s Antitrust Division, as well as a Chairman of the ABA’s Antitrust Section.

Jeffrey Ritter is the founder and CEO of The Ritter Academy, a leading online e-discovery education provider. In the role, he authors and approves the content of every course published by the Academy. Mr. Ritter serves on the Georgetown Law School E-Discovery Institute Advisory Board and is a frequent lecturer to professional audiences in records management, information security, and the legal profession. He is a lecturer at The Johns Hopkins University Whiting School of Engineering and the University of Oxford. He has also published three books on e-discovery.

Brian D. Roark is a Member in the Nashville office of Bass Berry & Sims and head of the firm's Healthcare Fraud Task Force, and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. Mr. Roark concentrates his practice on representing healthcare clients facing governmental investigations and related litigation, with a particular focus on matters brought by the U.S. Department of Justice and Office of Inspector General of the U.S. Department of Health and Human Services and other regulators, concerning alleged violations of various health care laws and regulations, including the False Claims Act.

Gary Robb of Robb & Robb LLC in Kansas City is one of only a handful of Plaintiffs' trial lawyers nationwide to have obtained at least five jury verdicts and five settlements in personal injury or wrongful death cases in excess of $20 million. Mr. Robb has obtained numerous record-breaking results on behalf of past clients, including the two highest jury verdicts in U.S. history for helicopter crash wrongful death and the largest pre-trial settlement for an injury in a helicopter crash.

Sharon Roberg-Perez is a Principal in the Intellectual Property and Technology Litigation Group at Robins Kaplan LLP and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. She is an M.I.T-trained Ph.D. who leverages over a decade of experience working as a molecular biologist in her legal practice. She serves on the firm’s diversity committee and has been an instructor in the firm’s Exceptional Advocate Training Program.

Richard Roberts is a Principal at Roberts, Raheb, & Gradler, LLC, a regulatory/legislative consulting firm that he co-founded in 2006. He provides strategic advice and targeted lobbying services for Fortune 500 and small business financial services clients. Mr. Roberts facilitates communication and engagement between clients and federal agencies and with the Congress.

Kim H. Roeder is a partner in King & Spalding’s Healthcare Practice Group in Atlanta and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. Her practice focuses on representation of healthcare providers, including hospital systems, academic medical centers, physician practice groups and suppliers. Roeder has assisted providers and suppliers in implementing compliance programs, as well as conducting compliance assessments and internal investigations. She has also represented healthcare providers in responding to Department of Justice and Office of Inspector General investigations and qui tam actions.

Anthony Rollo is a Member in McGlinchey Stafford's New Orleans office. Mr. Rollo is a trial lawyer primarily focusing on class action and complex litigation around the country involving all types of commercial and consumer disputes. His practice areas include: consumer class action and multidistrict litigation; licensing, regulatory, privacy and litigation aspects of selling products and services over the Internet and implementing online strategies.

John J. Ronayne, III is an attorney with Bernardi, Ronayne & Glusac, P.C. in Plymouth, Michigan where he specializes in media law, state and local taxation law, corporate law and arbitration. Mr. Ronayne served as an Assistant and Associate Professor at the Detroit College of Law between 1975 and 2000. He has also worked as a mediator with the Mediation Tribunal Association since 1987.

Edith A. Rosato is the Chief Executive Officer of the Academy of Managed Care Pharmacy, where she is an advocate for the expanding role for pharmacists in new care delivery models where a patient's care is coordinated across the health care system by many health care providers. She is also a registered pharmacist and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report.

Jonathan Rose, an Emeritus Professor of Law at Arizona State University's Sandra Day O'Connor College of Law, spent most of his career focusing on antitrust, regulation and legal ethics. His primary scholarly interests now involve medieval and early modern English legal history, and his research focuses on the history and regulation of the legal profession and the operation of the medieval legal system. Professor Rose has also written on early defamation law, medieval prisons, and the historiography of legal history.

David Rosen is a Partner and public policy lawyer with Foley & Lardner LLP and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. Mr. Rosen has extensive experience in health law, life sciences, and food and drug regulation, including a range of Food and Drug Administration (FDA) regulatory issues affecting prescription and over-the-counter pharmaceuticals, medical devices and biologics.

Douglas E. Rosenthal is a partner in Constantine Cannon LLP, who has 36 years of antitrust and international litigation experience. In recent years, Mr. Rosenthal has been increasingly involved in advising clients on the impact on their businesses of domestic and global competition laws and policy considerations.

Colin Roskey is a Partner in Alston & Bird LLP's Washington, D.C., office and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. He focuses his practice on federal health care program payment and operational issues affecting stakeholders with concerns ranging from licensure and survey and certification issues to complex prospective payment system methodologies and coverage, coding and reimbursement strategies for new services and technologies.

Douglas Ross is a Partner at Davis Wright Tremaine LLP and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. He concentrates his practice in antitrust and complex litigation. He entered private practice after spending four years with the government, primarily at the Antitrust Division of the U.S. Department of Justice. He served as chair of the firm’s litigation practice group from 2008 through 2013.

Kenneth Ross is Of Counsel and a former Partner to Bowman and Brooke LLP, where he practices in the areas of product safety, product liability prevention, and regulatory compliance. Mr. Ross advises U.S. and foreign manufacturers, product sellers, and the insurance industry on ways to identify, evaluate, minimize and avoid the risk of liability, especially product liability, contractual liability and regulatory liability.

Robert L. Roth is a Managing Partner at Hooper, Lundy & Bookman, P.C.'s Washington, D.C., office and serves as a member of the advisory boards of Bloomberg BNA's Health Law Reporter, Medicare Report, and Health Care Program Compliance Guide. He advises clients on matters arising under Medicare and Medicaid, focusing on payment, compliance, and licensing issues. A former senior attorney for the Centers for Medicare & Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS), and a former Assistant Attorney General for the State of Maryland, Mr. Roth represents a wide range of clients on federal and state regulatory and business matters.

Jack Rovner is an attorney and a Principal of The Health Law Consultancy and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. He has counseled health plans, hospital systems and other health organizations on a diverse array of matters, including health reform, health information privacy, security, transactions and technology, Medicare, Medicaid and other government health benefits programs, fraud and abuse control, antitrust and federal regulatory compliance.

Brian Rubin is a Partner in the Washington, D.C., office of Sutherland Asbill & Brennan LLP and office leader of the firm’s Litigation group and the Administrative Partner in charge of the Securities Enforcement and Litigation Team. With more than 20 years of experience in federal securities law, first prosecuting and now defending, Mr. Rubin represents clients being examined, investigated and prosecuted by the U.S. Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), other self-regulatory organizations and states.

Asher Rubin is the global co-head of the Hogan Lovells Life Sciences Industry Sector Team, a multidisciplinary team focused on providing a full spectrum of legal services to clients in the life sciences industry, and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. Mr. Rubin's practice is focused on all aspects of transactional, corporate, and securities matters for life sciences clients, including mergers and acquisitions, licensing and complex commercial agreements, and public and private financing transactions.

D. Alan Rudlin, a Partner in Hunton & Williams LLP's Richmond office, has handled a number of significant appellate, defamation and constitutional litigation matters and has extensive experience breaking down complex areas of expert evidence for judges and jurors. Mr. Rudlin has also extensive knowledge in the various types of alternative dispute resolution and has served as the Chair of his state bar’s Joint Committee on Alternative Dispute Resolution.

Charles F Rule is head of the Cadwalader, Wickersham, & Taft Antitrust Group, co-chair of the firm’s Litigation Department, Managing Partner of the Washington, D.C., office, and a member of the firm’s Management Committee. Mr. Rule focuses his practice on providing U.S. and international antitrust advice to major corporations in connection with “bet your company” matters, particularly high-profile mergers, acquisitions, and joint ventures.

Michelle Russell-Einhorn is Senior Director of the Office for Human Research Studies at the Dana-Farber Cancer Institute, which is responsible for the management of scientific review and institutional review board review and other regulatory matters involving all cancer research involving human subjects conducted at the five Harvard clinical institutions as part of the Dana-Farber/Harvard Cancer Center, and serves as a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report.

Louis Saccoccio is the CEO of the National Health Care Anti-Fraud Association, a private-public partnership focused exclusively on combating health care fraud, and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. He was previously General Counsel and Senior Vice President of Professional Services at America's Health Insurance Plans (AHIP).

Robert D. Sack has been a Judge of the U.S. Court of Appeals for the Second Circuit since August 6, 1998. He took senior status on August 6, 2009. During his 33 years in practice, he specialized in national and international press law.

Bob Sacoff, a Partner with Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP in Chicago, has concentrated his practice in trademark and unfair competition law and litigation for over 30 years. He has handled cases in courts throughout the country and in the Trademark Trial and Appeal Board involving such diverse industries and product fields as wine, fashion apparel, publishing, holiday lighting, agricultural and construction equipment, vehicle rental, online event ticketing, automobile parts and accessories, and computer and high technology products.

Jeffrey M. Samuels served as the Director of The Center for Intellectual Property Law and Technology and as the David L. Brennan Professor of Law from 1998 to 2014. He taught courses in trademark and unfair competition law, international intellectual property law, introduction to intellectual property law, trademark prosecution, current issues in IP law, intellectual property policy and politics and a seminar in counterfeiting and piracy.

Bruce Sanford is a Partner in the Washington, D.C., office of Baker & Hostetler LLP where he maintains a media and First Amendment law practice focused on representing high-profile clients in cutting edge and complex litigation. Noted for his knowledge of media law and its environment, he also serves as a counselor to families owning media conglomerates, advising on the evolution of their businesses in a digital world.

Joshua D. Sarnoff is a Professor of law at DePaul University, where he teaches patent law and other related courses. Prior to joining DePaul, he was a professor at the Washington College of Law, American University, teaching patent law and supervising students in the Glushko-Samuelson Intellectual Property Law Clinic. He also taught at the University of Arizona College of Law.

Michael Schaff is Chair of the Corporate and Healthcare Departments and Shareholder of Wilentz, Goldman & Spitzer P.A., and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. He has helped structure professional practices for many healthcare professionals including physicians, dentists, chiropractors and other business entities interested in buying, selling or merging businesses, and for a variety of other manufacturing, retail, and service businesses requiring legal experience. Additionally, Mr. Schaff has served as general corporate counsel for many privately-held companies.

Roger Schechter joined The George Washington University Law School faculty in 1980. He teaches the basic course in torts and a variety of intellectual property courses, such as copyright law and trademark law. He is also a bar review lecturer on torts and family law in numerous jurisdictions around the country. He has twice received the Law School’s Distinguished Faculty Service Award; he also was awarded the 1997 Trachtenberg Prize for University Service. In 2004, the Brand Names Education Foundation awarded him their Pattishall Medal for excellence in the teaching of trademark law.

Tom Schendt is a Partner in the Washington office of Alston & Bird where he is a member of the Employee Benefits and Executive Compensation Group. His practice focuses on employee plan litigation, civil and criminal agency audits, investigations and disputes and voluntary compliance initiatives. Mr. Schendt also regularly counsels large employers on the practical effect of various qualification requirements that are issued by appropriate government agencies.

Irving Scher is senior counsel in Greenberg Traurig's New York office. He focuses his practice on antitrust, marketing and unfair and deceptive trade practice litigation and counseling. Mr. Scher has wide-ranging experience in antitrust, marketing and advertising matters across a broad spectrum of products and services.

William G. Schiffbauer established the Schiffbauer Law Office in 1997, and currently serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. He began his private law practice after serving as Counsel and Legislative Assistant to U.S. Senator J. James Exon (D-Nebr.). He was previously a Partner in the law firm of Groom & Nordberg. Mr. Schiffbauer practices in the areas of federal and state legislation and regulation relating to health insurance, health plans, health care policy, ERISA, Medicare, Medicaid, and health insurance tax-related matters.

Jan R. Schlichtmann specializes in the area of complex civil litigation including consumer, environmental, product, toxic, and mass tort litigation. Mr. Schlichtmann received national recognition for his representation of eight Woburn, Massachusetts families against W.R. Grace and Beatrice Foods for the contamination of the Woburn City water supply. The Woburn case and Mr. Schlichtmann’s work in it was chronicled in the book, “A Civil Action."

Michael Schmidl is a specialist lawyer for information technology law (Fachanwalt für IT-Recht) in Baker & McKenzie's Munich office. Dr. Schmidl advises in all areas of contentious and non-contentious information technology law, including Internet, computer/software, data privacy and media law.

Michael C. Schmidt is the Vice Chair of Cozen O’Connor’s Labor and Employment Department, resident in the firm’s midtown office in New York City. For more than two decades, Mike has concentrated his practice on representing companies in litigation on all facets of employment law (including wage and hour, discrimination/harassment, disability and contract issues), and providing day-to-day advice to companies on issues from hiring to firing. Mike is also an adjunct professor of employment law at Touro Law School in Central Islip, New York, and regularly discussed employment law developments on Twitter (@MSchmidtEmpLaw) and on his blog (

Jerold I. Schneider has been actively involved in over 200 intellectual property lawsuits and has obtained over 1000 patents and trademarks for his clients. Mr. Schneider’s patent and trade secret litigation has involved cases in the electronic, chemical, mechanical, software, business methods and biotech industries. His trademark experience has covered a variety of products and marks, and his copyright litigation experience has involved virtually all aspects of copyright protection.

Maria Schneller is a former Partner with Venable LLP in Washington, D.C. Ms. Schneller previously worked for the Mobil Oil Corp. and was Technical Assistant to the Honorable Helen Nies of the U.S. Court of Appeals for the Federal Circuit. She has served as an a Lecturer at George Mason University Law School and the University of Maine Law School.

Mark K. Schonfeld is a litigation Partner in the New York office of Gibson, Dunn & Crutcher and Co-chair of the firm’s Securities Enforcement Practice Group. He is also a member of the Crisis Management and the White Collar Defense and Investigations Practice Groups. Mr. Schonfeld’s practice focuses on the representation of financial institutions, public companies, hedge funds, accounting firms and private equity firms in investigations conducted by the Securities and Exchange Commission (SEC), Department of Justice, States Attorneys General, FINRA and other regulatory organizations. Mr. Schonfeld also conducts internal investigations and counsels clients on compliance and corporate governance matters.

Kenneth Schuler is global Co-Chair of Latham & Watkins' Intellectual Property Litigation Practice and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. Mr. Schuler has extensive litigation experience in federal and state courts, as well as in commercial arbitrations. His practice primarily involves litigation concerning intellectual property rights, with a particular emphasis in pharmaceutical patent litigation involving claims arising under the Hatch-Waxman Act.

Victor Schwartz is a Partner in the Washington, D.C., office of the law firm of Shook, Hardy & Bacon L.L.P. and chairs its Public Policy Group. Mr. Schwartz has an active appellate practice, and advises product manufacturers on liability prevention, litigation, and public relations issues. Mr. Schwartz is on the Board of Directors of the Searle Civil Justice Institute at George Mason University School of Law.

Charles Seemann is a Partner in the New Orleans office of Jackson Lewis P.C. where he is a member of the Employee Benefits practice. His practice includes the defense of ERISA plans and plan fiduciaries at both public and private companies, multiemployer plans and plan fiduciaries, and financial institutions providing services to ERISA plans.

Donald J. Segal is a retired Vice President from Aon Hewitt in New York where he specialized in analysis, interpretation and application of laws and guidance as they apply to qualified retirement plans.  

Rochelle Seide is a Principal at RKS Consulting, where she specializes in life science business and IP consulting, and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. Dr. Seide has more than two decades of experience as a patent attorney, with the majority of it focused in the life sciences industry. Dr. Seide was previously the Vice-President, Intellectual Property for Valeant (formerly Biovail Laboratories).

Francis J. Serbaroli is a Shareholder in the Health & FDA Business Practice of Greenberg Traurig's New York office and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. Mr. Serbaroli has three decades of experience in the health care industry. His clients include health insurers and managed care plans; hospitals, nursing homes, clinics, ambulatory surgery centers and home health agencies; clinical laboratories; renal dialysis providers; faculty practice plans; pharmaceutical companies; and medical device and equipment manufacturers.

Bob Serino is Of Counsel of BuckleySandler LLP. Mr. Serino‘s practice focuses on supervision, regulation, enforcement and regulatory relations issues related to the financial services industry. He represents clients before federal and state agencies on matters affecting their operations and advises clients on the requirements and issues involved in Bank Secrecy/Anti-money laundering issues and various compliance and regulatory problems.

Daniel P. Shapiro is a Partner in the Chicago office of Katten Muchin Rosenman LLP who has successfully represented clients across the country in complex business litigation. Mr. Shapiro focuses his practice on commercial disputes, litigating and trying significant cases including disputes arising out of the purchase and sale of businesses and securities, business valuations, contracts, products liability claims and complex class actions.

James Sheehan is the Chief of the Charities Bureau for the New York State Department of Law, which is responsible for oversight of the state's non-profit sector, and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. He has more than 30 years of high-level experience working as an attorney for the city, state and federal governments, having previously served as the Chief Integrity Officer for the New York City Human Resources Administration, which is the nation's largest social services and health care benefits agency.

Deborah M. Shelton serves as in-house counsel to the Biotechnology Industry Organization, managing legal advice and services with respect to legal, policy, and regulatory healthcare matters affecting the biotechnology industry, primarily the regulatory activities of the FDA, CMS, and NIH, and related legislative activities, and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report.

Larri Short is a Partner in the Health Law Group of Arent Fox, LLP, where she focuses principally on regulatory, pricing, reimbursement, and compliance matters facing pharmaceutical and device manufacturers, distributors, and their customers, and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. Her practice also extends to HIPAA privacy program developments and counseling. Ms. Short is Co-Chair of Arent Fox’s Life Sciences Task Force and sits on the firm’s Prescription Drug, Biologics, and Vaccines Committee.

Charles Siegel is the head of the appellate practice at Waters, Kraus & Paul. He has argued appeals in eight federal appellate courts, in the supreme courts of Texas and five other states, and in numerous intermediate appellate courts around the country.

Alan Silberman is the Chair Emeritus of Dentons' Competition and Antitrust practice. Mr. Silberman has 48 years of experience in antitrust and franchising litigation, counseling and related transactional representation, as well as in general commercial litigation. He has represented franchisors in a number of negotiated, litigated and arbitrated disputes with franchisees and third parties and regularly represents franchising clients in domestic and international activities.

Stuart Silverman is an attorney with the Medicaid Fraud Control Unit in the District of Columbia Office of the Inspector General (OIG) and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. He also has been designated as a Special Assistant U.S. Attorney and a Special Assistant Attorney General for the District of Columbia. Mr. Silverman was previously in private practice with Greenberg Traurig, and was also with the Office of the General Counsel for the U.S. Department of Health and Human Services (HHS).

Richard Singerman is the Chief Innovation Officer for TrustNetMD and serves as a member of the advisory board of Bloomberg BNA's Health IT Law & Industry Report. He was previously an Associate Partner in IBM's Healthcare Transformation & Analytics practice where he was responsible for developing and implementing initiatives to support health system transformation.

Steven H. Sklar is a Member of Leydig, Voit & Mayer, Ltd. serving on the firm's Finance Committee, and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. He focuses his practice on intellectual property matters with an emphasis on patent litigation and counseling in the pharmaceutical and biotechnology fields. Mr. Sklar has particular experience on issues arising under the Hatch-Waxman Act.

Steve Skwara was appointed Omnicare's Chief Compliance Officer after having served as the Deputy Chief Compliance Officer, and currently serves as a member of the advisory board of Bloomberg BNA's Health Care Program Compliance Guide. Mr. Skwara oversees and leads Omnicare’s corporate compliance function, reporting directly to Omnicare’s Board of Directors and Chief Executive Officer.

Thomas Smedinghoff is a Partner in the Chicago office of Edwards Wildman Palmer LLP, where his practice focuses on the new legal issues relating to the developing field of information law and electronic business activities. Mr. Smedinghoff is internationally recognized for his leadership in addressing emerging legal issues regarding electronic transactions, identity management, privacy, information security, and online authentication issues from both a transactional and public policy perspective.

Craig B. Smith, who is Of Counsel with Smith Katzenstein Jenkins LLP, has over 30 years of experience in Delaware corporation law matters, including mergers, reorganizations, acquisitions, proxy contests, election contests, anti-takeover measures, stockholder voting requirements, legality of charter and bylaw provisions, sale of assets, indemnification, executive compensation, and special committees of the board of directors (including special litigation committees).

Tefft Smith is a Senior Litigation Counsel to the Litigation Practice Group at Kirkland & Ellis LLP, coordinating an integrated team of more than 150 Antitrust lawyers in Washington, D.C., Chicago, New York, Los Angeles, San Francisco, Palo Alto, London, Munich, Shanghai and Hong Kong.

Neil A. Smith is currently a Partner on the Intellectual Property Team at Rimon PC, San Francisco. Mr. Smith is also on the alternative dispute resolution panels for the U.S. District Court for the Northern District of California, the Federal Circuit Court of Appeals, and the World Intellectual Property Organization.

Roy Snell is the CEO of the Health Care Compliance Association (HCCA) and the Society of Corporate Compliance and Ethics (SCCE) and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. Mr. Snell was a co-founder and the organization’s first President. He has developed numerous partnerships with government, industry, and other professional associations, and he has facilitated collaboration between the compliance/ethics profession and the enforcement community.

Lynn Shapiro Snyder is a Senior Member of Epstein Becker Green in the Health Care and Life Sciences and Litigation practices in the firm's Washington, D.C., office, and is Strategic Counsel with EBG Advisors, Inc., and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. Ms. Snyder has over 30 years of experience at Epstein Becker Green, advising clients about federal, state, and international health law issues, including Medicare, Medicaid, TRICARE, compliance, and managed care issues. Her clients include health care providers, payors, pharmaceutical/device manufacturers, and those companies and financial services firms that support the health care industry.

Steven P. Solow is Co-Head of Katten's Environmental practice and Co-Head of the White Collar Defense, Internal Investigations and Compliance practice in the firm's Washington, D.C., office. Mr. Solow is also a Member of Katten’s Board of Directors and the Executive Committee.

Daniel Sommers is a Partner in the Washington, D.C. office of Cohen Milstein Sellers & Toll PLLC, which he joined in 1988. Mr. Sommers is Co-Chair of the firm’s Securities Fraud practice group and is a member of the firm’s Executive Committee. During his career at Cohen Milstein, Mr. Sommers served as lead or co-lead counsel or otherwise played a significant role in securities class actions in federal courts throughout the U.S.

Laurence T. Sorkin, Senior Counsel at Cahill Gordon & Reindel LLP, is a Senior Antitrust Advisor with over 35 years of experience in both counseling and litigation. Mr. Sorkin advises in connection with all aspects of antitrust law such as mergers and acquisitions, joint ventures, competitor collaborations, distribution and licensing practices, and price discrimination.

A. Gilchrist Sparks, III is Of Counsel and a former Partner at Morris, Nichols, Arsht & Tunnell LLP. Mr. Sparks is a member of the firm's Corporate and Business Litigation and the Delaware Corporate Law Counseling Groups. Mr. Sparks' practice is concentrated in litigation and counseling arising from mergers and acquisitions and disputes relating to the governance of Delaware corporations.

Donald Specter is the Executive Director of the Prison Law Office, a nonprofit law firm based in Berkeley, California that provides free legal services to California incarcerated offenders concerning their conditions of confinement. Mr. Specter has been lead counsel in numerous successful institutional reform cases challenging various conditions of confinement in California's adult and juvenile prison systems. He has also been chair of the California State Bar's Commission on Corrections.

Eleanor R. Spector serves as Vice President, Prime Contract Management for the Fluor Government Group. Ms. Spector previously worked as vice president of contracts for Lockheed Martin where she advised the company on program contracting strategies and was responsible for all corporate contracting policy. She has also held positions in the U.S. Defense Department as the Director of Defense Procurement and Deputy Assistant Secretary of Defense for Procurement.

James H.M. Sprayregen is a restructuring Partner in the Chicago and New York offices of Kirkland & Ellis LLP and serves on the firm’s worldwide management committee. Mr. Sprayregen is recognized as one of the outstanding restructuring lawyers in the U.S. and around the world and has led some of the most complex Chapter 11 filings in recent history.

Ingo W. Sprie, Jr. is a Partner in the New York office of Arnold & Porter LLP. Mr. Sprie's practice focuses on complex litigation, with an emphasis on class actions, mass torts, product liability, and significant business disputes. He has substantial experience defending putative class actions, cases employing novel claim aggregation theories, and cases involving other cutting-edge theories of law.

Norman Stein is a Professor of Law at the Earle Mack School of Law at Drexel University in Philadelphia where he specializes in pension, employee benefits and tax law.  Mr. Stein is a member of the Board of Governors of the American College of Employee Benefits Counsel, a fellow of the National Academy of Social Insurance and a Senior Policy Adviser to the Pension Rights Center.

John Steiner, Jr. is the Chief Compliance and Privacy Officer and Associate General Counsel for the Cancer Treatment Centers of America (CTCA) and serves as a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report. Mr. Steiner oversees the CTCA enterprise compliance program including the hospital, physician, pharmacy, research, and HIPAA compliance components. As associate general counsel, he provides legal advice and support to CTCA and its regional cancer centers. He is also a member of the CTCA executive team and leads the Executive Compliance Committee.

Richard Steuer is a Partner in the New York office of Mayer Brown where he focuses on the practice of antitrust law, including litigation, mergers and acquisitions, intellectual property licensing, franchising, and e-commerce. Mr. Steuer litigates at all levels of federal and state courts, on behalf of defendants and plaintiffs, in private suits and against government entities.

C. Evan Stewart is a Partner with Cohen & Gresser LLP in New York where his practice principally focuses on the financial services industry. Mr. Stewart handles litigation matters for domestic and international clients before federal and state trial and appellate courts, in arbitration forums, as well as before the Judicial Panel on Multidistrict Litigation and the U.S. Supreme Court.

T. Howard Stone directs the Human Research Review Section of the Washington State Department of Social and Health Services (DSHS) and serves as a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report. Mr. Stone manages human subject protection personnel and serves as the Human Protections Administrator for three Washington State agencies. He serves as the Executive Secretary of the Washington State Institutional Review Board (WSIRB), developing and implementing Washington State Agency policy and procedures on the protection of human research subjects.

George Strumpf, with EmblemHealth in the Washington office, advises the company on regulatory and policy issues with an emphasis on health reform and Medicare topics and is a registered lobbyist on behalf of EmblemHealth, and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. Mr. Strumpf has worked in the health care field for over 50 years as a regulator with the federal HMO Office, as an executive with managed care trade associations and for nonprofit and for-profit health insurance companies.

Angela B. Styles is a Partner in Crowell & Moring's Washington, D.C., office and co-chair of the firm's Government Contracts Group. Ms. Styles' current practice concentrates on government contracts counseling and litigation, including procurement ethics and compliance, civil and criminal fraud matters under the False Claims Act, mandatory disclosure, procurement integrity, the Anti-Kickback Act, General Services Administration (GSA) Schedule contracting with an emphasis on pricing issues, GSA leasing, and Buy American and Trade Agreements Act compliance. In addition, Ms. Styles conducts complex internal investigations, corporate compliance reviews, and training programs on ethics and public sector contract compliance.

Stuart Sucherman currently advises a number of entertainment and telecommunications companies, including network and cable television, motion picture, major league sports, Internet and technology media enterprises such as AETN, CNN, HLN, Paramount, NBC, Discovery Channel, BBC America and the New York Mets.

T. J. Sullivan is a health care transactional and tax Partner with Drinker Biddle & Reath LLP in Washington, D.C., with more than 20 years experience advising tax-exempt organizations on complex regulatory and business issues, and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. Mr. Sullivan specializes in matters related to tax-exempt entities including hospitals and clinics.

Win Swenson, a Partner with the Compliance Systems Legal Group, was deputy General Counsel at the U.S. Sentencing Commission (1990-96). Mr. Swenson headed the unit that developed the federal sentencing guidelines for organizations, which are widely viewed as establishing the principal model for corporate compliance/ethics programs in the U.S., and to some extent abroad.

Ariana J. Tadler, a Partner with Milberg LLP in New York, has more than 20 years of experience litigating and managing the full spectrum of complex securities and consumer class actions, including high-profile, fast–paced cases. Ms. Tadler is also a leading authority on electronic discovery in plaintiffs’ litigation.

Charles M. Tatelbaum, a Director of Tripp Scott in Fort Lauderdale, focuses his practice on bankruptcy and creditors’ rights issues, complex business litigation, Uniform Commercial Code transactions and lender liability litigation and other types of secured transactions, as well as domestic and international letters of credit.

Dean Jeffrey Telego is President of Risk Management Technologies, Inc., which performs expert environmental risk management consulting for industrial/ manufacturing clients and financial services companies. Mr. Telego is also President of RTM Communications, Inc., where he creates and chairs national conferences on environmental financing and risk management topics each year and develops customized training for the financial services industry in the U.S., Asia and in Eastern and Central Europe.

Monika A. Templeman is a consultant and attorney in Florida.  Before her retirement from the Internal Revenue Service, she was the Director of Employee Plans Examinations and was responsible for EP retirement plan compliance and enforcement programs nationwide. During her tenure as Director, she made major improvements to examination programs designed to bring retirement plans into compliance.  In her over 25 years of experience in IRS management positions, she served on the Design Team charged with re-engineering the IRS, where she was instrumental in the creation of the Customer Education and Outreach function in the Tax Exempt and Government Entities Division, restructuring and expanding the Employee Plan Team Audit large case program, and serving as Acting Director Employee Plans Rulings and Agreements and as the EP Area Manager, Great Lakes.

Sanford V. Teplitzky is a Principal in Ober|Kaler’s Health Law Group and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. His clients, typically large health care companies and delivery networks, rely on his experience and deep knowledge of the health care industry to identify and resolve fraud and abuse issues, and to represent them in federal and state investigations.

Jeane A. Thomas is Co-Chair of Crowell & Moring LLP's E-Discovery & Information Management Group and a Partner in the firm's Antitrust Group. In her role with the E-Discovery practice, Ms. Thomas has managed many types of E-Discovery matters in both government investigations and civil litigation. She regularly counsels clients on Information Governance, including the development and application of effective information management policies, legal hold practices, and E-Discovery response plans.

John R. Thomas is Professor of Law at the Georgetown University Law Center in Washington, D.C., where he joined the faculty in 2002. He has served as a Visiting Scholar at the Congressional Research Service and he was named the inaugural Thomas Alva Edison Visiting Scholar at the U.S. Patent and Trademark Office in 2011.

Bradley Thompson is a Member at Epstein Becker & Green, P.C. and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. He counsels medical device, drug, and combination product companies on a wide range of FDA regulatory, reimbursement, and clinical trial issues. Mr. Thompson regularly defends companies receiving FDA warning letters, on a wide gamut of subjects including good manufacturing practice compliance and off label promotion.

Charles D. Tobin is a Partner in the Washington, D.C., office of Holland & Knight LLP and chairs the firm's National Media Practice Team. A former journalist, Mr. Tobin has appeared in state and federal courts around the country, representing the media in libel and privacy lawsuits at both the trial and appellate levels.

Daron L. Tooch is head of the litigation department of Hooper, Lundy & Bookman and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. Mr. Tooch specializes in managed care litigation, and has recovered hundreds of millions of dollars for healthcare providers in civil actions and arbitrations against health plans.

Albert Tramposch is Deputy Executive Director for International and Regulatory Affairs at AIPLA, where he serves as a senior advisor to the Executive Director, and has principal day-to-day responsibility for all international intellectual property and regulatory issues of concern to the Association.

Joel H. Trotter is the global Co-chair of the Latham & Wakins' Public Company Representation Practice Group and the Deputy Chair of the Corporate Department in the Washington, D.C., office. He also serves as Co-chair of the firm's national office, a central resource for clients and Latham attorneys facing complex issues arising under the U.S. securities laws.

Erin Turley is a Partner in the Dallas office of K&L Gates where she is a member of the firm’s Benefits, ESOPs and Executive Compensation Group. Ms. Turley’s practice focuses on ERISA compliance with respect to employee benefits, including qualified and nonqualified plans, executive and deferred compensation, welfare benefit plans and regulatory compliance. She advises employers in the design, implementation, and administration of tax-qualified and nonqualified retirement plans, and represents clients before the Internal Revenue Service and the Department of Labor in audit and correction matters. Ms. Turley has advised employers with respect to issues raised in connection with corporate mergers, acquisitions and divestitures as they relate to the various benefit plans maintained by the affected corporate entity or entities.

Jill Uhl is the senior director of intellectual property at Johns Hopkins University Technology Ventures and serves as a member of the advisory board of Bloomberg BNA's Life Sciences Law & Industry Report. Ms. Uhl is the former vice president of legal affairs and corporate development at Arizona Technology Enterprises, was of counsel at Nixon Peabody and was a U.S. patent counsel at Serono Research Institute.

Jill Uhl is Director, Intellectual Property at The Johns Hopkins Technology Transfer Office, which is the university's intellectual property administration center, serving Johns Hopkins researchers and inventors as a licensing, patent, and technology commercialization office and acting as an active liaison to parties interested in leveraging JHU research or materials for academic or corporate endeavors.

Philip Urofsky is a Partner in Shearman & Sterling LLP's Litigation Group and a former former federal prosecutor with extensive experience investigating and prosecuting criminal and civil violations of the Foreign Corrupt Practices Act (FCPA), the money laundering and mail and wire fraud statutes, and economic sanctions laws and regulations.

Eduardo Ustaran is a Partner in Hogan Lovells' global Privacy and Information Management practice and an internationally recognised expert in privacy and data protection law. He is a dually qualified English Solicitor and Spanish Abogado based in London and advises some of the world's leading companies on the adoption of global privacy strategies and is closely involved in the development of the new E.U. data protection framework.

Debra Valentine was appointed Group Executive, Legal, External & Regulatory Affairs in 2009 having joined Rio Tinto as global head of Legal in 2008. She previously worked at United Technologies Corporation as Vice President, Deputy General Counsel and Corporate Secretary. Before then, she was a partner with O'Melveny & Myers, in Washington, D.C. Ms. Valentine served as general counsel at the U.S. Federal Trade Commission from 1997 to 2001.

Carrie Valiant is a Member of Epstein Becker & Green, P.C. in the Health Care and Life Sciences practice in the Washington, D.C., office, co-chairs the firm's health care fraud group, and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. She is also chair of the firm's Diversity and Professional Development Committee. Ms. Valiant has 25 years of experience concentrating in health care fraud and abuse and government health care program payment matters, including defending clients undergoing civil and criminal investigation for health care fraud by the U.S. Department of Justice, the U.S. Department of Health and Human Services Office of the Inspector General, and other state and federal governmental authorities.

Thomas N. Vanderford, Jr. is the Associate General Counsel and Executive Director of Litigation for Hyundai Motor America, located in Costa Mesa, California. He has practiced law at Hyundai Motor America since 1992. Mr. Vanderford oversees Hyundai's litigation throughout the U.S. and its territories. He has participated in trials and appeals across the U.S. and in Canada.

Thomas P. Vartanian is a corporate counselor, regulatory advisor, litigator, author and deal maker who has represented a wide variety of financial services clients before federal financial agencies and the Department of Justice on matters ranging from mergers and acquisitions, non-control investments, FDIC acquisitions, restructurings, enforcement, fair lending, administrative challenges, GSEs and D&O liability.

Mike Vernick is a Partner in the Washington, D.C. office of Hogan Lovells where he practices principally in the areas of government contracts and federally sponsored research, and serves as a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report. Mr. Vernick works with numerous colleges, universities, and other nonprofit institutions to help them respond to government audits, U.S. Justice Department of Justice False Claims Act investigations, and qui tam suits alleging the misuse of federal research funds.

Barbara Wall is Vice President and Senior Associate General Counsel of Gannett Co., Inc. She was named to her current position in April 2009. For the last 27 years Ms. Wall has represented Gannett’s interests on a variety of issues, including the First Amendment. During her tenure, over 1,000 subpoenas seeking the testimony of Gannett reporters have been quashed, over 500 libel suits have been successfully defended, and Gannett properties have filed hundreds of access suits forcing the disclosure of everything from records revealing the deaths of children in state custody, to secret settlements by government agencies, to sexual abuse by priests.

Howard T. Wall III is the Executive Vice President and Chief Administrative Officer, General Counsel and Secretary of RegionalCare Hospital Partners and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. Mr. Wall has nearly 28 years of healthcare law experience in both the public and private sectors. Mr. Wall was previously the General Counsel and Senior Vice President of Capella Healthcare and spent eight years as Senior Vice President, General Counsel, Secretary and Corporate Governance Officer of Province Healthcare Company.

Jim Wallace, a founding Partner of Wiley Rein LLP, has more than 30 years of experience litigating patents in the fields of communications satellites, data transmission, network interface devices, Internet business methods, pharmaceuticals, biotechnology, and semiconductors.

Spencer Weber Waller is a Professor at Loyola University Chicago School of Law and Faculty Director of the Institute for Consumer Antitrust Studies. Professor Waller was a full-time faculty member at Brooklyn Law School for 10 years until joining Loyola in 2000.

Herbert C. Wamsley is the Executive Director of the Intellectual Property Owners Association, where he has worked since 1983. He previously held several positions, including Chief of Staff, at the U.S. Patent and Trademark Office.

Robert E. Wanerman is a Member of Epstein Becker & Green, P.C's Health Care and Life Sciences practice, in the Washington, D.C., office and serves as a member of the advisory board of Bloomberg BNA's Medical Research Law & Policy Report. His practice concentrates on regulatory, reimbursement, and compliance matters affecting health care manufacturers, service providers, and investors in health care organizations.

John R. Washlick is a shareholder of Buchanan Ingersoll & Rooney PC and resident in the firm’s Philadelphia, PA and Princeton, NJ offices and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. He is a member of the firm’s Healthcare Practice Group and co-chair of the firm’s Healthcare Industry Group. Mr. Washlick has significant experience in tax, corporate and business law. His practice includes advising clients on a variety of healthcare matters, including related state and federal regulatory issues relating to structuring and implementing mergers, acquisitions and affiliations; equity and contractual joint ventures; hospital/physician integration and incentive compensation arrangements; ambulatory surgical centers, urgent care centers and other clinical delivery models; clinical co-management arrangements; accountable care organizations and patient centered medical homes.

J. Mark Waxman is a Partner and health care lawyer with Foley & Lardner LLP, where he is former chair of the Health Care Industry Team, and a member of the Government Enforcement, Compliance & White Collar Defense and Antitrust Practices, and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. Mr. Waxman was formerly a partner in the Los Angeles and Washington, D.C., offices of Foley.

Allen Waxman is Senior Vice President, General Counsel and Corporate Secretary for Eisai Inc. where he leads the company's legal, government affairs and product safety functions, and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. He was previously a Partner and Chair of Kaye Scholer LLP's Life Sciences Group, General Counsel of Pfizer and a Partner at Williams & Connolly LLP.

Stephanie A. Webster is a Partner in the Washington, D.C., office of Akin Gump Strauss Hauer & Feld LLP where her practice focuses on the area of Medicare and Medicaid reimbursement, and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. She represents hospitals in administrative and federal court litigation and counsels them regarding payment and compliance.

Richard Wegener is Counsel in the Minneapolis office of Faegre Baker Daniels, where he counsels clients on antitrust and trade regulation and FDA and regulatory law matters, particularly in the food and agriculture industry. He also provides regulatory and administrative law counseling and litigation before federal and state agencies, including the U.S. Food and Drug Administration (FDA), the U.S. Department of Agriculture (USDA), the Federal Trade Commission (FTC) and the Consumer Product Safety Commission (CPSC).

Gadi Weinreich is a Partner in Dentons' Washington, D.C., office and co-heads the firm's global Life Sciences and Health Care sector team, and serves as a member of the advisory boards of Bloomberg BNA's Health Care Fraud Report and Health Care Program Compliance Guide. Mr. Weinreich defends clients in U.S. False Claims Act (including qui tam/whistleblower) actions, as well as other enforcement actions involving alleged violations of federal and state health care laws and regulations.

Charles D. Weller, currently with the Law Offices of Charles D. Weller in Cleveland, has 40 years legal experience practicing antitrust, health care and health benefit law in private law firms (Jones Day; Baker & Hostetler) and the Antitrust Division of the Ohio Attorney General's Office. Mr. Weller has represented General Motors, EDS, Newport News Shipbuilding, Eaton Corporation, Cleveland Clinic, University Hospitals of Cleveland, Case Western Reserve Medical School, Medical Mutual of Ohio, and the American Medical Association.

Kristian Werling is a Partner in the Chicago office of McDermott Will & Emery LLP and serves as a member of the advisory board of Bloomberg BNA's Medical Devices Law & Industry Report. Mr. Werling focuses his practice on representing medical technology manufacturers, biotechs, diagnostics manufacturers and distributors of medical products in transactional and regulatory matters. He has extensive experience in representing private equity and venture capital investors. In this capacity, he works with cross-disciplinary teams to conduct legal due diligence and execute acquisitions, add-on acquisitions and divestitures, and provides ongoing legal services to portfolio companies.

Bill West is an experienced trial lawyer and Senior Counsel in Pillsbury Winthrop Shaw Pittman LLP's Intellectual Property practice and is located in the firm's Washington, D.C., office. Mr. West's practice focuses on intellectual property litigation that has included high stakes, bet the company cases. A registered patent attorney, Mr. West has particular strengths in conducting and advising on complex patent trials and appeals, as well as related antitrust and unfair competition litigation.

Jody R. Westby is the CEO and Founder of Global Cyber Risk LLC, where she provides consulting and legal services to public and private sector clients around the world in the areas of privacy, security, cybercrime, e-discovery, and outsourcing risk management. Ms. Westby currently serves as Adjunct Distinguished Fellow to Carnegie Mellon CyLab and co-authored its 2008 Governance of Enterprise Security Survey and Governing for Enterprise Security Implementation Guide.

Joel White is the Executive Director of the Health IT Now Coalition, a diverse group of organizations representing patients, health providers, health insurers, agents, brokers, employers and unions that have come together to help integrate information technology into health care, and serves as a member of the advisory board of Bloomberg BNA's Health IT Law & Industry Report.

Joseph E. B. White is a Partner in the law firm of Nolan Auerbach & White, P.A. and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. Mr. White is a leading qui tam advocate, having represented whistle-blowers before the U.S. Congress and in qui tam actions across the country. He has also testified in front of the United States Congress and nearly a dozen state legislative bodies.

G. Marc Whitehead is Owner of Global Liability Management, where he practices law and consults on environmental, human health, and toxic tort issues. Mr. Whitehead teaches and specializes in communication and persuasion in a legal context for expert witnesses, lawyers and others connected with the litigation or regulatory processes. Mr. Whitehead is also an experienced arbitrator, including significant experience in securities and commercial cases.

Wells Wilkinson is Project Director for Prescription Access Litigation at Community Catalyst and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. He previously worked for the Social Security Administration, preparing disability cases for agency hearings, while also starting a small private practice focusing on consumer protection.

Gabrielle Williamson is a Partner in the Brussels and Düsseldorf offices of Luther. She has practiced law for 30 years in the U.S. and Europe - the last 20 in Düsseldorf and Brussels. Before this she worked in Washington, D.C., in private practice and as Assistant General Counsel of the U.S. Chemical Manufacturers Association.

James A. Wilson is a Partner in the Vorys Columbus office and a member of the litigation practice group. Mr. Wilson represents clients in a wide variety of antitrust matters, including criminal investigations and trials, civil actions and Hart-Scott-Rodino investigations. He has represented more than a dozen individuals in antitrust criminal investigations during the last five years, including a number of foreign nationals. He has experience trying both criminal and civil antitrust matters, as well as other complex business litigation, including class actions.

Thomas M. Wilson III, Counsel with Tydings & Rosenberg LLP in Baltimore, has been a prominent antitrust attorney for more that 35 years. In 1974, he established the State of Maryland’s Antitrust Division, which he headed for five years as Assistant Attorney General and Chief. In 1979 he joined Tydings & Rosenberg LLP, where he has developed and chairs the firm's antitrust practice. Mr. Wilson primarily defends corporations in antitrust, franchising, unfair competition, business tort, trade regulation, and constitutional law litigation.

Kenneth B. Winer is a Partner and litigation lawyer with Foley & Lardner LLP. Mr. Winer represents clients in investigations by the Securities and Exchange Commission (SEC), self-regulatory organizations, the Department of Justice and other government agencies, and in securities litigation and internal investigations. In addition, Mr. Winer advises clients regarding compliance with the Foreign Corrupt Practice Act and conducts internal investigations. He is a member of the firm's Securities Enforcement & Litigation and Transactional & Securities Practices.

Kenneth T. Wise is a Principal Emeritus in the Brattle Group. Dr. Wise specializes in the application of economics and statistical techniques to analyze damages issues in connection with business and environmental litigation. He has developed expert economic analyses in connection with toxic tort, breach of contract, antitrust, and product liability matters.

John Witherspoon, now retired from private practice, practiced patent law in Washington, D.C., and is Professor Emeritus at George Mason University where he directed the Intellectual Property Program.

Patricia H. Wittie is a Partner with Wittie, Letsche & Waldo, where she specializes in Federal and State procurement law and related administrative matters. Her 35 years of experience include litigation of bid protests and claims worth hundreds of millions of dollars in Federal and State courts as well as before the Government Accountability Office and various Boards of Contract Appeals. She counsels her clients - which include Fortune 100 companies, small and mid-cap businesses, and individuals - in matters pertaining to source selection, contract formation and performance, multiple award, General Services Administration Schedule and IDIQ contracting issues, cost accounting, rights in intellectual property, subcontracting and teaming agreements, security clearances, regulatory compliance and dispute avoidance techniques.

Nicholas Wittner is Counsel at Dykema where he provides legal advice on product safety and liability prevention programs, product regulation, product liability, class action litigation and international civil litigation. He also presents seminars on product liability law and procedures to help reduce legal risk and helping develop state of the art case and cost management processes and systems for clients.

Howard Wizig, president and CEO of both Vivius Inc. and its primary subsidiary, Recovery Data Connect LLC, is an acknowledged national leader in the rapidly changing health care financing environment, including the development of consumer-driven and managed care products and programs, and the formation of companies that offer them. Mr. Wizig has over 25 years of experience in the field of health care financing and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report.

Jacqueline Wolff is a Partner and Co-Chair for Corporate Investigations & White Collar Defense
Litigation at Manatt, Phelps & Phillips, LLP and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. She has spent over 20 years defending companies and individuals accused of a wide array of white collar crimes. A former Chief of the Environmental Crimes Unit and Assistant U.S. Attorney for the District of New Jersey, Ms. Wolff focuses her practice on violations of the Foreign Corrupt Practices Act (FCPA), healthcare fraud, securities fraud, Food, Drug & Cosmetic Act (FDCA) violations, tax crimes, corporate immigration crimes and other regulatory-based violations.

Sam Woodall is a Partner in Sullivan & Cromwell LLP's General Practice Group. He represents a variety of clients before the U.S. Congress, as well as executive branch and federal financial regulatory agencies. Mr. Woodall has participated, on behalf of the Firm's clients, in the Congressional deliberations leading to enactment of the Gramm-Leach-Bliley Act (1999), the USA Patriot Act (2001), the Sarbanes-Oxley Act (2002), the Financial Services Regulatory Relief Act (2006) and, most recently, the Dodd-Frank Wall Street Reform and Consumer Protection Act (2010), as well as the regulatory implementation of these statutes. He has also advised the Firm's clients in connection with federal legislation and regulation governing student lending, industrial banks, private equity firms, and Government Sponsored Enterprises.

H. Catherine Woody is Vice President for media and industry relations at the Conference of State Bank Supervisors. Ms. Woody previously served as the Conference's director of communications and director of publications relations for policy and as a legislative analyst at the U.S. Department of Homeland Security.

Brian K. Wright practices in Shutts & Bowen's Corporate and Health Care Practice Groups based in the firm's Tampa office and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. Mr. Wright is a Florida Board Certified Specialist in Health Law.

Sarah Wright is a Partner at October Three Consulting LLC in New York where she is a member the firm’s Flexible Deferral Plan practice. Ms. Wright serves clients in the areas of actuarial consulting related to qualified and nonqualified plans, plan design, benefits issues in mergers and acquisitions and coverage and nondiscrimination testing.

Barbara Wrubel is a retired Partner at Skadden, Arps, Slate, Meagher & Flom LLP. Ms. Wrubel primarily represented defendants in products liability and mass torts litigation, serving as coordinating counsel in large, complex cases. Her clients have included manufacturers of various pharmaceutical, industrial, chemical and consumer products.

Miriam Wugmeister's advises organizations on the planning and execution of complex global compliance efforts, assists in the negotiation of strategic deals, and defends regulatory and litigation matters relating to privacy and data security in the U.S. and internationally. She regularly provides advice on data security breach issues; the global collection, use, sharing of employee, customer, vendor, and consumer personal information; ediscovery and monitoring conflicts; social media issues; and cloud computing deals, as well as on developing data security policies and procedures and cybersecurity preparedness and response plans.

Ken Yale is Vice President Clinical Solutions at ActiveHealth Management (AHM) and serves as a member of the advisory board of Bloomberg BNA's Health Insurance Report. Dr. Yale was previously Chief Executive Officer of the innovation business unit at a major, national health plan, where he had strategic and operational responsibility for innovations in Medicare and Medicaid chronic care and other care management services.

Deborah H. Yellin is Counsel in Crowell & Moring's Washington, D.C., office and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. She focuses her practice on intellectual property portfolio management, patent procurement, counseling and litigation. Ms. Yellin's practice has involved assisting both large and small clients with the creation and implementation of intellectual property protection and procurement programs. She works with clients to develop creative solutions to managing intellectual property assets and counsels clients regarding domestic and foreign patent filings and provides world-wide patent portfolio oversight.

Donna Lee Yesner is a Partner in Morgan Lewis's FDA Practice and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. Ms. Yesner focuses her practice on public healthcare and government contracts, with an emphasis on pharmaceutical and medical device public sector business. Ms. Yesner has experience in the acquisition and reimbursement of federal healthcare supplies and services, particularly involving the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services; compliance with laws and regulations governing Medicaid, Medicare, Tricare, and the 340B drug discount programs; debarment and public policy affecting these programs; and healthcare fraud.

Kristin Yohannan, a Special Counsel in the Washington, D.C., office of Cadwalader, Wickersham & Taft LLP, and serves as a member of the advisory board of Bloomberg BNA's Pharmaceutical Law & Industry Report. She is an experienced trial attorney and appellate advocate, who counsels clients in cases before the federal district courts and the U.S. International Trade Commission (ITC). Her experience covers patent, antitrust, and breach of contract cases in the pharmaceutical, chemical, biotechnological, semiconductor, liquid crystal display, software, electronic systems, mechanical systems, and metallurgical sectors. With an educational background in biology, chemistry, and molecular genetics, Ms. Yohannan combines technical knowledge with years of experience as a trial attorney litigating patent, trademark, and trade dress cases.

Steve Zansberg, a Partner in Levine Sullivan Koch & Schulz, LLP's Denver office, has represented media companies, online publishers, and individuals in defending claims based upon content, fighting subpoenas, and seeking access to government information and proceedings for nearly two decades. Mr. Zansberg represented the national news media in connection with coverage of the Aurora theater shooting case, the Oklahoma City bombing trials, and the Kobe Bryant rape prosecution, and he secured access to public records related to the murder of JonBenet Ramsey and the shooting at Columbine High School. Mr. Zansberg also litigates copyright and trademark matters.

Phil Zarone is a Partner with the law firm of Horty, Springer & Mattern, P.C. in Pittsburgh and serves as a member of the advisory board of Bloomberg BNA's Health Law Reporter. Mr. Zarone works extensively with hospitals and physician leaders on compliance with federal and state regulatory requirements and medical staff matters.

Barbara L. Zelner is Executive Director of the National Association of Medicaid Fraud Control Units (NAMFCU) and serves as a member of the advisory board of Bloomberg BNA's Health Care Fraud Report. She has represented the 50 state Medicaid Fraud Control Units since 1983. NAMFCU provides information about Medicaid fraud and resident abuse investigations and prosecutions and provides technical assistance and training to its member Units. Prior to joining NAMFCU, Ms. Zelner was Legal Editor of Aspen Systems Corporation’s Hospital Law Manual.

Eric Zimmerman is a Partner in the Washington, D.C., office of McDermott Will & Emery LLP and serves as a member of the advisory board of Bloomberg BNA's Medicare Report. Mr. Zimmerman is a recognized Medicare law and policy authority and registered lobbyist who represents clients before Congress and administrative agencies, and helps clients navigate federal legislative and regulatory processes related to Medicare coverage, coding, reimbursement and compliance. Mr. Zimmerman primarily counsels and represents hospitals and health systems, ambulatory surgery centers, clinical laboratories, pharmaceutical, biotechnology and device manufacturers and suppliers, medical trade associations and professional societies.